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Injuries to the brain belong to one of the leading causes of death worldwide, affecting a 
great number of people in developed countries and thus imposing a considerable 
economic burden on the society (Rajsic et al., 2019). Insufficient blood flow during 
cerebral ischemia, with resultant cell death, adds to neurological disorders that torment 
human race (Verma et al., 2018; Tannenberg et al., 2004). 
Therefore, regenerative medicine looks up to new strategies for treatment or 
replacement of diminishing numbers of neural cells. A good example of such strategies 
could be the potential utilization of precursor cells, naturally residing in the brain (Groves 
et al., 2019; Ravanelli et al., 2018), and capable of differentiating to other cell types 
(Vancamp et al., 2019; Honsa et al., 2016; Kriska et al., 2016). Additionally, the proteins 
of the Wnt (Wingless/Integrated) and Shh (Sonic hedgehog) families regulate a number of 
cellular processes during embryonic development (Borday et al., 2018; Carballo et al., 
2018), but they also play important roles in the cell cycle progression, differentiation of 
precursors, establishment of neurogenic niches, and programmed cell death after birth 
(Marinaro et al., 2012; Zhang et al., 1998). 
The goal of the thesis was to analyze the role of cellular signaling pathways in 
gliogenesis and neurogenesis in the postnatal central nervous system. These signaling 
pathways may refine and boost the differentiation potential of precursor cells during 
ischemia and subsequent reperfusion, and thus enhance the regeneration of affected 
nervous tissue. 
 
1.1 Ischemic brain injury 
The chapters about ischemia have been already published (Belov Kirdajova et al., 2020), 
and the text is adapted to the nature of this thesis. 
Stroke, or cerebral infarction, is one of the most common causes of mortality 
worldwide, as it is responsible for approximately six million deaths every year, with the 
lifetime risk for stroke estimated at around 9% (Woodruff et al., 2011; Seshadri et al., 
2006), and ~15% mortality (Marini et al., 1999). Aging, genetic polymorphisms, and 
presentations of unhealthy lifestyle, such as hypertension, obesity, smoking, or shift work, 
are all among risk factors (Boehme et al., 2017; Brown et al., 2009). It has been reported 
that age-specific stroke rates are higher in men; however, women suffer from higher total 
number of stroke events due to their longer life expectancy and overall higher incidence 
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at greater age. Additionally, it has been proven that women have worse post-stroke 
outcomes than their male counterparts (Etherton et al., 2017; Reeves et al., 2008). 
Characteristic symptoms of stroke range from mild to severe and may encompass 
dizziness, impairments in vision or body movement, difficulty speaking, and 
unconsciousness (Nadarajan et al., 2014). 
Ischemic stroke due to a blocked artery comprises more than 85% of all stroke 
incidents, while cerebral hemorrhage accounts for the rest (Woodruff et al., 2011). The 
most frequently affected vessel of the brain is the middle cerebral artery and its occlusion 
causes poor blood flow, followed by glucose and oxygen deprivation resulting in cell 
death, in a large lateral surface area of the brain (Puig et al., 2018) (Figure 1). 
 
 
Figure 1. Ischemic stroke. Local cerebral ischemia occurs when the blood flow to the brain is 
restricted because of a blood clot, typically thrombus or embolus. The most frequently occluded 
artery is the middle cerebral artery, causing ischemic stroke, with symptoms such as sensory loss, 
ataxia, or speech impairments (adapted from http://brainmind.com/Stroke.html). 
 
An apparent fall in the number of cells in the brain parenchyma is caused by its 
high demand of aerobic metabolism. The adult human brain represents a relatively small 
proportion of the body weight (only ~2%); however, it accounts for more than 20% of the 
whole-body energy budget (Doyle et al., 2008). Physiological cerebral blood flow (CBF) 
is at ~50 ml/100 g/minute and ischemic injury occurs once the CBF drops to less than 
40% of its normal values (Baron, 2001; Heiss et al., 2004). As the CBF gets below 10 
ml/100 g/minute, rapid irreversible damage to neurons ensues (Matsumoto et al., 1990). 
These irreversible changes involve a decrease in oxidative phosphorylation, adenosine 
triphosphate (ATP) depletion, and homeostatic imbalance of intracellular and 
23 
extracellular molecules (Figure 2), which results in excitotoxicity, oxidative stress, 




Based on the duration of ischemia, neuronal cells die first, followed by glial cells 
– oligodendrocytes, astrocytes, and polydendrocytes (Caltana et al., 2009; Doyle et al., 
2008; White et al., 2000). Ischemic brain injury leads to motoric, sensoric, and cognitive 
dysfunctions and it is accompanied by elevated neurogenesis in the hippocampus and the 
subventricular zone (SVZ) of the lateral ventricles (LV). Glial cells also react to ischemic 
injury. Astrocytes and polydendrocytes undergo reactive gliosis, which is characterized 
by higher proliferation rate and hypertrophy, followed by glial scar formation, which 
impedes regenerative axonal growth in the central nervous system (CNS), but also 
prevents detrimental factors from entering the compromised area (Anderova et al., 2011; 
Pivonkova et al., 2010; Komitova et al., 2006). Moreover, microglial cells activate and 
transform into phagocytic cytotoxic cells. Oligodendrocytes undergo degenerative 
Figure 2. Ischemic cascade. 
Compromised blood flow to the brain 
causes a decrease in the adenosine 
triphosphate (ATP) production. Low 
concentration of ATP in turn negatively 





) pump, which leads to 
depolarization due to ionic imbalance in 
the intra- and extracellular space. As a 
result, high concentration of calcium 
(Ca
2+
) triggers glutamate release and 
glutamate activates calcium-transmitting 
channels, forming thus a vicious circle of 
excitotoxicity. This results in the 
activation of downstream Ca
2+
-dependent 
enzymes that are involved in processes 
such as inflammation and apoptosis 
(adapted from Rama and García (2016)). 
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changes that result in the degradation of the myelin sheath covering axons (Bu et al., 
2004). 
Immediate restoration of blood flow with clot-dissolving (thrombolytic) drugs 
remains the most utilized approach trying to limit the extent of brain injury after stroke 
(Wardlaw et al., 2014). Nevertheless, recent studies attempt to take advantage of cell 
therapy, in which stem cells from various sources are used to replace damaged or dead 
cells in the neural tissue (Ruzicka et al., 2017). It is worth mentioning that the study of 
multipotent precursor cells, namely neural stem/progenitor cells (NS/PCs) and neuron-
glial antigen 2 (NG2)-positive glia (also called polydendrocytes), that give rise to other 
cell types in the mature CNS, may provide new data on the role of these cells in the 
regeneration after ischemic injury of nervous tissue. 
 
1.1.1 Focal cerebral ischemia 
Based on the extent and localization, ischemic injury can be divided into two subtypes: 
focal and global ischemia. While global cerebral ischemia (GCI) stems from an overall 
decrease in blood flow in the whole parenchyma of the brain due to transient cardiac 
arrest, focal cerebral ischemia (FCI) is a result of an occlusion of specific arteries that 
supply the brain with oxygen and glucose (Yao et al., 2018). 
As the name implies, FCI, or stroke, is confined to a locally defined region of the 
brain. This type of ischemia is usually a result of thrombosis (caused by a blood clot) or 
embolism (caused by a dislodged and relocated thrombus) (VanGilder et al., 2012; Figure 
1). Focal cerebral ischemia may be either transient (CBF reestablished) or permanent; 
nevertheless, both types cause only a local decrease in the CBF. In the vicinity of the 
occluded vessel, two distinct zones can be distinguished: a zone of severe ischemia – the 
infarction core, and a zone of moderate ischemia – the penumbra (Rossi et al., 2007). 
While at the onset of ischemia, the size of both zones is almost equivalent (Ginsberg, 
2003), the ischemic core spreads at the expense of penumbra as the ischemic injury 
progresses (Zhao et al., 1997). 
On the one hand, the infarction core is characterized by insufficient amounts of 
ATP, pathological concentrations of ions, increased concentrations of glutamate, and 
tissue acidosis – all features typical of excitotoxicity (Figures 3 and 4). Cell death already 




Figure 3. Focal cerebral ischemia. There are two distinguishable zones in the close vicinity of 
an occluded artery – infarction core and penumbra. The infarction core is characterized by high 
concentrations of extracellular potassium (K
+
) and glutamate (Glu), and intracellular calcium 
(Ca
2+
) as well as low values of extracellular sodium concentration (Na
+
), stored adenosine 
triphosphate (ATP), or pH. The farther from the ischemic core, the more physiological values of 
above-mention variables are observed, while the penumbra serves as a transition zone between the 
ischemic core, with necrotic tissue, and intact, healthy tissue (author's own scheme; drawn 
according to information from Rossi et al. (2007)). 
 
 
Figure 4. Core of focal cerebral ischemia. A 
scheme depicting events that occur in the 
ischemic core. Similar actions may be 
observed also during global ischemia. A 
decrease in the adenosine triphosphate (ATP) 





) ATPase, which changes the 
transmembrane ion gradients. This causes 
depolarization and glutamate (Glu) release 
into the extracellular space. Ischemic injury as 
well results in extracellular acidification. 
Abbreviations: Ca
2+
 – calcium; Vm – 
membrane potential (Rossi et al., 2007). 
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On the other hand, there is a residual blood flow in the penumbra because of the 
presence of collateral arteries (Harukuni and Bhardwaj, 2006; Jung et al., 2017), with 
decreased but still sufficient ATP concentrations, only marginally shifted ionic 
concentrations and recurrent episodes of cortical spreading depression also called peri-
infarct depolarization (Hinzman et al., 2015; Oliveira-Ferreira et al., 2019; Figure 3 and 




Another factor that may add to the spared nervous tissue in the penumbral region 
of focal ischemia is the presence of the circle of Willis that creates a sort of redundancy 
for collateral circulation in the brain (Figure 6). It has been reported that abnormalities in 
the circle of Willis are often present in ischemic stroke localized in the middle cerebral 
artery territory (Husson et al., 2016; Du et al., 2011). 
 
Figure 5. Penumbra of focal cerebral 
ischemia. A scheme showing events in 
the penumbral region of focal brain 
injury. A decrease in adenosine 
triphosphate (ATP) is less severe; 
nevertheless, it triggers recurrent 
transient depolarizations coupled with 
ion shifts, while glutamate (Glu) 
concentrations rise slowly but steadily. 
Upon early reperfusion, penumbral tissue 
may be spared. However, during longer-
lasting ischemia, the penumbra is 
'devoured' by the ischemic core and 
necrosis occurs also in this region. 
Abbreviations: Ca
2+





 – sodium; Vm – 
membrane potential (Rossi et al., 2007). 
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Figure 6. Anatomy of the circle of Willis. Schematic illustration of blood vessels supplying the 
rodent brain, where the posterior cerebral artery, posterior communicating artery, internal carotid 
artery, middle cerebral artery, anterior cerebral artery, and anterior communicating artery form the 
circle of Willis. This structure is named after Thomas Willis, who believed that it was 
a compensatory mechanism for a blocked brain vessel. The middle cerebral artery is prone to the 
occlusion, and together with variations in the circle of Willis, focal ischemia may occur to various 
extents (Vrselja et al., 2014). 
 
The penumbra also draws attention of regenerative medicine, since it is believed 
that normal functions might be restored especially in this zone (Jung et al., 2017). 
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Nevertheless, residual or even newly formed viable neurons have been also detected in 
the ischemic core (Jiang et al., 2017). 
All the processes listed before take place at the site of injury – in the cerebral 
cortex; however, in our experiments on NS/PCs, we focused on a region distant from the 
cortex, specifically on the SVZ. This zone is localized around the LV in the medial region 
of the brain. It has been documented that the induction of focal ischemia has a consistent 
impact also on the physiological functions of cells residing there (Ginsberg, 2003). 
 
1.2 Postnatal neurogenesis 
The process of transition from NS/PCs to matured neurons and glial cells is called 
neurogenesis and gliogenesis, respectively. Neurogenesis occurs predominantly at 
embryonic stages of the mammalian ontogenetic development. During embryogenesis, 
neurons are produced from embryonic neural stem cells (NSCs) in the neural tube, while 
gliogenesis is suppressed and increases at the perinatal stage and continues postnatally 
(Miller and Gauthier, 2007). Over the course of neurogenesis, radial glial cells in the 
ventricular zone (VZ) act as primary NSCs and are the main source of newly formed 
neuronal cells in many CNS regions (Lui et al., 2011). Another source of neurons is a 
pool of radial-glia-derived intermediate progenitors, also termed basal progenitor cells, 
occupying the SVZ (Noctor et al., 2004; Haubensak et al., 2004). After several waves of 
symmetric and asymmetric divisions, NSCs differentiate to neurons. However, neurons 
do not form neural circuits immediately as they first migrate relatively long distances to 
the forming cortex and mature there (Rakic, 1995). 
Nerve cells are post-mitotic, which means that they do not divide, and for many 
years, a premise saying that neurogenesis ceases after birth was set. However, not all 
neurons are generated during embryogenesis, since there are precursor cells that 
proliferate in the postnatal CNS and might potentially differentiate and mature into 
functional neurons and glial cells (Gage et al., 1995; Ramasamy et al., 2013). These two 
main endogenous sources of new neurons in the mammalian brain are NS/PCs (Butti et 
al., 2019) and polydendrocytes (also named NG2 glia) (Kirdajova and Anderova, 2019; 
Tsoa et al., 2014; Belachew et al., 2003). 
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1.2.1 Neural stem/progenitor cells 
In 1960s, postnatal neurogenesis in the CNS was documented for the first time (Altman 
and Das, 1965). Under physiological conditions, adult neurogenesis takes place in two 
distinct regions of the mammalian brain – the subgranular zone (SGZ) of the dentate 
gyrus in the hippocampus, and the SVZ of the LV, which is adjacent to the striatum 
(Figure 7) (Vukovic et al., 2011; Ihrie and Alvarez-Buylla, 2008; Doetsch et al., 1999). 
These two regions are considered bona fide neurogenic zones of the adult brain, as they 
have been shown to comprise NS/PCs that possess the trait of generating distinct cell 
types in vitro as well as in vivo (Lie et al., 2005; Bizen et al., 2014). These NS/PCs also 
self-renew in vitro and in vivo indefinitely, and thus meeting the definition of “stem cells” 
(Malatesta et al., 2008). However, they proliferate at a much slower pace than during 
embryogenesis (Furutachi et al., 2013). Besides the two neurogenic regions of the adult 
CNS, there is a body of evidence that during ischemia, multiple neurogenic sites within 
the brain parenchyma are activated, lasting for more than one month after the induction of 
ischemic injury (Kokaia et al., 2006). 
 
 
Figure 7. Neurogenic niches of the mature mouse brain. The illustrations depicting sagittal 
(top) and coronal (bottom) sections of the brain. There are two distinct regions of the rodent 
brain where adult neurogenesis takes place (depicted in blue) – the subgranular zone (SGZ) of the 
dentate gyrus in the hippocampus, and the subventricular zone (SVZ) of the lateral ventricles 
(LV). The SGZ produces neurons that incorporate in the hippocampus, while the neurons derived 
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from the SVZ migrate along the so-called rostral migratory stream (RMS) to the olfactory bulb 
(OB) and mature there (adapted from Vukovic et al. (2011)). 
 
Adult NS/PCs share some common properties with astrocytes, which could be a 
reason why they were discovered just recently. Both cell types express glial fibrillary 
acidic protein (GFAP) and vimentin (Vim), are interconnected with gap junctions, and 
their membranes possess glutamate transporters. Moreover, they also resemble each other 
morphologically (Namba et al., 2005; Doetsch, 2003). Despite these similarities between 
astrocytes and stem cells, adult neurogenesis is presumably maintained by the local 
microenvironment, or niche, and the presence of specific factors and molecules is the 
most crucial difference separating NS/PCs from astrocytes (Lee et al., 2012). 
In our study, we focused on NS/PCs residing in the SVZ, of which the architecture 
is well described in mice (Figure 8). This region contains three main cell types (A-, B-, 
and C-type cells): astrocytes (B-type), being bona fide stem cells, and giving rise to 
highly proliferative transient amplifying cells (C-type) that, in turn, generate migratory 
neuroblasts (A-type). These neuroblasts eventually differentiate to mature neurons in the 
olfactory bulb (OB), where they incorporate into the existing neuronal circuit (Ihrie and 
Alvarez-Buylla, 2008; Gil-Perotin et al., 2013). 
 
 
Figure 8. Architecture of the subventricular zone (SVZ) in mice. The illustration showing 
coronal section of the brain (left) and the cellular composition of the neurogenic niche (right). 
This region is adjacent to the walls of the lateral ventricles (LV) and is composed of B-type cells, 
corresponding to bona fide astrocytic stem/progenitor cells, rapidly dividing C-type cells, derived 
from the B-type cells, and their progeny – A-type cells that represent neuroblasts migrating to the 
olfactory bulb where they differentiate to neurons. The SVZ cells contact ependymal cells (E), the 
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basal lamina (BL), and microglia (M) and are in the vicinity of blood vessels (BV) (Ihrie and 
Alvarez-Buylla, 2008). 
 
However, adult neurogenesis in humans is rather disputable, since no significant 
presence of postnatally generated neurons has been observed in many studies (Sorrells et 
al., 2018; Coletti et al., 2018). This could be due to the fact that in humans, newly 
generated neuronal precursors from the SVZ do not migrate to the olfactory bulb unlike in 
rodents (Bergmann et al., 2012). On the other hand, there is evidence of neurogenesis in 
the striatum of the postnatal human brain (Ernst et al., 2014). 
In the adult brain, a subpopulation of NS/PCs at neurogenic niches expresses 
mouse homologue of drosophila dachshund gene (mDach1) that is also expressed in the 
embryo (Machon et al., 2002). In the experimental setting, these stem cells differentiated 
under physiological conditions only to glial cell types. However, after FCI, enhanced 
neurogenesis was observed and newly-derived neuronal precursors migrated to the OB, 
where they matured (Honsa et al., 2013). When mDach1-expressing NS/PCs were 
transplanted into the lesioned brain, they also differentiated to neurons with 
characteristics similar to those found in the intact brain. This might favour this type of 
stem cells to replace lost cells in the damaged or diseased brain in regenerative therapies 
(Prajerova et al., 2010a). 
 
1.2.2 NG2 glia 
At the beginning of 1980s, the very first reference to NG2 glia was made. These cells 
were described in immunofluorescent double-labeling experiments as a cell type that has 
some properties associated with neuronal cells and some characteristics common with 
glia (Stallcup, 1981). Presumably, their name stems from this discovery, as it is an 
abbreviation of neuron-glial antigen 2. This antigen is also called chondroitin sulfate 
proteoglycan 4 and is encoded by the Cspg4 gene. Additionally, these cells can be also 
identified by the expression of platelet-derived growth factor alpha receptor (PDGFαR), 
of which ligand is responsible for their survival and proliferation (Rivers et al., 2008; 
Calver et al., 1998). 
NG2 cells enjoy various pseudonyms as they exercise many functions in the CNS. 
They are oligodendrocyte precursor cells (OPCs) because their subpopulation gives rise 
to oligodendrocytes under physiological conditions (Boshans et al., 2019; Figure 9). They 
are also termed polydendrocytes because they possess many elaborate, highly branched 
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processes (Chittajallu et al., 2004). Especially in grey matter they thus resemble 
astrocytes; however, the processes of NG2 cells are not that well-developed and bushy. 
Last but not least, they are also termed synantocytes because they often contact neurons at 
their synapses and nodes of Ranvier (Serwanski et al., 2017; Bergles et al., 2000). 
 
 
Figure 9. NG2 cells in the oligodendrocyte lineage. A scheme depicting development of 
polydendrocytes (top) with markers characterizing different developmental stages (bottom). 
There are two markers, neuron-glial antigen 2 (NG2) and platelet-derived growth factor alpha 
receptor (PDGFαR), that are expressed only in polydendrocytes and not in neural stem cells or 
oligodendrocytes. As NG2 cells differentiate to myelinating cells, the expression of specific 
proteins commences. Abbreviations: MBP – myelin basic protein; O4 – oligodendrocyte antigen 
O4; OLIG2 – oligodendrocyte transcription factor OLIG2; SOX10 – transcription factor SOX10 
(Nishiyama et al., 2009). 
 
Synantocytes also display a complex membrane current pattern composed of 
passive potassium (K
+
) conductance, with inwardly and outwardly rectifying K
+
 currents 
(Lin and Bergles, 2002). During development, NG2 cells are densely packed at 
neurogenic areas occupied by stem cells (Spassky et al., 1998). Conversely, 
polydendrocytes in the adult CNS are spread within both white and grey matter and are 
almost as numerous as astrocytes. They form 8-9% of all cells in white matter, while they 
comprise only 2-3% of all cells in grey matter (Dawson et al., 2003). Especially in grey 
matter, they populate the nervous tissue in territories, meaning that every single NG2 cell 
has its own space and 'monitors' the neighboring tissue with its processes (Nakano et al., 
2017). 
It is now well established that NG2 glia is a mature macroglial cell type in the 
adult CNS, distinct from astrocytes and oligodendrocytes. Polydendrocytes persist 
throughout the postnatal CNS and proliferate slowly. Nevertheless, they are considered 
the most proliferative glial cell type in the adult mammalian brain (Dawson et al., 2000). 
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NG2 cells that express the gene 2',3'-cyclic nucleotide 3'-phosphodiesterase 
(Cnp), also known as CNPase, were shown to differentiate also to neurons in vitro. The 
same was also confirmed in in vivo experiments, where these proliferative precursors of 
the adult CNS gave rise to functional neurons that propagated action potentials (Belachew 
et al., 2003). Moreover, postnatal NG2 cells from the SVZ migrated to the OB and 
differentiated to interneurons or oligodendrocytes. On the other hand, polydendrocytes 
from the cortex differentiated to oligodendrocytes or astrocytes. This diverse 
differentiation potential of NG2 cells from various regions of the postnatal brain implies a 
region-specific variance within this cell type (Aguirre and Gallo, 2004), which has also 
been confirmed by the finding that grey and white matter NG2 cells show distinct 
membrane properties (Chittajallu et al., 2004). It has been demonstrated that early 
postnatal NG2 cells from the SVZ show characteristics similar to those of transient 
amplifying multipotent cells of C-type (Aguirre et al., 2004), while another study claimed 
that NG2 cells definitely represent a cell population that is distinct from NS/PCs in the 
postnatal SVZ (Komitova et al., 2009). Moreover, similarly to the moot point in NS/PCs, 
there is also a strong disagreement about the neurogenic potential of NG2 cells (Kang et 
al., 2010). 
Although NG2 cells are known to provide the CNS with oligodendrocytes during 
development and normal functioning of the mature CNS, or with remyelinating cells in 
demyelinated lesions, the situation is completely different after ischemia (Valny et al., 
2017). A proportion of the resident NG2-expressing cell population in the vicinity of the 
lesion promptly responds to ischemic injury, which includes migration towards the site of 
injury, cell proliferation and reactive gliosis (Bonfanti et al., 2017; Tanaka et al., 2001). 
The alteration in the differentiation potential of NG2 cells induced by CNS injury is also 
a subject for discussion. Recent fate-mapping experiments showed that NG2 glia acquire 
a multipotent phenotype after the occlusion of the middle cerebral artery. These 
precursors differentiated to reactive astrocytes (Valny et al., 2018; Honsa et al., 2016; 
Honsa et al., 2012). Differentiation to this cell type may promote the survival of spared 
neurons as GFAP-positive reactive astrocytes contribute to the formation of glial scar and 
thus prevent detrimental substances from entering the affected tissue. Nevertheless, glial 
scar can act as a double-edged weapon, since in later stages of ischemic injury, it inhibits 
neurite outgrowth and CNS regeneration (Pekny et al., 2014). However, despite the 
findings that the NG2 molecule inhibits the growth of axons, some studies indicated that 
NG2 cells provide an adhesive substrate and facilitate axonal growth (Yang et al., 2006). 
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Additionally, there is some evidence that NG2 glial cells isolated from adult rodents are 
progenitors of newly derived doublecortin (DCX)-positive neuronal cells (Honsa et al., 
2012). Neuronal fate of polydendrocytes after CNS injury had been already challenged. 
However, the experiments were performed in a model of amyotrophic lateral sclerosis 
rather than in a model of FCI (Kang et al., 2010). And since the fact that polydendrocytes 
react differently to various types of CNS injuries is well-accepted, the results from the 
above-mentioned publications do not contradict each other. For example, after a stab 
wound injury, only a small subpopulation of reactive astrocytes was generated from NG2 
glia (Komitova et al., 2011), which was not the case in the ischemic brain (Honsa et al., 
2012). 
The reported neurogenic potential of NG2 cells after ischemia or in other CNS 
pathologies might increase the recuperation of the damaged tissue and thus better the 
overall outcome. 
 
1.3 Cellular signaling pathways 
Neurogenesis, hand in hand with gliogenesis, largely depends on molecular and genetic 
inputs such as growth factors and cellular signaling pathways, but these processes are also 
modulated during pathological states (Lamus et al., 2020; O'Keeffe et al., 2009). 
In our study, we focused on two highly influential signaling cascades that 
modulate the fate of cells from the embryo, throughout the life of an organism until its 
demise. These two cellular pathways are called the Wnt and the Shh signaling pathway. 
Their role in the development of the brain has been well established, since both of them 
were identified as survival factors for embryonic NS/PCs (Kalani et al., 2008; Komada et 
al., 2008). Nevertheless, recent research riveted its attention more on the function of these 
morphogens in neurogenesis and in the modulation of progenitor cells properties after 
birth (Lie et al., 2005; Lai et al., 2003). 
 
1.3.1 Wnt signaling pathway 
Neural progenitors are strongly influenced by their microenvironment. Among many 
transcription factors, growth factors and small molecules affecting the regulation of cell 
precursors, it is Wnt signaling that steps into the limelight (Bowman et al., 2013; Bonnert 
et al., 2006). 
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The Wnt ligands belong to a large group of secreted cysteine-rich glycosylated 
proteins that are involved in many cellular processes, such as embryonic cell patterning, 
cell proliferation and differentiation, synaptic plasticity, or programmed cell death 
(Chodelkova et al., 2018; Clevers et al., 2014; Lim and Nusse, 2013; Alvarez et al., 
2004). There are 19 distinct Wnt genes in the mammalian genome and three major Wnt 
signaling pathways have been identified: the canonical Wnt (β-catenin) pathway and two 
non-canonical pathways – the planar cell polarity and Wnt/calcium (Ca
2+
) pathways. 
Since in our experiments, we focused on canonical Wnt signaling, non-canonical 
pathways are only briefly described in this literary review. The planar cell polarity 
pathway orchestrates the orientation of the cells that reside in the tissue. It does not 
involve β-catenin and signals through the frizzled receptor and activates small proteins 
and kinases that regulate cytoskeleton. In the Wnt/Ca
2+
 pathway, the signal is relayed 
through phospholipase C, which triggers the Ca
2+
 release from the endoplasmic 
reticulum. Elevated intracellular Ca
2+
 concentration activates Ca
2+
-dependent enzymes 
that regulate cell adhesion and migration (van Amerongen, 2012). 
The signaling relay of the canonical Wnt (β-catenin) pathway starts at the 
cytoplasmic membrane and ends in the nucleus. In the absence of a Wnt signal, the multi-
protein destruction complex is formed in the cytoplasm. Kinases of this complex put a 
molecular tag on β-catenin, the key factor of the whole cascade, and thus mark it for 
degradation in the proteasome. Nevertheless, activation of the canonical Wnt pathway 
stabilizes β-catenin. This stabilization is achieved via a negative regulation of glycogen 
synthase kinase 3β (GSK-3β), followed by accumulation of β-catenin in the cytoplasm 
and its subsequent translocation to the nucleus, where it binds to the transcription factors 
T-cell factor/lymphoid enhancer factor (TCF/LEF), and thus influences the expression of 
Wnt target genes (Wiese et al., 2018; Nusse, 2008; Hamada et al., 1999; Figure 10). 
Many of these genes are implicated in proliferation and differentiation of neural 
precursors, or in self-regulation of the pathway, with its numerous negative feedback 




Figure 10. Canonical Wnt signaling pathway. In the absence of wingless and integrated (Wnt) 
ligand, the so-called destruction complex is formed in the cytoplasm, consisting of axin, casein 
kinase 1 (Ck1), dishevelled (Dvl), adenomatous polyposis coli (APC), and glycogen synthase 
kinase 3 (Gsk3), which marks β-catenin, the key protein of the pathway, for degradation in the 
proteasome. However, once the Wnt signal binds the receptors frizzled and low density 
lipoprotein receptor-related protein (Lrp), no destruction complex is formed, β-catenin 
accumulates in the cytoplasm and subsequently translocates to the nucleus where it binds to 
transcription factors T-cell factor/lymphoid enhancer factor (Tcf/Lef), which activates Wnt target 
genes such as leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) and Axin2 
(adapted from Wiese et al. (2018)). 
 
As it was already indicated above, the Wnt pathway exercises a plethora of 
functions during embryogenesis. As an example, in mice with disrupted Wnt signaling, a 
part of the midbrain did not develop, indicating that the Wnt cellular relay is essential for 
the survival of stem cells that form this part of the brain, as well as for their 
differentiation (Brault et al., 2001). Conversely, stabilized β-catenin protein in NS/PCs 
led to enlarged brains with enlarged lateral ventricles, which was caused by higher 
numbers of precursor cells in this region (Chenn and Walsh, 2002). The key element of 
canonical Wnt signaling, β-catenin, plays a crucial role in gene transcription and cell 
adhesion (Mosimann et al., 2009; Nelson and Nusse, 2004). All these data support the 
notion that the Wnt signaling pathway regulates the activity of stem cells in 
embryogenesis. 
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However, the role of Wnt signaling is indisputable also in the postnatal stages of 
ontogenesis. Activation of β-catenin-dependent signaling promoted proliferation of 
precursor cells in the SVZ, while its inhibition reduced the number of newly generated 
cells (Adachi et al., 2007). Similar effects of Wnts were observed also in the other 
neurogenic niche of the adult brain, the SGZ, where the Wnt3 ligand was specifically 
responsible for an increase in neurogenesis in vitro as well as in vivo, while in the 
presence of Wnt inhibitors, neurogenesis was almost extinguished (Lie et al., 2005). 
Moreover, components of Wnt signaling have been shown to interact with a variety of 
other molecules such as fibroblast growth factor (FGF) or retinoic acid and influence thus 
the pool of NS/PCs (ten Berge et al., 2008; Jacobs et al., 2006). 
Additionally, it has been shown that hypoxia and FCI increase the number of 
NS/PCs in the hippocampus and GFAP-positive neural progenitors in the SVZ, 
respectively, and also promote the expansion of neuroblasts one month after middle 
cerebral artery occlusion (MCAO), and canonical Wnt signaling is involved in this 
process (Zhang et al., 2014a; Cui et al., 2011). Similarly, the impact of β-catenin on the 
ability of NS/PCs to give rise to neurons, as well as to oligodendrocytes, in ischemic 
conditions was confirmed also in another study (Zhang et al., 2016). Moreover, Wnt 
signaling contributed to functional recovery following focal ischemia in mice (Shruster et 
al., 2012). 
The output of the Wnt pathway can be regulated in many ways and at many 
subcellular levels. For example, the activity of Wnt signaling can be attenuated by 
ribonucleic acid interference (RNAi). Small interfering RNA (siRNA), inhibiting the 
related to receptor tyrosine kinase (Ryk), caused a significant decrease in TCF-driven 
transcription (Lu et al., 2004). Another approach may be the addition of small molecules, 
since this has been shown to either inhibit or activate Wnt signaling to various degrees. 
Pai et al. (2004) used deoxycholic acid that induced stabilization of β-catenin and its 
subsequent translocation to the nucleus, which, in turn, led to a higher expression of 
cyclin D1, one of the Wnt signaling target genes. Others utilized purified natural 
compounds, or their synthetically developed derivates, to disrupt the β-catenin/Tcf 
protein-protein interaction, and thus inhibit the Wnt pathway (Chen et al., 2009; 
Lepourcelet et al., 2004). Moreover, treatment with andrographolide, a competitive 
inhibitor of GSK-3β, increased NS/PCs proliferation and the number of newborn neurons 
in the hippocampus (Varela-Nallar et al., 2015). Another way of manipulating Wnt 
signaling at different subcellular levels could represent microinjections of messenger 
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ribonucleic acid (mRNA) into the blastomeres of an embryo (Glinka et al., 1998; 
Molenaar et al., 1996). However, the current method of choice is employing animal 
models, especially various transgenic mouse strains (Kriska et al., 2016; Korinek et al., 
1998). 
All the above-described findings show the importance of the Wnt/β-catenin 
pathway in proliferation and differentiation of NS/PCs in the adult brain, especially 
during different pathophysiological conditions involving ischemia. Additionally, knowing 
that neural progenitors have the capacity to differentiate to other cell types of the CNS, 
altering this signaling may ameliorate or even overcome the difficulties associated with 
the diseased CNS. 
  
1.3.2 Sonic hedgehog signaling pathway 
Another cellular pathway that affects neurogenesis and gliogenesis is Shh signaling. This 
pleiotropic secreted protein, which acts as morphogen and mitogen in embryogenesis, 
belongs to the hedgehog family, together with two other ligands – indian hedgehog and 
desert hedgehog (Xia et al., 2019). Nevertheless, our work was dedicated only to Shh, 
major activating ligand in the brain, which has an irreplaceable role in the organization of 
the developing brain and is required for the formation of precursor cells (Merkle et al., 
2014; Rash and Grove, 2011). 
In the absence of a Shh signal, protein kinase A (PKA) phosphorylates 
transcription factors glioma-associated oncogenes (GLIs) that are subsequently 
proteolytically processed by the proteasome and act as transcriptional repressors. 
However, once a Shh ligand is attached to its receptor patched (Ptch), abolishing thus its 
inhibiting modulation on the transmembrane receptor smoothened (Smo), the expression 
of Smo is increased and the protein starts to accumulate at the primary cilium of the cell. 
This in turn causes a decrease in the activity of PKA (Callejo et al., 2007). Downstream 
GLI proteins can be then modified and translocated to the nucleus where they activate so-




Figure 11. Sonic hedgehog (Shh) signaling pathway. Once the Shh ligand binds to the patched 
(Ptch) receptor at the cell membrane, the signaling pathway is activated. The receptor no longer 
inhibits smoothened (Smo) as this protein accumulates at the primary cilium, a microtubule-based 
organelle, and promotes the downstream relay of signals. Smo activates glioma-associated 
oncogene (Gli), which enters the nucleus and binds to the Shh target genes. Abbreviations: Kif7 – 
kinesin-4 family protein 7; SUFU – supressor of fused (Carballo et al., 2018). 
 
The Shh pathway promotes NS/PCs survival and proliferation, since its disruption 
caused deficient formation of the telencephalon (Komada et al., 2008). Studies also 
revealed that Shh is necessary for the production of oligodendrocytes from neural 
progenitors during embryogenesis, while a decrease in the population of oligodendrocytes 
after the deletion of the Shh signaling effector Smo was compensated by increased 
proliferation of NG2 cells (Winkler and Franco, 2019). 
This signaling is active also postnatally, especially in the neurogenic niches, 
where its activation resulted in enhanced proliferation of precursor cells in these regions 
(Lai et al., 2003). The experiments performed in the SVZ indicated that B-cells (stem 
cells), followed by C-cells (transient amplifying cells), were the major Shh-responding 
populations, and that inhibition of this pathway led to decreased numbers of new neurons 
(Palma et al., 2005). 
Moreover, higher activity of Shh signaling has been also observed during acute 
brain injury, in which this ligand promoted reactive gliosis and cell proliferation 
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(Amankulor et al., 2009). Similar upregulation of Shh signaling was also identified during 
brain ischemia, while this mitogen was found to be a mediator contributing to ischemia-
induced expansion of NS/PCs in vitro and in vivo (Androutsellis-Theotokis et al., 2006). 
Additionally, it was shown that in cerebral ischemia, Shh is necessary and sufficient to 
trigger the 'multipotency mode' of reactive glia that then acquire the characteristics of 
stem cells (Sirko et al., 2013). On the other hand, under physiological conditions, neuron-
derived Shh had an opposite effect and prevented astrocytes from the transformation to 
their reactive form (Garcia et al., 2010). Interestingly, it has been proven that the SVZ is 
organized in microdomains of NS/PCs that differentiate to distinct types of neurons, 
while various components of the Shh pathway are specifically expressed in these 
microdomains (Ihrie et al., 2011). 
Another work on Wnt as well as Shh signaling showed that these pathways altered 
the differentiation potential of neonatal NS/PCs, as they both increased neurogenesis and 
suppressed gliogenesis. Moreover, these two signaling relays influenced proliferation and 
differentiation of stem cells differently. Only Wnt enhanced the formation of cellular 
processes and increased proliferation at the early stage of in vitro differentiation, while 
Shh had no effect on the development of the processes and maintained higher 
proliferation rate of cells during the entire course of differentiation (Prajerova et al., 
2010b). Additionally, a new role of these two signaling pathways emerged recently. They 
interact with the receptor for activated C kinase (Rack1) to control the accurate 















2 AIMS OF THE STUDY 
The purpose of this study was to elucidate the role of cellular signaling pathways 
(canonical Wnt signaling and Shh signaling) in gliogenesis and neurogenesis utilizing 
precursor cells (NS/PCs from the SVZ or NG2 glia from the cortex) isolated from 
neonatal (up to postnatal day 2) as well as adult (2-month-old and older) transgenic mice 
with tamoxifen (TAM)-inducible Cre-mediated recombination of deoxyribonucleic acid 
(DNA). 
We assessed the effect of signaling pathways under physiological conditions as 
well as after the induction of FCI. The phenotype of cells derived from the precursor cells 
was identified using the patch-clamp technique in the whole-cell configuration, 
immunochemical analysis, reverse transcription quantitative polymerase chain reaction 
(RT-qPCR), and Western blotting. For this study, we put together our principal 
hypothesis saying that the manipulation (either inhibition or activation) of canonical Wnt 
signaling after FCI may change the differentiation potential of precursor cells and thus 
ameliorate the negative effects of ischemic brain injury. This hypothesis was 
subsequently divided into three partial hypotheses and four associated specific aims as 
follow: 
 
Hypothesis 1: The differentiation potential of NS/PCs isolated from neonatal and adult 
mice is influenced by Wnt signaling manipulation. 
 
Aim 1: To evaluate three transgenic mouse models that enable Wnt signaling 
manipulation in in vitro experiments employing RT-qPCR, immunocytochemical 
analysis, and Western blotting. 
 
Aim 2: To assess neonatal and adult NS/PCs under physiological conditions utilizing 
electrophysiological analyses, immunocyto/histochemical analyses, Western blotting, and 
RT-qPCR. 
 
Hypothesis 2: Ischemic injury itself triggers proliferation and differentiation of NS/PCs. 
We assume that the differentiation potential of NS/PCs isolated from the SVZ following 
permanent FCI is modulated by Wnt signaling manipulation. 
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Aim 3: To disclose the differentiation potential of adult NS/PCs after ischemic brain 
injury using electrophysiological and immunohistochemical analyses, RT-qPCR, and 
Western blotting. 
 
Hypothesis 3: The differentiation potential of polydendrocytes (NG2 glia) isolated from 
adult mice can be modulated by FCI, and Wnt and Shh signaling pathways. 
 
Aim 4: To evaluate adult NG2 glia after ischemic brain injury employing FACS, single-
cell RT-qPCR, immunohistochemical and electrophysiological analyses, and the 


























3 MATERIALS AND METHODS 
To fulfil the set goals, we employed transgenic mouse strains as a source of neural 
progenitors (NS/PCs and NG2 glia) and as a tool for manipulating the canonical Wnt 
signaling pathway, MCAO as a means of inducing FCI, and a series of experimental 
procedures to prepare the specimens for analyses and to assess the changes in the 
differentiation potential of NS/PCs and NG2 cells under various experimental conditions. 
 
3.1 Transgenic animal models 
In our experiments, we employed transgenic mouse strains that enabled us to alter the 
activity of cellular signaling pathways in distinct cell types or to track the fate of neural 
progenitors derived from various regions of the rodent brain. The procedures that 
involved the employment of laboratory animals were carried out in accordance with the 
European Communities Council Directive from November 24, 1986 (86/609/EEC) and 
with the guidelines of the Institute of Experimental Medicine, Czech Academy of 
Sciences, which was approved by the Animal Care Committee (approval numbers 
18/2011, 146/2013, and 2/2017). Additionally, all efforts were made to minimize both the 
suffering and the numbers of mice assigned to the individual experiments. 
 
3.1.1 Mouse strains for experiments on neural stem/progenitor cells 
In our experiments on NS/PCs, neonatal (postnatal day 0-3) mice or adult (postnatal day 
50-56) male mice were employed, and three different transgenic mouse strains were 
utilized. These animals facilitated the manipulation of the canonical Wnt signaling 
pathway at different subcellular levels, specifically at the nuclear, membrane, or 
cytoplasmic levels. First, we employed the Rosa26-Dkk1 mice (Wu et al., 2008), in which 
after Cre-mediated excision of a transcriptional blocker, the mice produced the 
extracellular Wnt pathway inhibitor Dickkopf 1 (Dkk1) from the ubiquitous Rosa26 locus 
(Figure 12), blocking membrane receptors of the pathway. Next, the Catnb
lox(ex3)
 mice 
harbored the floxed allele of the Ctnnb1 gene (the gene that encodes protein β-catenin; 
Harada et al., 1999). In these mice the allele enabled conditional stabilization of β-catenin 
(Figure 12). Lastly, the Rosa26-tdTomato-EGFP/dnTCF4 mice (Janeckova et al., 2016) 
produced dominant negative (dn)TCF4 protein from the Rosa26 locus and this protein 
acted as a nuclear Wnt pathway inhibitor (similarly to the Rosa26-Dkk1 strain, dnTCF4 
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expression was triggered upon Cre-mediated excision of a transcriptional blocker that was 
located upstream of dnTCF4 complementary DNA (cDNA); Figure 12). Moreover, this 
strain was designed to produce tandem dimeric (td) red fluorescent protein Tomato 
(Tom), which was replaced by enhanced green fluorescent protein (EGFP) after Cre-
mediated DNA excision. All these mouse strains were individually crossbred with the 
general Cre deletor mouse Rosa26-CreERT2 that possessed TAM-inducible Cre 
recombinase fused with a mutant form of estrogen receptor (ERT2) (Ventura et al., 2007; 
Figure 12). According to the resulting genotype, the mice enabled inhibition of Wnt 
signaling either at the nuclear level (genotype Rosa26
dnTCF4/CreERT2
; further termed 
'dnTCF4' mice/cells), or at the membrane level (genotype Rosa26
Dkk1/CreERT2
; further 




 mice (where 'del' 
stands for deletion; further termed 'Ex3' mice/cells), produced a stable form of β-catenin 
protein that hyper-activated the canonical Wnt signaling pathway upon Cre-mediated 
excision of the DNA sequence for exon 3 of the Ctnnb1 gene. 
 
 
Figure 12. Modulation of the Wnt signaling pathway in transgenic mice. (Left) Schemes 
depicting genetic modifications present in the mouse strains used in the study of neural 
stem/progenitor cells. Suppression of Wnt signaling at the membrane level, due to the over-
expression of a secreted Wnt inhibitor Dickkopf 1 (Dkk1). Activation of the pathway caused by 
the production of a stable variant of β-catenin. Cre-mediated excision of exon 3 (E3 or Ex3, red 
rectangle) removes the amino acid sequence involved in the degradation of the protein, and thus 
stable β-catenin aberrantly activates Wnt target genes. The Wnt-responsive transcription in the 
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nucleus is blocked by dominant negative T-Cell factor 4 (dnTCF4). Cre deletor mouse, Rosa26-
CreERT2, carries the gene encoding tamoxifen-inducible Cre recombinase, fused with a mutated 
form of the estrogen receptor (CreERT2). (Right) Simplified scheme of the canonical Wnt 
signaling pathway that shows where the alterations take place. Red arrows point to the 
interference site affected in the transgenic mice used in the study. Abbreviations: APC – 
adenomatous polyposis coli; Cre – Cre recombinase; Dvl – dishevelled; E2-10 – exon 2-10; EGFP 
– enhanced green fluorescent protein; GSK-3β – glycogen synthase kinase 3β; LRP5/6 – low-
density lipoprotein 5/6; P – phosphorylated site; pA – polyadenylation site; PGK-Neo – neomycin 
resistance cassette; TCF/LEF – T-Cell Factor/Lymphoid Enhancer Factor; td – tandem dimer; 
Wnt – Wingless/Integrated (adapted from Kriska et al. (2016)). 
 
The Cre-recombination-mediated manipulation of Wnt signaling was achieved 
either by addition of 1 μM (Z)-4-hydroxytamoxifen (4OHT; dissolved in ethanol (EtOH); 
Sigma-Aldrich, St. Louis, MO, USA) into the differentiation medium, or by 
intraperitoneal (i.p.) injections of TAM (200 mg/kg of the animal's body weight; Toronto 
Research Chemicals, Toronto, Ontario, Canada) dissolved in corn oil (CO; Sigma-
Aldrich, St. Louis, MO, USA). Mice/cells treated only with the vehicle (EtOH or CO) 
were considered as controls and labeled as 'EtOH' and 'CO', respectively, while mice/cells 
with manipulated Wnt signaling were labeled as '4OHT' or 'TAM'. Intraperitoneal (i.p.) 
injections of TAM were delivered in two doses, each once a day of two consecutive days 
and experiments (MCAO or tissue collection) were performed on the third day after the 
last TAM injection. 
 
3.1.2 Mouse strain for experiments on NG2 glia 
Our experiments on NG2 cells (also termed polydendrocytes) were performed in 3-
month-old offspring of B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J mice crossbred with mice of 
the strain B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (further termed 'Cspg4-
Tom' mice/cells; Jackson Laboratory, Bar Harbor, ME, USA; Figure 13). In these mice, 
the expression of TAM-inducible Cre recombinase was controlled by the Cspg4 promoter 
(Zhu et al., 2011). After TAM administration, tdTomato red fluorescent protein was 
expressed in Cspg4-positive (or Cspg4
+
) mice/cells, which included mainly NG2 cells 




Figure 13. Scheme showing genetic modifications present in the mouse strain used for 
experiments on NG2 cells. These mice possess deoxyribonucleic acid (DNA) for red fluorescent 
protein tdTomato, which is blocked by transcriptional blocker (STOP), in all cells of the organism 
(Rosa26 locus). At the same time, their genome comprises DNA for Cre recombinase fused with a 
mutated form of estrogen receptor (CreEsr1) that is expressed in all cells with active Cspg4 
promoter, a hallmark of NG2 cells. However, this fused protein cannot enter the cell nucleus 
because of its conformation. Nevertheless, upon tamoxifen administration, the protein changes its 
conformation, allowing thus translocation to the nucleus where it cuts out the STOP sequence. 
The expression of the fluorescent protein is no longer blocked and Cspg4-positive cells turn red. 
This procedure creates mice/cells that are further called 'Cspg4-Tom'. Abbreviations: Cre – Cre 
recombinase; Cspg4 – chondroitin sulfate proteoglycan 4; Esr1 – estrogen receptor 1; pA – 
polyadenylation site; td – tandem dimer (author's own scheme). 
 
Tamoxifen was administered in a form of i.p. injections for two consecutive days 
(200 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) and experiments were carried out 14 
days after the last TAM injection, unless stated otherwise. In order to inhibit or activate 
Shh signaling in these mice, i.p. injections of either specific antagonist cyclopamine (Cyc, 
25 mg/kg, LKT Laboratories, St. Paul, MN, USA; Chen et al., 2002) or selective Smo 
agonist (SAG, 20 mg/kg, VDM Biochemicals, Bedford Heights, OH, USA; Lewis and 
Krieg, 2014) were administered for 7 consecutive days. 
 
3.2 Induction of focal cerebral ischemia 
Adult mice underwent permanent MCAO, a procedure which has become a conventional 
model of FCI. Mice were anesthetized with 2% isoflurane (Abbot, IL, USA) and 
maintained at 1% isoflurane using a vaporizer (Tec-3, Cyprane Ltd., Keighley, UK). An 
incision in the skin between the orbit and the external auditory meatus was made and the 
temporal muscle was retracted. Afterwards, a ~1.5 mm hole was drilled through the 
47 
frontal bone, ~1.0 mm rostrally to the fusion of the zygoma and the squamosal bone, and 
~3.5 mm ventrally to the dorsal surface of the brain. After the dura mater was opened and 
removed, the middle cerebral artery (MCA; Figure 14) was exposed and cauterized with a 




Body temperature of the mouse was maintained at 37 ± 1 °C using a heating pad 
during the surgery (Honsa et al., 2012). After the operation, the mice were injected 0.5 ml 
of saline solution subcutaneously. Analgesics were also administered when necessary. 
Operated mice were labeled as 'MCAO', while non-operated animals were considered as 
controls and labeled as 'CTRL'. This distal model of MCAO has a high survival rate 
(>95%) and a good reproducibility, as it typically yields an infarct lesion of a relatively 
small volume only in the cortical region (Honsa et al., 2013). 
For the visualization of ischemic region, we performed staining with 2% 2,3,5-
triphenyltetrazolium chloride (TTC; Sigma-Aldrich, St. Louis, MO, USA) at room 
temperature for 20 minutes (Figure 15). 
 
 
Figure 14. Middle cerebral artery occlusion. 
The 'Y'-shaped middle cerebral artery (MCA; 
black arrow) of the left hemisphere is exposed 
and will be cauterized with a pair of bipolar 
tweezers, which induces focal cerebral ischemia. 
Note the retracted temporal muscle to the left to 
the MCA (photograph by courtesy of author's 
trainee Hana Bernhardová). 
Figure 15. Staining with 2,3,5-
triphenyltetrazolium chloride. Coronal section 
of the mouse brain after middle cerebral artery 
occlusion. The occluded artery was in the left 
hemisphere (right side of the photograph), 
causing focal cerebral ischemia. White area 
represents tissue of the cortex that was affected 
by ischemia (photograph by courtesy of author's 
colleague Zuzana Heřmanová). 
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3.3 Tissue isolation and cell cultures preparation 
To prepare tissue or cell culture specimens for our analyses, we isolated the frontal lobe 
of neonatal mice or cut coronal sections of the adult mouse brain and cut out specific 
brain regions for further processing. 
 
3.3.1 Isolation and processing of tissue for cultures of neural 
stem/progenitor cells 
Primary cultures were prepared from NS/PCs isolated from neonatal or adult mouse 
brains. Neonatal mice were hypothermed, while adult animals were deeply anesthetized 
first with 4% isoflurane (Abbot, IL, USA) and subsequently with pentobarbital solution 
(PTB; 100 mg/kg, i.p.; Sigma-Aldrich, St. Louis, MO, USA), and perfused transcardially 
with ice-cold isolation buffer containing (in mM): 110 N-Methyl-D-glucamine (NMDG)-
Cl, 2.5 KCl, 24.5 NaHCO3, 1.25 Na2HPO4, 0.5 CaCl2, 7 MgCl2, 20 glucose, osmolality 
290 ± 3 mOsmol/kg. 
After decapitation, the brains were quickly dissected out and a part of the frontal 
lobe of the neonatal brain (with the presumptive SVZ region) or the SVZ derived from 
coronal sections of adult mice was isolated. 
Neonatal brain tissue was further processed using a 1 ml pipette. The tissue was 
mechanically dissociated in a 2-ml-Eppendorf tube with 1 ml of proliferation medium 
containing Neurobasal-A medium (Life Technologies, Waltham, MA, USA), 
supplemented with the B27 supplement (B27; 2%; Life Technologies, Waltham, MA, 
USA), L-glutamine (2 mM; Sigma-Aldrich, St. Louis, MO, USA), antimicrobial reagent 
primocin (100 µg/ml; Invivogen, Toulouse, France), fibroblast growth factor-basic 
(bFGF; 10 ng/ml) and epidermal growth factor (EGF; 20 ng/ml; both were purchased 
from PeproTech, Rocky Hill, NJ, USA). The cells were subsequently filtered through a 
70 µm cell strainer, into a 100 mm-diameter Petri dish containing additional 9 ml of 
proliferation medium. The cells were cultured as neurospheres, at 37 °C and 5% carbon 
dioxide (CO2). 
After seven days of in vitro proliferation, the formed neurospheres (Figure 16, 
left) were collected and transferred into a 12 ml Falcon tube, and centrifuged at 1020×g 
for 3 minutes. The supernatant was discarded, and 1 ml of protease trypsin (Sigma-
Aldrich, St. Louis, MO, USA) was added to the pelleted neurospheres. After 3 minutes of 
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trypsin incubation, 1 ml of trypsin inhibitor (Sigma-Aldrich, St. Louis, MO, USA) was 
added to the dissociated cells, to block the proteolytic effect of trypsin. Subsequently, a 
negligible portion (~100 µl) of the cell suspension was used to count cells in the 
hemocytometer. The rest of the cell suspension was centrifuged at 1020×g for 3 minutes. 
The cells were plated on poly-L-lysine (PLL)-coated (Sigma-Aldrich, St. Louis, MO, 





The cultures were treated with differentiation medium, which had the same composition 
as the proliferation medium, but it was devoid of EGF, and with higher (20 ng/ml) 
concentration of bFGF. The cultivation conditions were maintained at 37 °C and 5% CO2, 
with medium exchange on every third day. After 8-9 days of in vitro differentiation 
(Figure 16, right), the cells were used for electrophysiological measurements, 
immunocytochemistry, Western blotting analysis, and RT-qPCR. To estimate the impact 
of Wnt signaling inhibition or activation during differentiation of NS/PCs, 4OHT and 
EtOH cultures were compared. 
 
 
Figure 16. Cultivation of neural stem/progenitor cells in vitro. (Left) Neural stem/progenitor 
cells form neurospsheres during the proliferation stage of in vitro cultivation. (Right) Neural 
stem/progenitor cells after 8-9 days of differentiation form relatively highly confluent cell cultures 
(author's own photographs). 
 
Primary cultures of adult NS/PCs were derived from the SVZ of the LV; from 
both right and left SVZs from CTRL mice, while only from the SVZ ipsilateral to the site 
of injury in mice three days after MCAO (Figure 17). After decapitation, brains were 
quickly removed from the skull and sliced into ~500 µm coronal slices using vibratomes 
HM 650 V (MICROM International GmbH, Walldorf, Germany) or Leica VT 1200S 
(Baria s.r.o., Czech Republic), and the SVZs were carefully dissected out and cut into 
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smaller pieces using a razor. To obtain a single-cell suspension, the tissue was first 
incubated with continuous shaking at 37 °C for 45 minutes in 1 ml of papain solution (20 
U/mL) with 0.2 ml of deoxyribonuclease (DNase; both from Worthington, Lakewood, 
NJ, USA). After papain treatment, the activity of the enzyme was inhibited with 1 ml of 
trypsin inhibitor (Sigma-Aldrich, St. Louis, MO, USA), and the tissue was afterwards 
mechanically dissociated by gentle trituration using a 1 ml pipette and centrifuged at 
1020×g for 3 minutes. After centrifugation, the supernatant was discarded and the cells 
were resuspended in 1 ml of proliferation medium, of which composition was equal to the 
one used for the cultures derived from neonatal mice; however, the concentration of EGF 
was higher, at 30 ng/ml. The rest of the procedure was the same as for neonatal mice, 
with one exception – the cells were cultured as neurospheres for longer period of time to 
secure enough cells for further analyses, which required ~12 days of in vitro proliferation. 
 
 
Figure 17. Isolation of the subventricular zone. For the experiments on adult neural 
stem/progenitor cells, the tissue around the subventricular zones was isolated (red solid lines). 
After the induction of focal cerebral ischemia (red dashed line), only the subventricular zone 
ipsilateral to the site of injury was isolated. Some of the major brain structures are labeled in the 
scheme (author's own scheme). 
 
Tissue for Western blotting or RT-qPCR was also isolated from the SVZs of adult 
CTRL and MCAO animals. Mice were anesthetized with 4% isoflurane (Abbot, IL, USA) 
and subsequently with 1% PTB and perfused transcardially with ice-cold isolation buffer. 
After decapitation, brains were quickly removed from the skull and cut into ~500 µm 
coronal sections using the vibrating microtome. The SVZs were dissected out and cut into 
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smaller pieces using a razor. Afterwards, the tissue was transferred into empty 2 ml 
Eppendorf tubes or tubes containing TRI Reagent (Sigma-Aldrich, St. Louis, MO, USA) 
for further Western blotting and RT-qPCR analyses, respectively. The tubes containing 
tissue were immediately placed on dry ice and subsequently stored at -80 °C. 
 
3.3.2 Isolation and processing of tissue for cultures of NG2 glia 
Control mice or mice three, four, seven, or fourteen days after FCI were deeply 
anesthetized with PTB (100 mg/kg, i.p.), and perfused transcardially with ice-cold 
isolation buffer. The cerebral cortex was cut into ~600 µm coronal sections using the 
vibratome and the region around the ischemic lesion was carefully dissected out from the 
white matter tracks. The tissue from CTRL animals was isolated from the same regions. 
The tissue was incubated with continuous shaking at 37 °C for 45 minutes in 1 ml of 
papain solution supplemented with DNase. After the incubation in papain, the tissue was 
gently mechanically dissociated with a 1 ml pipette. Dissociated cells were subsequently 
layered on top of 5 ml of ovomucoid inhibitor solution (Worthington, Lakewood, NJ, 
USA) and harvested by low-speed centrifugation (140×g for 6 minutes), with subsequent 
filtration through a 70 µm cell filter. At this stage, the resulting single-cell suspension 
could be kept on ice and used for cell counting or fluorescence-activated cell sorting 
(FACS; BD Influx, San Jose, CA, USA). To prepare primary cell cultures, the cells were 
plated at the same cell density as NS/PCs and maintained in Dulbecco's Modified Eagle 
Medium/Nutrient Mixture F12 (DMEM/F12) with antibiotics 
penicillin/streptomycin/amphotericin (PSA; all from Invitrogen, Carlsbad, CA, USA), 20 
ng/ml platelet-derived growth factor alpha (PDGFα; Peprotech, Rocky Hill, NJ) and 4 
mM glutamine (Sigma–Aldrich, St. Louis, MO, USA). This DMEM/F12-based medium 
is further referred to as 'basal medium'. For the first 24 hours of in vitro cultivation, the 
basal medium was supplemented with 15% fetal bovine serum (FBS; HyClone, Thermo 
Scientific, Waltham, MA, USA). Then, the cell cultures were transferred to the 
differentiation medium consisting of basal medium with B27 supplement (Invitrogen, 
Carlsbad, CA, USA). To activate Shh signaling in NG2 cells, Shh (20 ng/ml; Peprotech, 
Rocky Hill, NJ, USA) or SAG (300 ng/ml, VDM Biochemicals, Bedford Heights, OH, 
USA) were added, and to block Shh signaling, Cyc (4 mg/ml, LKT Laboratories, St. Paul, 
MN, USA) was added. Seven days after the onset of in vitro differentiation, the 
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phenotype of differentiated Tom-positive NG2 glia was analyzed using the patch-clamp 
technique in the whole-cell configuration and immunochemical staining. 
 
3.4 Preparation of coronal tissue sections for 
immunohistochemical staining 
Adult mice were deeply anesthetized with PTB (100 mg/kg, i.p.; Sigma-Aldrich, St. 
Louis, MO, USA) and perfused transcardially using saline solution (ArdeaPharma, a.s., 
Sevetin, Czech Republic) with 0.65% heparin (Zentiva Group, a.s., Prague, Czech 
Republic) at room temperature and subsequently with ice-cold 4% paraformaldehyde 
(PFA; Sigma-Aldrich, St. Louis, MO, USA). The brain was then left in PFA for 3 more 
hours for thorough fixation, with subsequent transfer to the sucrose gradient for 
cryoprotection. The tissue was incubated in 10% sucrose for 12 hours, then in 20% 
sucrose for 24 hours, followed by 30% sucrose incubation for further 72 hours. Thirty-
µm-thick coronal sections were prepared using a cryostat (Leica CM1850, Leica 
Microsystems, Wetzlar, Germany) and subsequently stored at -20 °C in a 
cryopreservation solution prepared in the laboratory. 
 
3.5 Patch-clamp measurements 
The electrophysiological properties of in vitro differentiated cells were recorded using the 
patch-clamp technique in the whole-cell configuration. Recording micropipettes with a tip 
resistance of ~10 MΩ were made from capillaries of borosilicate glass (Sutter 
Instruments, Novato, CA, USA) using a P-97 Brown-Flaming puller (Sutter Instruments, 
Novato, CA, USA) and subsequently filled with artificial intracellular solution containing 
(in mM): 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 130 KCl, 0.5 
CaCl2, 2 MgCl2, 5 ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid 
(EGTA), with pH 7.2, and in some cases also mixed with Alexa Fluor hydrazide 488 
(A488; Molecular Probes, Carlsbad, CA, USA) for visualization of recorded cells. The 
measurements were made in artificial cerebrospinal fluid (aCSF) containing (in mM): 122 
NaCl, 3 KCl, 1.5 CaCl2, 1.3 MgCl2, 1.25 Na2HPO4, 28 NaHCO3, and 10 D-glucose 
(osmolality 300 ± 5 mmol/kg) and this solution was continuously gassed with 5% CO2 to 
maintain a final pH of 7.4. All recordings were made at room temperature on coverslips 
perfused with aCSF in the recording chamber of an upright Axioscop microscope (Zeiss, 
Gottingen, Germany) equipped with 2 electronic micromanipulators (Luigs & Neumann, 
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Ratingen, Germany) and a high-resolution AxioCam HR digital camera (Zeiss, Gottingen, 
Germany). Electrophysiological data were measured with a 10 kHz sample frequency 
using EPC9/10 amplifiers controlled by the PatchMaster software (HEKA Elektronik, 
Lambrecht/Pfalz, Germany) and filtered using a Bessel filter. 
The value of the membrane potential (Vm) was measured by switching the 
EPC9/10 amplifiers to the current-clamp mode. Using the FitMaster software (HEKA 
Elektronik, Lambrecht/Pfalz, Germany), input resistance (IR) was calculated from the 
current value at 40 ms after the onset of the depolarizing 10 mV pulse from the holding 
potential of -70 mV. Membrane capacitance (Cm) was determined automatically from the 
Lock-in protocol by the software. Current patterns were obtained by hyperpolarizing and 
depolarizing the cell membrane from the holding potential of -70 mV to the values 
ranging from -160 mV to 40 mV in 10 mV steps, while the duration of each pulse was 50 
ms. The inwardly rectifying K
+
 (KIR), the fast activating and inactivating outwardly 
rectifying K
+
 (KA), and the delayed outwardly rectifying K
+
 (KDR) current components 
were determined as follows. In order to isolate the KDR current components, a voltage 
step from -70 to -60 mV was used to subtract the time- and voltage-independent currents. 
To activate the KDR currents only, the cells were held at -50 mV, and the amplitude of the 
KDR currents was measured at 40 mV, 40 ms after the onset of the pulse. The KIR currents 
were determined analogously at -140 mV, also 40 ms after the onset of the pulse, while 
the cells were held at -70 mV. The KA currents were measured at 40 mV and were 
isolated by subtracting the current traces, clamped at -110 mV from those clamped at -50 
mV, and its amplitude was measured at the peak value. While measuring tetrodotoxin 
(TTX)-sensitive sodium (Na
+
) currents, the cells were held at -70 mV and the current 
amplitudes were isolated by subtracting the current traces measured in solution containing 
1 µM TTX (Alomone Labs, Jerusalem, Israel) from those measured in the absence of 
TTX in aCSF. The Na
+
 current amplitudes were measured at the peak value. The current 
densities were calculated by dividing the maximum current amplitudes by the 
corresponding Cm values for each individual cell. The action potentials were obtained in 
the current-clamp mode. The current values in the protocol ranged from 50 to 1000 pA, at 
50 pA increments, and the pulse duration was 300 ms. A more detailed description can be 
found in the publications of our department (Anderová et al., 2006; Neprasova et al., 
2007). 
After recording, the cells on the coverslips were fixed in 4% PFA dissolved in 0.2 
M phosphate buffer (PB; pH 7.4) for 9 minutes, then transferred to 10 mM phosphate-
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buffered saline (PBS; pH 7.2) and stored at 4 °C for post-recording identification using 
immunofluorescence staining. 
 
3.6 Immunocyto/histochemistry and confocal microscopy 
The primary cultures on coverslips or 30-µm-thick coronal brain slices (in this section 
both further referred to as 'specimens') were washed 3 times for 10 minutes in PBS. 
Afterwards, they were rinsed for 2 hours and at 4 °C in blocking solution containing 5% 
Chemiblocker (Millipore, Billerica, MA, USA) and 0.5% Triton X-100 (Sigma-Aldrich, 
St. Louis, MO, USA) diluted in 10 mM PBS. The same blocking solution was also used 
as the diluent for all primary and secondary antibodies. The specimens were incubated 
overnight at 4 °C with primary antibodies. The following primary antibodies were used: 
rabbit polyclonal anti-GFAP (1:800; Sigma-Aldrich, St. Louis, MO, USA), mouse 
monoclonal anti-GFAP conjugated to A488 (1:300; Thermo Fisher Scientific, Waltham, 
MA, USA), mouse monoclonal anti-GFAP (1:800; Sigma-Aldrich, St. Louis, MO, USA) 
conjugated to cyanine dye 3 (Cy3), rabbit polyclonal anti-PDGFαR (1:200; Santa Cruz 
Biotechnology, Dallas, TX, USA), rabbit polyclonal anti-DCX (1:1000; Abcam, 
Cambridge, UK), rabbit polyclonal anti-DCX (1:500; Santa Cruz Biotechnology, Dallas, 
TX, USA), mouse monoclonal anti-microtubule-associated protein 2 (MAP2; 1:800; 
Merck Millipore, Billerica, MA, USA), mouse monoclonal anti-proliferating cell nuclear 
antigen (PCNA; 1:1000; Abcam, Cambridge, UK), mouse anti-adenomatous polyposis 
coli clone CC1 (CC1; 1:200; Merck, Frankfurt, Germany), rabbit anti-Ki67, a marker of 
proliferation (1:1000; Abcam, Cambridge, UK), rabbit anti-CNPase (1:100; Sigma-
Aldrich, St. Louis, MO, USA), mouse anti-myelin/oligodendrocyte-specific protein 
(MOSP; 1:400; Merck Millipore, Billerica, MA, USA), rabbit anti-NG2 (1:400; Merck 
Millipore, Billerica, MA, USA), rabbit anti-platelet-derived growth factor β receptor 
(PDGFβR; 1:200; Santa Cruz, Dallas, TX, USA). On the following day, the specimens 
were washed 3 times for 10 minutes with PBS, which was followed by incubation with 
secondary antibodies for two more hours at 4 °C. The secondary antibodies were goat 
polyclonal anti-rabbit/mouse immunoglobulin G (IgG) conjugated to A488, or Alexa 
Fluor 594 or 660 (A594/660; 1:200; Molecular Probes, Carlsbad, CA, USA). The 
specimens were afterwards again washed 3 times for 10 minutes in PBS and rinsed for 5 
more minutes, this time at room temperature, in 300 nM 4′,6-diamidino-2-phenylindole 
(DAPI; Molecular Probes, Carlsbad, CA, USA) diluted in PBS for cell nuclei 
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visualization. At the end of the procedure, the specimens were mounted onto microscope 
slides using Aqua Poly/Mount (Polysciences Inc., Eppelheim, Germany). Once the 
mounting medium solidified, the specimens were ready to be analyzed by confocal 
microscopy. 
To evaluate the proliferation rate of precursor cells, 5-ethynyl-2´-deoxyuridine 
(EdU; 0.2 mg/ml; Sigma-Aldrich, St. Louis, MO, USA) or 5-bromo-2'-deoxyuridine 
(BrdU; 1 mg/ml; Sigma-Aldrich, St. Louis, MO, USA) were added to the drinking water 
and administered to the mice for three or seven days. For EdU visualization, we used the 
AlexaFluor-647 Click-iTEdU Cell Proliferation Assay Kit (Sigma-Aldrich, St. Louis, 
MO, USA) and then washed the specimens in PBS. The mouse anti-BrdU primary 
antibody (1:200, Abcam, Cambridge, UK), in the combination with one of the secondary 
antibodies mentioned above, was utilized for BrdU visualization. 
An LSM 5 DUO confocal fluorescence microscope (Zeiss, Gottingen, Germany) 
equipped with an Arg/HeNe laser was used for immunofluorescence analysis and, 
furthermore, the fluorescence signals were analyzed using the ImageJ software (NIH, 
Bethesda, MD, USA). For NS/PCs analysis, superimposed images of GFAP, PDGFαR, 
DCX or MAP2 stainings were obtained by overlaying several individual confocal planes. 
The images were subsequently digitally filtered and the immunopositive areas were used 
for quantification. The areas corresponding to the immunoreactivity of the cells were 
calculated in random regions of interest and divided by DAPI-positive area to normalize 
them to the cell number. At least six random regions of interest (ROIs) from two 
independent cultures with similar confluence were used for the quantification of each 




Figure 18. Quantification of immunopositive areas. (A) Superimposed image of doublecortin 
(DCX) staining, obtained by overlaying 4 individual confocal planes (each 318.2 µm x 318.2 µm 
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large). (B, C) Digitally filtered image (red area) outlined in yellow was used for the quantification 
of the fluorescent signal (Kriska et al., 2016). 
 
Immunocytochemical staining against β-catenin was similar to the previous 
staining and more detailed description may be found elsewhere (Doubravska et al., 2011). 
In short, cells were fixed for 10 minutes in 4% PFA, permeabilized with 0.25% Triton X-
100 for another 10 minutes and washed in PBS. Overnight incubation with primary 
mouse monoclonal antibody (1:2000; BD Transduction Laboratories, San Jose, CA, 
USA) at 4 °C was followed by incubation with goat anti-mouse secondary antibody 
conjugated to A488 dye for 1 hour at room temperature. Finally, DAPI (Sigma-Aldrich, 
St. Louis, MO, USA) was used for counterstaining. Fluorescent microscopy images 
(n=12) were taken from EtOH and 4OHT cultures. The A488 and DAPI fluorescence 
signals were analyzed with the ImageJ software and the intensity of β-catenin staining 
was normalized to the cell number in every image. Obtained data were evaluated by 
Student's t-test. 
To assess the differentiation potential of progenitor cells of the SVZ in situ in 
coronal sections, we utilized a spinning disc confocal fluorescent microscope Dragonfly 
530 Andor (Oxford Instruments, Oxford, UK), equipped with Zyla 4.2 PLUS sCMOS 
camera and Fusion acquisition system. Superimposed images of GFAP, DCX, and PCNA 
stainings were obtained by overlaying 6-12 individual confocal planes that were 
beforehand digitally fused using the Fusion stitching tool. Obtained images were 
processed in the Imaris visualization software (Oxford Instruments, Oxford, UK). The 
immunopositive SVZ areas were dissected and quantified using the Fiji ImageJ software 
(NIH, Bethesda, MD, USA). The areas corresponding to immunopositive cells of the SVZ 
were calculated and normalized to DAPI-positive area. Together six SVZ sections from 
two biological replicates were analyzed in each immunostaining data set. 
The LSM 5 DUO confocal microscope with 40× oil objective was also used for 
immunochemical analysis of NG2 glia. Stacks of consecutive confocal images at the 
thickness of 3 µm were acquired sequentially with two lasers to avoid any crosstalk 
between the channels. The background noise of each confocal image was reduced by 
averaging four input images. The co-localization of fluorescence signals was assessed by 
employing the maximum Z-projection feature in the Zeiss LSM Image Browser (Zeiss, 
Gottingen, Germany). The assessment of the cells in the glial scar was performed in 
confocal images of coronal brain sections of at least three mice and the cell counts were 
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estimated from superimposed images generated in the GSA Image Analyzer (Bansemer & 
Scheel GbR, Rostock, Germany). 
 
3.7 Reverse transcription quantitative polymerase chain 
reaction 
For the NS/PCs experiments, the tissue was isolated and stored as described at the end of 
section 3.3.1. Furthermore, RNA was purified using TRI Reagent (Sigma-Aldrich, St. 
Louis, MO, USA) or RNA Blue (Top-Bio, Prague, Czech Republic) according to the 
manufacturers’ protocols. The reverse transcription of RNA and RT-qPCR were 
performed using LightCycler® 480 SYBR Green I Master (Roche Diagnostics, 
Indianapolis, IN, USA; Lukas et al., 2009). The primers for RT-qPCR are listed in Table 
1. 
Since the RT-qPCR analysis was performed on Tom-expressing NG2 glia, we 
were able to take advantage of the single-cell approach. A negligible amount of the 
fluorescent dye Hoechst 33258 (Life Technologies, Carlsbad, CA, USA) was added to the 
cell suspension to identify and subsequently discard damaged or dead cells. Individual 
cells were collected employing FACS (BD Influx, San Jose, CA, USA). The cell sorter 
was set to place one cell in each well of 96-well microtiter plates (Life Technologies, 
Carlsbad, CA, USA) filled with 5 µl of nuclease-free water mixed with bovine serum 
albumin (BSA; 1 mg/ml; Fermentas, Rockford, IL, USA) and RNaseOut (20 U; Life 
Technologies, Carlsbad, CA, USA). The expression of almost one hundred genes was 
assessed and the lists of primers for RT-qPCR can be found in Honsa et al. (2016) and 
Valny et al. (2018). The mRNA was reverse-transcribed into cDNA with SuperScript III 
(ThermoFisher Scientific, Waltham, MA, USA), with further pre-amplification and 
analysis in the BioMark platform (Fluidigm, San Francisco, CA, USA). The data were 
analyzed using the GenEx 6 software (MultiD, Sweden). 
Self-organizing maps (SOM) that divided Tom-positive cells into four subpopulations 
were trained in the GenEx 6 software (MultiD, Sweden), while 0.60 learning rate, 4 
neighbors, and 5,000 iterations were all used as the settings. The subpopulations were 




Table 1. Sequences of primers used for reverse transcription quantitative polymerase chain 
reaction experiments. 
Gene symbol Sequence 
Actb FP: 5'-GATCTGGCACCACACCTTCT-3' 
RP: 5'-GGGGTGTTGAAGGTCTCAAA-3' 
Axin2 FP: 5'-TAGGCGGAATGAAGATGGAC-3' 
RP: 5'-CTGGTCACCCAACAAGGAGT-3' 
Ccnd1 FP: 5'-AGTGCGTGCAGAAGGAGATT-3' 
RP: 5'-CTCTTCGCACTTCTGCTCCT-3' 
GAPDH FP: 5'-AACTTTGGCATTGTGGAAGG-3' 
RP: 5'-ATCCACAGTCTTCTGGGTGG-3' 
Nkd1 FP: 5'-AGGACGACTTCCCCCTAGAA-3' 
RP: 5'-TGCAGCAAGCTGGTAATGTC-3' 
Sp5 FP: 5'-GGACAGGAAACTGGGTCGTA-3' 
RP: 5'-AATCGGGCCTAGCAAAAACT-3' 
Troy FP: 5'-GCTCAGGATGCTCAAAGGAC-3' 
RP: 5'-CCAGACACCAAGACTGCTCA-3' 
Ubb FP: 5'-ATGTGAAGGCCAAGATCCAG-3' 
RP: 5'-TAATAGCCACCCCTCAGACG-3' 
Wnt4 FP: 5'-AACGGAACCTTGAGGTGATG-3' 
RP: 5'-TCACAGCCACACTTCTCCAG-3' 
Wnt5a FP: 5'-AGGAGTTCGTGGACGCTAGA-3' 
RP: 5'-ACTTCTCCTTGAGGGCATCG-3' 
Wnt5b FP: 5'-CGCTTTGGAAGATGTTGGTC-3' 
RP: 5'-ACATCTCCGGTCTCTGCACT-3' 
Wnt7a FP: 5'-GCCTGGACGAGTGTCAGTTT-3' 
RP: 5'-TGGTACTGGCCTTGCTTCTC-3' 
Wnt7b FP: 5'-AGTGCCAGCACCAGTTCC-3' 
RP: 5'-CCTTCCGCCTGGTTGTAGTA-3' 
Wnt9a FP: 5'-TCGTGGGTGTGAAGGTGATA-3' 
RP: 5'-TGGCTTCATTGGTAGTGCTG-3' 
Wnt10b FP: 5'-CTTCGACATGCTGGAGGAG-3' 
RP: 5'-CCCAGCTGTCGCTTACTCAG-3' 
Abbreviations: Actb – β-actin; Ccnd1 – cyclin D1; FP – forward primer; GAPDH – 
glyceraldehyde-3-phosphate dehydrogenase; Nkd1 – naked cuticle homolog 1; RP – reverse 
primer; Sp5 – SP5 transcription factor; Troy – tumor necrosis factor receptor superfamily, 




3.8 Western blotting 
Protein analysis employing Western blotting was performed by two different approaches, 
depending on whether cell cultures or tissue specimens were analyzed. If cell cultures 
cultivated in vitro on plastic dishes were assessed, cells were lysed in standard 1x radio 
immunoprecipitation assay (RIPA) buffer, containing 25 mM Tris-HCl, pH 8.0; 150 mM 
NaCl; 1% NP-40; 1% sodium deoxycholate; 0.1% sodium dodecyl sulfate (SDS); 1 mM 
ethylenediaminetetraacetic acid (EDTA), and supplemented with inhibitors of proteases 
(Roche, Basel, Switzerland) and phosphatases (20 mM NaF; 1 mM Na3VO4). The total 
protein content in the homogenates was determined using the Pierce BCA™ protein assay 
kit (Thermo Fisher Scientific, Waltham, MA, USA). Equal amounts of proteins, 
supplemented with 100 mM dithiothreitol, were subjected to SDS-polyacrylamide gel 
electrophoresis (PAGE; 10 – 15%). The proteins were then transferred onto nitrocellulose 
membrane (Hybond ECL 0.45 μM; Little Chalfont, Amersham, UK) and detected by 
specific primary antibodies as follows: anti-β-actin (1:1000; Santa Cruz Biotechnology), 
anti-β-catenin (1:2000; BD Biosciences), anti-phosphorylated (p)β-catenin (1:300; Cell 
Signaling), anti-β III tubulin (1:400; Sigma-Aldrich). The primary antibodies were 
combined with horseradish peroxidase-conjugated secondary antibodies (1:5000; Jackson 
Immunoresearch, West Grove, PA, USA). Peroxidase activity was detected using 
enhanced chemiluminescence (ECL) detection reagents (Little Chalfont, Amersham, 
UK). 
Tissue was isolated and stored as described at the end of section 3.3.1. Frozen 
tissue specimens were homogenized with steel balls (Quiagen, Germantown, MD, USA) 
in 10 µl/mg of ice-cold lysis buffer (50 mM HEPES/KOH, pH 7.4, 1% Triton X-100, 50 
mM NaF, 5 mM Na2H2P2O7, 400 mM NaCl, 40 mM β-glycerophosphate, 12.5 mM 
EGTA, 1.5 mM MgCl2, 1 mM Na3VO4, 0.5 mM serine protease inhibitor 
phenylmethylsulfonyl fluoride (PMSF) and 10 µl/ml of protease inhibitor cocktail 
containing 1 mM benzamidin, 0.28 mM leupeptin, 0.2 mM pepstatin, 0.22 mM antipain). 
The lysates were cleared by high-speed centrifugation (30000×g, 30 minutes), combined 
with Laemmli sample buffer and the samples were incubated for 20 minutes at 70 °C. 
Total amount of 50 µg of proteins were loaded per lane. The proteins were separated on 
SDS-PAGE (8.2% acrylamide (AA) with 0.2% bisacrylamide (BIS), or 6% AA with 
0.2% BIS for MAP2 protein) and transferred to Immobilon-P
SQ
 membrane (Millipore, 
Billerica, MA, USA) using Trans-Blot SD Semi-dry Transfer Cell (BioRad, Hercules, 
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CA, USA). The usual Towbin transfer buffer was used with the exception of the 6% gel 
for MAP2 protein for which the Bjerrum-Schaffer-Nielsen buffer (48 mM Tris, 39 mM 
glycine, 0.0375% SDS, pH 9.2.) was used. Samples were blocked for 1 hour with 5% 
non-fat milk and then incubated with following primary antibodies: mouse monoclonal 
anti-β-catenin (1:2000; ExBio), rabbit anti-non-phospho (active) β-catenin (1:500; Cell 
Signaling), rabbit monoclonal anti-GFAP (1:500; Cell Signaling), rabbit anti-DCX 
(1:500; Cell Signaling), rabbit monoclonal anti-MAP2 (1:500; Cell Signaling), mouse 
monoclonal anti-β III tubulin (1:400; Sigma-Aldrich), and rabbit monoclonal anti-heat 
shock protein 90 (Hsp90) (1:1500; Cell Signaling). After one hour of incubation with the 
primary antibodies (diluted in 5% BSA in PBS with 0.2% Tween 20) at room 
temperature, the membranes were washed five times for 15 minutes with PBS with 0.2% 
Tween 20, and incubated with either anti-rabbit IgG or anti-mouse horseradish 
peroxidase-conjugated antibody (1:3500; Cell Signaling) for one hour at room 
temperature. Peroxidase activity was detected using ECL detection reagent LumiGlo 
(Cell Signaling, Leiden, The Netherlands). 
 
3.9 Calcium imaging measurements 
Coverslips with cell cultures were incubated for 45 minutes in 0.5 ml of differentiation 
medium containing 4.5 µM Oregon-Green Bapta-1, AM (OGB-1) and 0.09% Pluronic F-
127 (Life Technologies, Waltham, MA, USA) in an incubator at 37 °C and 5% CO2. The 
coverslips were then transferred to the microscope superfusion chamber and three 
measurements were made on each coverslip with a sufficient distance between the 
measurement regions. During the measurements, the microscope superfusion chamber 
was continually perfused at room temperature at a flow rate of 2.5 ml/minute with 
HEPES-based aCSF containing (in mM): 135 NaCl, 2.7 KCl, 1 MgCl2, 2.5 CaCl2, 1 
Na2HPO4, 10 glucose, 10 HEPES (pH 7.4, osmolality 305 mOsm/kg, equilibrated with 
O2). The solutions of ATP, L-glutamic acid (glutamate) (both from Sigma-Aldrich, St. 
Louis, MO, USA) and HEPES-based aCSF, in which part of NaCl was replaced for KCl 
to reach 50 mM concentration of K
+
 (H-aCSF50K+), were applied through a capillary 
(internal diameter of 250 µm) located 0.5-1 mm from the measurement region and 
connected to a Perfusion Pressure Kit pressurized application system (flow rate 600 
µl/minute) controlled by a ValveBank II controller (AutoMate Scientific, Inc. Berkeley, 
CA, USA). The HEPES-based aCSF was applied before and after the applications with 
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the same flow rate so that the responses were not influenced by the application itself. The 
OGB-1 fluorescence was detected with a TILL Photonics Imaging System installed on a 
Zeiss Axioskop 2 FS Plus microscope equipped with a long-distance 40x lens (IR 
Achroplan 0.8 W, Zeiss, Gottingen, Germany). A digital camera (PCO Sensicam, 
Kelheim, Germany) was controlled by the TILLvisION software. The excitation light 
(484 nm) was generated by a Polychrome V (TILL Photonics GmbH, Grafelfing, 
Germany), filtered by a band-pass (BP) 450-490 excitation filter, reflected by a FT 510 
beam splitter and the emitted light was filtered by a long-pass (LP) 515 filter (Filter Set 
09, Zeiss, Gottingen, Germany). Images were acquired at 0.83 Hz and were analyzed 
offline. Fluorescence intensity (F) was measured in the cell bodies and expressed as 
ΔF/F0, where F0 is the baseline fluorescence intensity before drug application. The 
threshold for Ca
2+
 responses was 110% of the baseline fluorescence and the maximum 
intensity, which occurred within 1 minute from the onset of application, was taken into 
account. After the measurements, immunocytochemical stainings for GFAP, DCX, 
MAP2, and PDGFαR were performed to confirm the identity of the measured cells. 
 
3.10 Data analysis 
The data are presented as means ± standard error of the mean (S.E.M.) or as means ± 
standard deviation (S.D.) for a number (n) of cells. Student’s t-test was used to determine 
significant differences between two experimental groups, and one-way or two-way 
ANOVA with Tukey’s post hoc test was performed to determine significant differences 
among more experimental groups, unless indicated otherwise. The significance was 
calculated in the GraphPad Prism software (San Diego, CA, USA), and the values of p < 
0.05 were considered significant (*/
#
/°, one asterisk, hashtag, or circle), p < 0.01 very 
significant (**/
##
/°°, two asterisks, hashtags, or circles), and p < 0.001 extremely 
significant (***/
###










In the present work, we assessed the differentiation potential of precursor cells. The 
gathered results are divided into three more or less successive chapters. Initially, we 
performed experiments on NS/PCs derived from neonatal mice. Further, we carried out 
similar experiments on adult animals, in which we also looked into the impact of Wnt 
signaling on the differentiation potential of NS/PCs following the induction of FCI. 
Finally, we aimed to elucidate the effects of cellular signaling pathways (Wnt and Shh) 
and ischemia on the differentiation potential of NG2 glia. The chapters treating NS/PCs 
were composed of the results published in Kriska et al. (2016) together with so far 
unpublished data, while the chapters about NG2 cells were compiled based on two other 
publications (Valny et al., 2018; Honsa et al., 2016) on which the author collaborated. 
 
4.1 The differentiation potential of neonatal neural 
stem/progenitor cells 
Initial experiments on NS/PCs were commenced in neonatal mice since young animals 
are more easily available, the processing of the tissue is less time-consuming and, most 
importantly, they enable higher yields of cells. Moreover, our goal was to compare three 
transgenic mouse strains in our hands and decide which ones would be employed in 
further experiments on adult NS/PCs. We utilized several approaches evaluating cellular 
changes at mRNA, protein, and functional levels. 
 
4.1.1 Expression of Wnt signaling pathway components 
Since all the experiments on NS/PCs derived from neonatal mice were conducted in vitro, 
we first analyzed which of the 19 identified mammalian Wnt ligands were present in our 
cultures. The RT-qPCR analysis revealed the presence of Wnt4, Wnt5a, Wnt5b, Wnt7a, 
Wnt7b, Wnt9a and Wnt10b ligands, while the expression of the other Wnt ligands was 
very low or they were not expressed at all. The most abundant ligands were Wnt5a, 
Wnt7a, and Wnt7b and we observed no differences in the expression pattern among 




Figure 19. Expression of Wnt ligands in in vitro cultures. For each neonatal mouse strain, the 
expression of Wnt ligands was analyzed in two independent control samples (each performed in 
technical triplicates) that were void of 4OHT treatment. Four founder mice were used to derive 
NS/PCs for each mouse strain and the analysis was performed in technical triplicates. The average 
cycle threshold (Ct) values were normalized to the ubiquitin and β-actin housekeeping genes. The 
cells were analyzed eight days after the onset of in vitro differentiation. Abbreviations: 4OHT – 
(Z)-4-hydroxytamoxifen; Dkk1 – Dickkopf 1; dnTCF4 – dominant negative T-cell factor 4; Ex3 – 
exon 3; Wnt4-10b – Wnt signaling ligands (Kriska et al., 2016). 
 
Furthermore, we analyzed several Wnt signaling pathway components in order to 
confirm that our in vitro setting with three distinct transgenic mouse strains (Figure 12) 
represents a suitable tool for manipulating the Wnt signaling pathway. We carried out 
immunocytochemical staining (Figure 20) and Western blotting analysis (Figure 21) of β-
catenin, the main effector of the canonical Wnt pathway. After inhibiting the signaling in 
the nucleus via the production of dnTCF4, there was no significant difference in the 
levels of β-catenin protein (Figure 20A, D). Nevertheless, suppression of Wnt signaling 
by Dkk1 resulted in a marked decrease in the amount of β-catenin (Figure 20B, D). 
Conversely, the expression of the stabilized β-catenin form led to its higher abundance in 




Figure 20. Immunocytochemical staining of β-catenin. (A-C) Representative fluorescent 
images of DAPI and β-catenin staining in differentiated neonatal neural stem/progenitor cells with 
inhibited (dnTCF4, Dkk1), or activated (Ex3) Wnt signaling. Cells were treated either with 
ethanol (EtOH) or with (Z)-4-hydroxytamoxifen (4OHT) and analyzed eight days after the onset 
of in vitro differentiation. (D) Quantification of β-catenin expression, showing the proportion of 
the area of positively-stained cells to the DAPI-positive area (n=12). The area of β-catenin 
fluorescence in control cells (EtOH) was arbitrarily set to 1. The values are represented as mean ± 
S.D. (standard deviation). Statistical significance was calculated using t-test; ***, p ˂ 0.001. 
Abbreviations: DAPI – 4',6-diamidino-2-phenylindole; Dkk1 – Dickkopf 1; dnTCF4 – dominant 
negative T-cell factor 4; Ex3 – exon 3; n – number (adapted from Kriska et al. (2016)). 
 
This stabilized, truncated β-catenin protein in Ex3 cells was also detected on 
Western blots (Figure 21A, B). Note that β-catenin in Ex3 cultures migrates as a doubled 
band because of the fact that the mutated variant lacks amino acids encoded by exon 3. 
As we expected, lower quantity of the N-terminally phosphorylated protein was also 
observed in these cultures. 
Using Quantity One software (Bio-Rad, Hercules, CA, USA), we estimated the β-
catenin-to-phosphorylated-β-catenin ratio of the peak heights in control EtOH- and 
4OHT-treated cells. In differentiated NS/PCs derived from dnTCF4 and Dkk1 strains, the 
ratio lowered only negligibly (from 1.27 to 0.84 in Dkk1, and from 1.00 to 0.85 in 
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dnTCF4 mice). On the contrary, in Ex3 cells the ratio increased considerably from 0.90 in 
EtOH to 7.46 in 4OHT. Additionally, we performed the densitometric analysis (Figure 
21B), which confirmed the changes in the β-catenin expression that corresponded to 
inhibition or activation of the pathway. 
 
 
Figure 21. Levels of β-catenin protein in differentiated neonatal neural stem/progenitor 
cells. (A) Western blotting analysis of total (β-cat) and phosphorylated (pβ-cat) β-catenin, with 
intensity profiles representing the number and size of the respective bands. Arrowheads mark the 
molecular weight of β-catenin, which is 92 kDa. Together, four founder mice were used to derive 
NS/PCs for each mouse strain, and the analysis was performed in technical triplicates. The cells 
were analyzed eight days after the onset of in vitro differentiation. (B) Densitometric analysis 
representing quantification of the Western blots shown in (A). The diagrams show the average 
optical density (OD) of detected β-catenin and phosphorylated β-catenin bands. Values obtained 
from cells in controls (EtOH) were arbitrarily set to 100%. The levels of the individual proteins, 
or their forms, were normalized to the β-actin (β-act) signal. Error bars represent S.D. (standard 
deviation). Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Dkk1 – Dickkopf 1; dnTCF4 – 
dominant negative T-cell factor 4; Ex3 – exon 3 (adapted from Kriska et al. (2016)). 
 
Additionally, we analyzed the expression of three Wnt signaling target genes, 
namely Axin2, SP5 transcription factor (Sp5), and tumor necrosis factor receptor 
superfamily member 19 (Troy; Figure 22). Suppression of Wnt signaling in the nucleus 
led to lower expression of Sp5 (average cycle threshold (Ct) value of 34.23 ± 0.37 in 
EtOH changed to average Ct value of 36.13 ± 0.13 in 4OHT-treated cultures) and Troy 
(28.11 ± 0.06 to 28.47 ± 0.11), while no changes in the expression of Wnt target genes 
were detected after inhibiting the pathway at the membrane level. Hyper-activation of the 
Wnt/β-catenin pathway resulted in markedly higher expression of all examined target 
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genes (32.74 ± 0.14 to 27.49 ± 0.10 in Axin2, 35.88 ± 0.17 to 26.55 ± 0.10 in Sp5, and 
28.86 ± 0.42 to 23.75 ± 0.21 in Troy). 
 
 
Figure 22. Expression of Wnt target genes in differentiated neonatal neural stem/progenitor 
cells. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis of Wnt 
signaling target genes was employed. Together, four founder mice were used to derive NS/PCs 
for each mouse strain and the analysis was performed in technical triplicates. The average cycle 
threshold (Ct) values were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
and two other housekeeping genes (ubiquitin (Ubb) and β-actin (β-act)) are shown in the graph. 
Axin2, Sp5 and Troy are Wnt target genes. The expression level of a given gene in control cells 
(EtOH) was arbitrarily set to 1. The cells were analyzed eight days after the onset of in vitro 
differentiation. Statistical significance was calculated using t-test; *, p ˂ 0.05; **, p ˂ 0.01; ***, p 
˂ 0.001. Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Dkk1 – Dickkopf 1; dnTCF4 – 
dominant negative T-cell factor 4; Ex3 – exon 3; NS/PCs – neural stem/progenitor cells; Sp5 – 
SP5 transcription factor; Troy – tumor necrosis factor receptor superfamily member 19 (adapted 
from Kriska et al. (2016)). 
 
Collectively, the analysis of the components of the Wnt pathway described above 
indicate that employing NS/PCs from the neonatal brain of the three transgenic mouse 
strains may represent a suitable in vitro system for manipulating Wnt signaling. In these 
experiments, we showed that activation of the pathway resulted in higher amounts of β-
catenin protein with a consequent increase in the expression of Wnt target genes in 
differentiated NS/PCs. The analysis of inhibited pathway at the membrane level or in the 
nucleus revealed lower quantities of β-catenin protein and decreased expression of Wnt 
target genes, respectively. 
 
4.1.2 Cell types generated from neonatal NS/PCs and their incidence 
In the following series of experiments, we first aimed to identify cellular types generated 
from NS/PCs in our in vitro system, and then to evaluate their incidence in EtOH- and 
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4OHT-treated cultures. In order to estimate the impact of Wnt signaling inhibition or 
activation on neonatal NS/PCs differentiation, we employed the patch-clamp technique in 
the whole-cell configuration and with this approach, we assessed the current profiles of 
cells differentiated in vitro. The measurement of electrophysiological properties was 
supplemented with immunocytochemical staining. Together, we identified three distinct 
subpopulations of cells in EtOH- (n=347) and 4OHT-treated (n=380) cultures. These cell 
types were subsequently divided into three groups according to their electrophysiological 
and immunochemical properties (Figure 23A-G). Flat-shaped GFAP-positive cells 
(n=242; Figure 23D) predominantly displayed passive time- and voltage-independent K
+
 
currents (Figure 23A), their average Vm was -86.38 ± 0.26 mV, and their IR was 81.62 ± 
1.91 MΩ. Round DCX/MAP2-positive cells (n=289; Figure 23F, G), expressing KA and 
KDR currents (Figure 23C), were characterized by Vm of -72.04 ± 0.90 mV, and high 
values of IR (1649.79 ± 44.05 MΩ). Branched PDGFαR-positive cells (n=196; Figure 
23E), with a complex current pattern, expressed KIR currents, in addition to KDR and KA 
currents (Figure 23B), their Vm was -85.78 ± 0.45 mV, and IR was 218.56 ± 8.24 MΩ. 
Additionally, we took advantage of A488-filled glass capillaries and performed post-
recording immunocytochemical identification that revealed that the majority of cells 
expressing passive currents were GFAP-positive, while most of the cells displaying 
outwardly rectifying currents were positive to DCX or MAP2. Complex currents were 




Figure 23. Characterization of cell types identified in the cultures of differentiated neural 
stem/progenitor cells. Together, three distinct cell types were found in the in vitro cultures. Cells 
with a passive current pattern (A) are mostly GFAP-positive and flat-shaped (D). They display 
predominantly time- and voltage-independent K
+
 currents, together with small amplitudes of 
delayed outwardly rectifying K
+
 currents (KDR) and inwardly rectifying K
+
 currents (KIR). The 
majority of cells displaying a complex current profile (B) are branched or bipolar, and PDGFαR-
positive (E). They express fast activating and inactivating outwardly rectifying K
+
 currents (KA), 
as well as KDR and KIR currents. Cells with an outwardly rectifying current pattern (C) are 
DCX/MAP2-positive, with a round shape (F, G), and express KA and KDR currents. Current 
patterns were obtained by hyper- and depolarizing the cell membrane from the holding potential 
of -70 mV to the values ranging from -160 mV to 40 mV, at 10 mV increments. Scale bar = 50 
µm. Abbreviations: DCX – doublecortin; GFAP – glial fibrillary acidic protein; MAP2 – 
microtubule-associated protein 2; PDGFαR – platelet-derived growth factor alpha receptor 
(Kriska et al., 2016). 
 
The electrophysiological analyses also showed that Wnt signaling inhibition in 
both dnTCF4 and Dkk1 cultures markedly lowered the incidence of cells displaying 
outwardly rectifying currents, and also marginally raised the incidence of cells with a 
passive current profile (Figure 24). On the other hand, activation of the pathway (Ex3) led 
to decreased numbers of cells with a passive current profile, and to increased numbers of 
cells with an outwardly rectifying current pattern. However, neither of these changes in 
the cell incidence was significant (Figure 24). Any manipulation of the pathway caused 
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an increase in the incidence of cells displaying complex currents. Nevertheless, such 
increase was statistically significant only in dnTCF4 cells (Figure 24). 
 
 
Figure 24. Alterations in the incidence of distinct cell types after Wnt signaling 
manipulation. The incidence of cells displaying passive (pas), complex (com) or outwardly 
rectifying (out) current profiles in neonatal cell cultures was assessed. Four (Dkk1 mice) or three 
(dnTCF4 and Ex3 mice) founder mice were used to derive NS/PCs, and the incidence was 
quantified from the following total number of cells (in brackets): dnTCF4-EtOH (149), dnTCF4-
4OHT (184), Dkk1-EtOH (97), Dkk1-4OHT (101), Ex3-EtOH (101), and Ex3-4OHT (95). The 
relative incidence of cells in controls (EtOH) was arbitrarily set to 1; *, p ˂ 0.05; **, p ˂ 0.01. 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Dkk1 – Dickkopf 1; dnTCF4 – dominant 
negative T-cell factor 4; Ex3 – exon 3; NS/PCs – neural stem/progenitor cells (adapted from 
Kriska et al. (2016)). 
 
Immunocytochemical analysis confirmed lower expressions of DCX and MAP2 in 
the cultures with suppressed Wnt signaling and decreased expression of GFAP in the 
cultures with activated Wnt signaling (Figure 25A, B). Furthermore, Western blotting 
revealed higher β III tubulin expression in the cultures with hyper-activated pathway 




Figure 25. Immunocytochemical staining of cell-type-specific proteins. (A) Representative 
images of stainings against glial fibrillary acidic protein (GFAP; top), doublecortin (DCX; 
middle) and microtubule-associated protein 2 (MAP2; bottom). Scale = 50 µm. (B) 
Quantification of GFAP, DCX and MAP2 expression showing the area of positively stained cells 
within 318.2 µm x 318.2 µm large inspected region (n=6). The area of immunopositive 
fluorescence in control cells (EtOH) was arbitrarily set to 1. Western blotting analysis of β III 
tubulin (βIIItub; see inset); **, p ˂ 0.01; ***, p ˂ 0.001. Abbreviations: 4OHT – (Z)-4-
hydroxytamoxifen; β-act – β-actin; Dkk1 – Dickkopf 1; dnTCF4 – dominant negative T-cell 
factor 4; Ex3 – exon 3; n – number (adapted from Kriska et al. (2016)). 
 
Hence, activation of the Wnt signaling pathway increases the expression of β III 
tubulin, a neuronal marker, and decreases the incidence of GFAP-positive glial cells 
displaying passive time- and voltage-independent K
+
 currents. In contrast, upon 
suppression of the Wnt pathway, the incidence of GFAP-positive cells is increased. At the 
same time, the number of DCX/MAP2-positive neuronal cells showing outwardly 
rectifying K
+
 currents is decreased. Taken together, all these findings imply that our in 
vitro approach may serve as a suitable tool to study the role of Wnt signaling in neonatal 
neurogenesis and gliogenesis. 
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4.1.3 Properties of differentiated neonatal neural stem/progenitor cells 
Finally, we tried to characterize the three identified cell types after Wnt signaling 
manipulation. For this reason, we assessed the membrane properties of differentiated 
neonatal NS/PCs using the patch-clamp technique in the whole-cell configuration and 
calcium imaging. 
The electrophysiological membrane properties of 1245 differentiated cells were 
analyzed by the patch-clamp technique. In the cells displaying a passive current pattern, 
the impact of Wnt signaling pathway manipulation on their electrophysiological 
properties was minimal (Table 2). Inhibited Wnt signaling affected mainly passive 
electrophysiological properties (Vm, Cm), as we found that dnTCF4 and Dkk1 expression 
resulted in hyperpolarized cell membrane, and lower Cm values. However, Wnt/β-catenin 
signaling had a more profound effect on electrophysiological properties of differentiated 
progenitors showing a complex current pattern (Table 3). Their Cm decreased after Wnt 
signaling inhibition, while it was marginally elevated after its activation. Interestingly, 
current densities of KIR currents were higher regardless of Wnt signaling 
inhibition/activation. Wnt signaling manipulation also affected electrophysiological 
properties of cells expressing outwardly rectifying currents (Table 4). Both inhibition and 
activation of the Wnt pathway caused hyperpolarization of the cell membrane, but only 
Wnt signaling inhibition resulted in lower Cm values. Current densities of KDR currents 















Table 2. Membrane properties of differentiated neonatal NS/PCs displaying a passive 
current pattern. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -83.3±0.6 -86.2±0.4** -85.2±0.4 -87.0±0.3* -85.7±0.3 -87.0±0.4 
IR [MΩ] 73.6±3.1 73.2±2.3 71.2±2.3 71.6±1.8 69.8±3.2 83.8±5.5 
Cm [pF] 34.4±2.2 31.3±1.6 36.7±2.0 28.2±1.2* 35.4±2.4 32.1±2.2 
KIR [pA] 74.1±7.6 77.2±5.4 58.0±4.6 56.3±3.3 71.4±6.1 86.7±6.5 
KIR/Cm [pA/pF] 2.3±0.2 3.9±0.3** 2.3±0.2 2.7±0.2 2.7±0.2 4.2±0.3** 
KDR [pA] 127.0±17.1 119.4±11.4 82.3±7.5 78.6±8.1 116.4±12.2 156.5±18.6 
KDR/Cm [pA/pF] 3.8±0.5 4.3±0.4 3.2±0.3 3.9±0.5 4.1±0.4 5.3±0.6 
n 74 92 76 110 89 65 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KDR – delayed outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; 
KIR/Cm, KDR/Cm – current densities; n – number of cells; Vm – membrane potential. Values in bold 
indicate significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 


















Table 3. Membrane properties of differentiated neonatal NS/PCs displaying a complex 
current pattern. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -83.6±1.3 -84.1±0.7 -85.2±0.9 -86.3±0.7 -86.2±1.0 -87.5±0.7 
IR [MΩ] 202.9±18.0 214.2±11.4 185.6±15.2 135.8±8.4*** 231.4±27.9 164.3±15.2 
Cm [pF] 21.9±1.7 13.7±0.7*** 22.4±1.2 16.7±0.8** 17.4±1.8 23.5±1.8 
KIR [pA] 81.2±6.6 87.4±4.7 83.0±6.6 106.7±4.9* 74.2±8.2 141.2±11.2** 
KIR/Cm [pA/pF] 4.2±0.3 7.4±0.4*** 4.0±0.3 7.8±0.5*** 4.3±0.4 7.4±0.6** 
KDR [pA] 514.9±44.2 463.0±29.4 659.8±59.3 434.6±38.7* 618.5±61.2 605.8±40.9 
KDR/Cm [pA/pF] 33.7±4.3 46.9±3.4 38.0±4.4 38.3±4.2 43.3±4.4 36.0±3.5 
KA [pA] 290.3±35.5 205.0±12.4* 369.4±62.3 278.4±22.3 229.8±24.0 275.6±38.3 
KA/Cm [pA/pF] 23.2±4.0 23.1±1.6 28.5±6.1 22.0±2.0 20.5±3.5 13.4±1.6 
n 35 95 31 58 19 40 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed 
outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; KIR/Cm, KDR/Cm, KA/Cm – 
current densities; n – number of cells; Vm – membrane potential. Values in bold indicate 
significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, 














Table 4. Membrane properties of differentiated neonatal NS/PCs displaying an outwardly 
rectifying current pattern. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -69.1±1.3 -70.7±1.7 -63.6±1.7 -74.9±2.9** -67.0±2.1 -78.7±1.6*** 
IR [MΩ] 1856.0±78.0 1817.7±98.8 1797.7±95.6 1514.3±181.8 1924.7±82.1 1434.3±115.9** 
Cm [pF] 10.6±0.4 7.5±0.3*** 11.3±0.5 7.7±0.4** 10.3±0.4 9.9±0.5 
KDR [pA] 691.0±23.2 637.3±26.0 830.1±34.6 881.1±79.0 652.7±25.3 695.6±42.1 
KDR/Cm [pA/pF] 72.1±2.2 101.0±5.1*** 87.4±3.8 132.3±14.3** 71.2±3.1 75.9±3.6 
KA [pA] 634.5±27.5 479.2±27.7** 795.1±38.5 524.0±49.5** 675.9±37.6 441.8±37.1*** 
KA/Cm [pA/pF] 68.7±3.1 78.9±5.1 92.7±5.1 79.0±9.7 80.3±5.2 55.9±5.0* 
n 128 78 90 25 77 63 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed 
outwardly rectifying K
+
 currents; KDR/Cm, KA/Cm – current densities; n – number of cells; Vm – 
membrane potential. Values in bold indicate significant differences between EtOH- and 4OHT-
treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, p ˂ 0.001 (adapted from Kriska et al. (2016)). 
 
Besides the differences in the passive membrane properties, and the expression of 
K
+
 channels, we also identified changes in the expression of voltage-dependent Na
+
 
channels in DCX/MAP2-positive neuron-like cells that expressed an outwardly rectifying 
current pattern (Figure 26A). Moreover, we detected changes in the incidence of such 
cells (Figure 26B), which were also capable of generating action potentials (Figure 26C). 
Inhibition of the Wnt signaling pathway at the membrane and nuclear level led to the 
absence of cells expressing Na
+
 channels (Figure 26B), while activation of the pathway 
caused an increase in both the Na
+




Figure 26. Voltage-gated Na
+
 channels in cells with an outwardly rectifying current profile. 
(A) A typical current pattern of a cell expressing outwardly rectifying K
+
 currents, together with 
inwardly rectifying Na
+
 currents. (B) After Wnt signaling inhibition (dnTCF4 or Dkk1), the 
incidence of cells expressing Na
+
 channels decreased. Conversely, Wnt pathway activation (Ex3) 
increased the incidence as well as the current densities of voltage-dependent Na
+
 channels. The 
numbers of cells with Na
+
 currents identified in the individual cultures were as follow (in 
brackets): dnTCF4-EtOH (4), dnTCF4-4OHT (0), Dkk1-EtOH (4), Dkk1-4OHT (0), Ex3-EtOH 
(1), and Ex3-4OHT (3). (C) A trace that represents action potentials generated by some of the 
cells. Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – 
Dickkopf 1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; Na/Cm, 
current densities of Na
+
 currents (adapted from Kriska et al. (2016)). 
 
Finally, measurements of intracellular calcium revealed that after inhibition of the 
pathway at the cell membrane level, the percentage of MAP2/DCX-positive cells 
responding to 100 µM glutamate decreased significantly, from ~90% in EtOH to ~20%, 
and the average amplitude of the glutamate-evoked response decreased by ~66% (Figure 
27A). Additionally, Dkk1 over-expression also resulted in a higher response to 50 µM 
ATP application, when compared to the controls (Figure 27A); however, the average 
amplitude of responding cells remained unchanged. On the other hand, activation of the 
pathway led to the lower average amplitude in response to ATP application (Figure 27B), 
while the Ca
2+
 elevations in response to glutamate application were comparable with 
those observed in controls (Figure 27B). Inhibition of the pathway in the nucleus 





Figure 27. Calcium responses evoked by glutamate and ATP in DCX/MAP2-positive cells. 
(A) Inhibition of Wnt signaling at the membrane level (Dkk1) significantly lowered Ca
2+
 
responses (% of responding cells and their average amplitude) to 100 µM glutamate (glu) 
application, and increased the response rate to 50 µM adenosine triphosphate (ATP) application. 
(B) Activation of the pathway (Ex3) resulted in lower average amplitudes of ATP-responding 
cells. The number of cells used in this analysis was as follows (in brackets): Dkk1-EtOH (9), 
Dkk1-4OHT (6), Ex3-EtOH (7), and Ex3-4OHT (7); 
*/#
, p ˂ 0.05; 
***/###
, p ˂ 0.001. Abbreviations: 
4OHT – (Z)-4-hydroxytamoxifen; DCX – doublecortin; Dkk1 – Dickkopf 1; EtOH – ethanol; Ex3 
– exon 3; F0 – baseline fluorescence intensity; MAP2 – microtubule-associated protein 2 (adapted 
from Kriska et al. (2016)). 
 
These results show that the alterations in β-catenin signaling influence the 
distribution of distinct K
+
 channels as well as the ability of cells to transport Ca
2+
 after the 
application of glutamate and ATP. Furthermore, the activation of the Wnt signaling 
pathway increases the incidence of cells expressing outwardly rectifying K
+
 currents 




Taken together, the data from our in vitro systems modulating the output of the canonical 
Wnt signaling pathway suggest that hyper-activation of the pathway leads to higher 
neurogenesis, while gliogenesis is suppressed. Conversely, inhibition of the pathway at 
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both membrane receptor and nuclear levels showed comparable results and promoted 
gliogenesis at the expense of neurogenesis. These findings are summarized in the 
following diagram (Figure 28). 
 
 
Figure 28. Graphical representation of the changes observed in neonatal mice. According to 
our analyses, Wnt signaling inhibition (dnTCF4 or Dkk1) led to the differentiation of NS/PCs to 
the glial phenotype, while activation of the pathway by the stabilization of protein β-catenin (Ex3) 
promoted neurogenesis. Abbreviations: Dkk1 – Dickkopf 1; dnTCF4 – dominant negative T-cell 
factor 4; Ex3 – exon 3; NS/PCs – neural stem/progenitor cells (Kriska et al., 2016). 
 
4.2 The differentiation potential of adult neural 
stem/progenitor cells 
The analysis of various Wnt pathway components in neonatal animals taught us that we 
cannot leave out any of the three mouse strains because each of them behaves slightly 
differently. Therefore, after we assessed the effect of canonical Wnt signaling on cell 
cultures derived from neonatal mice, we went on to the experiments on NS/PCs isolated 
from adult (two-month-old) animals of the same transgenic strains. The purpose of these 
experiments was to disclose the differentiation potential of NS/PCs also in a model that 
resembles more the processes occurring in the mature age. To elucidate the impact of the 
Wnt/β-catenin pathway on the differentiation potential of NS/PCs in non-operated 
(CTRL) mice and mice after the induction of permanent FCI (MCAO), we compared 
either in vitro cultures treated with 4OHT to their respective controls (EtOH) or tissue 
specimens from mice with manipulated Wnt signaling (TAM) to control mice with intact 




4.2.1 Expression of Wnt signaling pathway components 
Similarly to the experiments on cells derived from neonatal mice, we aimed to determine 
the extent to which the components of the canonical Wnt pathway are altered in our 
models. Initially, we utilized immunocytochemical staining against the principal element 
of the signaling, i.e. β-catenin (Figure 29). Although we did not detect any changes in the 
expression of the protein after Wnt signaling inhibition in the cell nucleus (Figure 29A, 
D), we identified decreased amounts of β-catenin after Wnt signaling inhibition at the 
membrane receptor level (Figure 29B, D). In cells with hyper-activated Wnt signaling 
(Ex3), the expression of the protein was increased (Figure 29C, D). All these results 
correlate well with the findings in neonatal cultures (Figure 20). 
 
 
Figure 29. Immunocytochemical staining of β-catenin. (A-C) Representative fluorescent 
images of DAPI and β-catenin staining in differentiated adult neural stem/progenitor cells with 
inhibited (dnTCF4, Dkk1), or activated (Ex3) Wnt signaling. Cells were treated either only with 
ethanol (EtOH) or with (Z)-4-hydroxytamoxifen (4OHT) dissolved in ethanol, and analyzed eight 
days after the onset of in vitro differentiation. (D) Quantification of β-catenin expression, showing 
the proportion of the area of positively-stained cells to the DAPI-positive area (n=12). The area of 
β-catenin fluorescence in control cells (EtOH) was arbitrarily set to 1. The values are represented 
as mean ± S.D. (standard deviation). Statistical significance was calculated using t-test; **, p ˂ 
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0.01. Abbreviations: DAPI – 4',6-diamidino-2-phenylindole; Dkk1 – Dickkopf 1; dnTCF4 – 
dominant negative T-cell factor 4; Ex3 – exon 3; n – number (unpublished data). 
 
In the following experiments, we evaluated the effect of Wnt signaling 
manipulation in tissue slices or their lysates. The incentive behind using tissue specimens 
was the low yield of cells that were derived from adult mice and cultured in vitro. First, 
we assessed the quantities of total β-catenin protein and its non-phosphorylated, active 
form (Figure 30). However, the results from Western blotting did not correspond well 
with the findings from immunocytochemistry (Figure 29). We were not able to detect any 
differences in the expression of total β-catenin. Moreover, the expression of active β-
catenin showed no changes in CTRL animals, but we observed significant alterations 
after the induction of FCI (Figure 30). We identified decreased amounts of this protein 
after Wnt signaling inhibition in the nucleus (from 6.56 ± 0.56 to 2.70 ± 0.38) and Wnt 
signaling hyper-activation (from 2.93 ± 0.19 to 1.62 ± 0.16), while inhibition at the 
cellular membrane increased the expression of active β-catenin (from 2.30 ± 0.07 to 3.93 
± 0.02). 
Next, to estimate the activity of β-catenin, we calculated the non-phosphorylated-
β-catenin-to-β-catenin ratio. In cells with inhibited Wnt signaling in the nucleus, the ratio 
decreased from 1.15 to 0.89 in controls and it decreased almost to the half, from 1.01 to 
0.52 after FCI. The data from controls correlated well with our findings in neonatal mice 
and the results from MCAO mice showed that ischemia increased the effect of Wnt 
signaling. Inhibition at the membrane level led to a slight decrease from 0.42 to 0.31 in 
CTRL mice, while after FCI, the ratio raised two-fold, from 0.12 to 0.24. The overall low 
values in Dkk1 cultures were caused by relatively high expression of total β-catenin. 
Surprisingly, activation of the Wnt pathway resulted in a lower non-phosphorylated-β-
catenin-to-β-catenin ratio (from 1.12 to 0.69 in CTRL cells and from 1.02 to 0.88 in 
MCAO cells). This decrease in the proportion of active protein after Wnt signaling hyper-

















Figure 30. Levels of β-catenin protein 
in differentiated adult neural 
stem/progenitor cells. Densitometric 
analysis of Western blots assessing total 
(β-cat) and active, non-phosphorylated 
(non-P β-cat) β-catenin. Together, eight 
founder mice were used to isolate the 
subventricular zones from each mouse 
strain. The tissues were analyzed either  
in non-operated, control mice (CTRL) or mice after middle cerebral artery occlusion (MCAO), 
with Wnt signaling either non-manipulated (CO) or manipulated (TAM). Error bars represent 
S.E.M. (standard error of the mean). Abbreviations: CO – corn oil; Dkk1 – Dickkopf 1; 
dnTCF4 – dominant negative T-cell factor 4; Ex3 – exon 3; TAM – tamoxifen (unpublished 
data). 
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Additionally, we analyzed the expression of Wnt target genes using RT-qPCR 
(Figure 31). In adult NS/PCs, four different target genes were examined, namely Axin2, 
naked cuticle homolog 1 (Nkd1), Sp5, and Troy. Their expression was either 
downregulated or not changed in CTRL mice of all strains. There was one exception, the 
Sp5 gene, which was always upregulated. The expression pattern was similar in MCAO 
mice; however, a striking increase in the expression of Wnt target genes was observed 
(Figure 31). Interestingly, the expression of the Sp5 gene was dramatically decreased after 
the induction of FCI. 
Thus, the analysis of the expression of Wnt signaling pathway components 
revealed several similarities with neonatal cell cultures. The system worked very well in 
vitro. We detected the same expression pattern of β-catenin protein, but different 
expression of its active form, especially after Wnt signaling hyper-activation. Moreover, 
the expression of the Wnt target genes was influenced by Wnt signaling manipulation and 





Figure 31. Expression of Wnt target 
genes in differentiated adult neural 
stem/progenitor cells. Reverse 
transcription quantitative polymerase 
chain reaction (RT-qPCR) analysis was 
used to assess the mRNA abundance of 
Wnt target genes. Together, eight founder 
mice were used to isolate the 
subventricular zones from each mouse 
strain, and the analysis was performed in 
technical triplicates. The average cycle 
threshold (Ct) values were normalized to 
glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). Axin2, Nkd1, 
Sp5, and Troy are Wnt target genes. The 
expression levels of a given gene in 
control cells (CTRL+CO) were arbitrarily 
set to 1. The tissues were analyzed either 
in non-operated control mice (CTRL) or 
mice after middle cerebral artery occlusion 
(MCAO), with Wnt signaling either non-
manipulated (CO) or manipulated (TAM). 
Statistical significance was calculated 
using t-test; *, p ˂ 0.05; **, p ˂ 0.01; ***, 
p ˂ 0.001. Abbreviations: CO – corn oil; 
Dkk1 – Dickkopf 1; dnTCF4 – dominant 
negative T-cell factor 4; Ex3 – exon 3; 
mRNA – messenger RNA; Nkd1 – naked 
cuticle homolog 1; Sp5 – SP5 transcription 
factor; TAM – tamoxifen; Troy – tumor 
necrosis factor receptor superfamily 
member 19 (unpublished data). 
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4.2.2 Cell types derived from adult NS/PCs and their incidence 
In accordance with the study in neonatal mice, we identified the same three cell types that 
represent differentiated adult NS/PCs (Figure 23). The division into the three groups was 
based on the electrophysiological and immunocytochemical properties of the cells. Their 
incidence in in vitro cultures derived from adult mice was calculated from the patch-
clamp experiments. With this technique, we analyzed the properties of 413 EtOH- and 
452 4OHT-treated cells from CTRL mice. In MCAO mice, we assessed 230 EtOH- and 
231 4OHT-treated cells. Initially, we failed to identify any alterations in the cell incidence 
caused by Wnt signaling pathway manipulation in CTRL cells (Figure 32A). This is in 
contrast with neonatal mice, where we disclosed suppressed neurogenesis after Wnt 
signaling inhibition. Interestingly, the trend in the incidence of differentiated cells after 
MCAO resembled the results from neonatal mice. However, significant changes were 
found only in the cultures with inhibited Wnt signaling at the membrane level (Dkk1 
mice; Figure 32B). In these cultures, we observed decreased numbers of cells showing an 
outwardly rectifying current pattern (from 49.17 ± 3.61% in EtOH to 16.91 ± 5.11% in 
4OHT) and increased counts of cells with a complex current profile (from 20.42 ± 3.25% 




Figure 32. Changes in the incidence of distinct cell types after Wnt signaling manipulation 
in intact and ischemic mice. The incidence of cells showing passive (pas; in green), complex 
(com; in blue) or outwardly rectifying (out; in red) current patterns was examined in neural 
stem/progenitor cell (NS/PC) cultures derived from adult control, non-operated (CTRL) as well as 
operated (MCAO) mice. Eight founder mice were used to derive NS/PCs from each mouse strain. 
The incidence was quantified from the following total number of cells (in brackets): CTRL-
dnTCF4-EtOH (145), CTRL-dnTCF4-4OHT (141), CTRL-Dkk1-EtOH (116), CTRL-Dkk1-
4OHT (114), CTRL-Ex3-EtOH (152), CTRL-Ex3-4OHT (197), MCAO-dnTCF4-EtOH (75), 
MCAO-dnTCF4-4OHT (72), MCAO-Dkk1-EtOH (75), MCAO-Dkk1-4OHT (79), MCAO-Ex3-
EtOH (80), and MCAO-Ex3-4OHT (80). The incidence of cells in controls (EtOH) was compared 
to the incidence of the same cell types in cells with manipulated Wnt signaling (4OHT) with 
Student’s t-test. **, p ˂ 0.01. Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; MCAO – middle 
cerebral artery occlusion (unpublished data). 
 
Next, we analyzed the expression of cell-type-specific proteins utilizing Western 
blotting (Figure 33). We evaluated the proteins characteristic of astrocytes (GFAP), 
neuroblasts (DCX) and mature neurons (MAP2 and β III tubulin) in tissue lysates; 
however, changes in their expression caused by Wnt signaling manipulation were rare. 
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After inhibition of the Wnt pathway in the nucleus (dnTCF4), we detected lower 
expression of β III tubulin in mice after FCI (MCAO). The trend of decreased numbers of 
neuron-like cells was observed also in the experiments analyzing the incidence of distinct 
cell types. Surprisingly, after Wnt signaling inhibition due to the over-expression of Dkk1 
protein, cells displayed higher expression of MAP2 only after ischemia. Finally, hyper-
activated Wnt signaling led to lower expression of DCX in CTRL mice, while the 
expression of MAP2 increased after FCI. Increased expression of neuronal markers after 
Wnt signaling activation was identified also in neonatal mice, while together with the 




Figure 33. Expression of cell-type-
specific proteins in differentiated 
adult neural stem/progenitor cells. 
Densitometric analysis of Western 
blots assessing the abundance of 
proteins GFAP (marker of 
astrocytes), DCX (neuroblasts), 
MAP2, and β3-tubulin (both 
neurons). The tissues were analyzed 
either in non-operated, control mice 
(CTRL) or mice after middle cerebral 
artery occlusion (MCAO), with Wnt 
signaling either non-manipulated 
(CO) or manipulated (TAM). Error 
bars represent S.E.M. (standard error 
of the mean); *, p ˂ 0.05; **, p ˂ 
0.01. Abbreviations: CO – corn oil; 
DCX – doublecortin; Dkk1 – 
Dickkopf 1; dnTCF4 – dominant 
negative T-cell factor 4; Ex3 – exon 
3; GFAP – glial fibrillary acidic 
protein; MAP2 – microtubule-
associated protein 2; TAM – 
tamoxifen (unpublished data). 
86 
 
Additionally, we performed immunohistochemical analysis in situ in coronal brain 
sections where we analyzed the expression of DCX (marker of neuroblasts), GFAP 
(marker of astrocytes), and PCNA (marker of dividing cells) in the SVZ (Figure 34). We 
observed higher overall immunopositivity after the induction of FCI (Figure 34A, B, C, 
D), which is a hallmark of ischemia-induced changes in the brain and corresponds well 
with the results obtained from RT-qPCR analysis (Figure 31) and to some extent also 
with the data from Western blotting experiments (Figure 33). Furthermore, Wnt signaling 
inhibition caused higher expression of GFAP and lower expression of DCX in both 
CTRL and MCAO mice, while the immunopositivity of PCNA was decreased only in 
MCAO mice. These observations were more significant after Wnt signaling inhibition in 
the cell nucleus (Figure 34B, C). Conversely, Wnt signaling hyper-activation resulted in 
the overexpression of PCNA and DCX in CTRL mice, while this effect was diminished 
after FCI. Moreover, activation of the pathway resulted in the decreased expression of 




Figure 34. Immunohistochemical analysis of the subventricular zone of adult mice. Inhibition 
or activation of the canonical Wnt signaling pathway changes the incidence of cell types in the 
88 
adult mouse subventricular zone (SVZ) under control, physiological conditions (CTRL) as well as 
upon focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO). (A) 
Representative images of the SVZ isolated from CTRL and MCAO mice. Increased stainings of 
neuroblasts marked by doublecortin (DCX), glial fibrillary acidic protein (GFAP)-positive 
astrocytes, and dividing cells harboring proliferating cell nuclear antigen (PCNA) were recorded 3 
days after the induction of ischemia. Scale bar = 0.2 mm. (B-D) Quantification of 
immunohistochemical staining in the SVZ of CTRL and MCAO mice treated either with 
tamoxifen (TAM) or vehicle, corn oil only (CO). Tamoxifen-induced production of dominant 
negative human TCF4 protein (dnTCF4; B) and Dickkopf-1 Wnt inhibitory protein (Dkk1; C) 
were used to achieve Wnt signaling inhibition and, conversely, production of constitutively active 
β-catenin (Ex3; D) was initiated in order to obtain Wnt pathway activation. Experiments were 
performed using two biological replicates and three technical replicates for each treatment (n = 6). 
Average values of the control mice (CTRL CO) were arbitrary set to 100% of immunogenic 
signal. Error bars represent standard deviation (S.D.) and one-way ANOVA was used to 
determine significant differences among the experimental groups; *, p < 0.05; **, p < 0.01; ***, p 
< 0.001; ****, p < 0.0001. Abbreviations: DAPI – 4',6-diamidino-2-phenylindole; Ex3 – exon 3; 
n – number; TCF4 – T-cell factor (unpublished data). 
 
Taken together, our data showed that Wnt signaling influences the incidence of 
distinct cell types; however, various experimental approaches proved this to various 
extents. Electrophysiological measurements revealed alterations in the incidence only 
after FCI induction (Figure 32), while the immunohistochemical analysis showed a wide 
variety of changes caused by Wnt signaling manipulation in both non-ischemic and 
ischemic tissue (Figure 34). 
 
4.2.3 Properties of differentiated adult neural stem/progenitor cells 
The electrophysiological characterization of membrane properties was conducted also in 
adult mice as we utilized the patch-clamp technique measurements on in vitro 
differentiated NS/PCs. Together 1,355 cells were analyzed and the effect of Wnt 
signaling manipulation in CTRL and MCAO mice was investigated in cells with a 
passive, complex and outwardly rectifying current profile (Tables 5-10). 
 
Cells with a passive current profile 
In cells with a passive current pattern, the changes in the membrane properties were 
sporadic (Tables 5 and 6). Wnt signaling manipulation affected only the passive 
electrophysiological properties and the strongest effect was identified in the Vm after the 
induction of FCI. We found that after Wnt signaling inhibition, the cells became 
hyperpolarized. In dnTCF4 mice, the Vm changed from -84.9 ± 0.7 mV in EtOH to -87.1 
89 
± 0.4 mV in 4OHT, while in Dkk1 mice, its value changed from -86.0 ± 0.6 mV in EtOH 
to -89.1 ± 0.3 mV in 4OHT. Such hyperpolarization under ischemic conditions was 
observed in all analyzed cell types. 
 
Table 5. Membrane properties of differentiated adult NS/PCs isolated from CTRL mice, 
and showing a passive current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -84.5±0.7 -83.0±1.0 -86.8±0.9 -85.5±1.0 -85.4±0.7 -87.6±0.6* 
IR [MΩ] 67.6±4.2 66.7±2.8 49.1±3.1 75.3±4.5*** 89.4±5.0 79.2±4.0 
Cm [pF] 27.1±2.3 30.4±2.9 31.4±2.8 21.7±1.7** 22.6±1.8 20.7±1.4 
KIR [pA] 59.4±5.0 56.1±6.3 62.2±14.0 63.9±8.3 57.0±12.8 45.8±4.6 
KIR/Cm [pA/pF] 2.9±0.3 2.5±0.4 2.4±0.7 3.2±0.4 3.5±0.9 2.7±0.3 
KDR [pA] 75.9±18.4 126.8±26.9 166.2±39.1 144.0±31.9 116.7±20.4 74.9±11.8 
KDR/Cm [pA/pF] 4.0±0.8 6.3±1.5 7.4±2.3 8.7±3.0 5.8±1.0 3.9±0.6 
n 62 55 25 25 61 63 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KDR – delayed outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; 
KIR/Cm, KDR/Cm – current densities; n – number of cells; Vm – membrane potential. Values in bold 
indicate significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 














Table 6. Membrane properties of differentiated adult NS/PCs isolated from MCAO mice, 
and showing a passive current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -84.9±0.7 -87.1±0.4** -86.0±0.6 -89.1±0.3*** -86.1±0.3 -85.5±0.6 
IR [MΩ] 50.1±3.6 47.2±1.9 44.4±3.5 46.3±2.5 45.9±2.1 48.3±2.8 
Cm [pF] 40.6±5.0 36.3±2.4 46.6±4.7 36.5±3.5 53.5±9.5 51.4±10.6 
KIR [pA] 91.7±10.6 67.6±13.3 109.0±27.0 113.3±14.8 77.9±13.1 70.7±9.0 
KIR/Cm [pA/pF] 2.4±0.4 1.9±0.3 2.9±0.6 4.2±0.6 2.0±0.3 2.1±0.3 
KDR [pA] 151.1±20.6 133.1±16.8 227.6±48.1 180.4±28.5 218.0±29.4 173.2±26.5 
KDR/Cm [pA/pF] 5.9±1.1 4.2±0.5 5.6±1.0 4.6±0.7 5.8±0.7 4.7±0.7 
n 25 40 23 32 39 30 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KDR – delayed outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; 
KIR/Cm, KDR/Cm – current densities; n – number of cells; Vm – membrane potential. Values in bold 
indicate significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 
0.01 (unpublished data). 
 
Cells with a complex current profile 
In cells with a complex current pattern, we observed opposite effects of Wnt signaling 
inhibition and activation on the values of Vm (Tables 7 and 8). Inhibition of the pathway 
resulted in hyperpolarization, while Wnt signaling activation led to depolarization of the 
membrane. Besides the passive membrane properties, Wnt signaling manipulation 
influenced also the expression of voltage-gated K
+
 channels in this cell type. After Wnt 
signaling activation in CTRL mice, the densities of all examined K
+
 currents decreased. 
This effect of Wnt signaling subsided after the induction of FCI, which is in accordance 
with our observation that under ischemic conditions, the majority of K
+
 currents were 






Table 7. Membrane properties of differentiated adult NS/PCs isolated from CTRL mice, 
and showing a complex current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -82.9±1.0 -88.6±0.7*** -89.0±0.9 -86.9±0.9 -88.8±0.8 -86.5±0.7* 
IR [MΩ] 138.2±12.8 153.0±13.8 136.4±9.7 136.3±9.0 175.6±14.0 138.6±7.7* 
Cm [pF] 16.9±1.6 12.7±0.8* 14.5±1.1 15.2±1.3 15.7±1.2 16.6±1.1 
KIR [pA] 85.9±8.4 85.5±9.2 106.7±9.6 119.4±10.0 105.4±9.4 61.1±5.9*** 
KIR/Cm [pA/pF] 6.1±0.6 7.7±0.9 8.3±0.8 10.7±1.2 7.9±0.7 4.5±0.5*** 
KDR [pA] 489.7±65.6 517.5±64.7 708.2±80.3 881.1±73.3 545.4±59.9 377.4±38.5* 
KDR/Cm [pA/pF] 34.9±5.1 52.8±9.0 54.1±6.3 76.0±9.6 42.1±5.5 25.6±2.9** 
KA [pA] 331.9±84.4 200.4±21.3 507.2±62.3 302.4±24.9* 253.9±50.1 143.6±26.6 
KA/Cm [pA/pF] 22.3±4.3 20.8±3.7 45.4±6.3 25.1±2.7* 19.2±4.3 11.4±2.4 
n 43 45 39 38 45 58 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed 
outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; KIR/Cm, KDR/Cm, KA/Cm – 
current densities; n – number of cells; Vm – membrane potential. Values in bold indicate 
significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, 














Table 8. Membrane properties of differentiated adult NS/PCs isolated from MCAO mice, 
and showing a complex current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -84.7±1.3 -88.2±0.7* -87.2±0.7 -89.4±0.6* -86.0±0.5 -85.2±1.3 
IR [MΩ] 171.9±33.5 120.7±16.3 115.4±26.3 111.8±10.6 93.1±11.4 110.6±11.9 
Cm [pF] 21.4±3.5 20.3±3.3 23.3±2.4 15.2±1.2** 34.5±13.8 18.9±2.9 
KIR [pA] 98.1±13.2 91.6±11.0 111.0±13.3 135.8±11.6 83.4±8.8 122.1±13.7* 
KIR/Cm [pA/pF] 6.1±1.0 6.3±1.2 6.3±1.4 11.7±1.6* 5.1±0.9 9.0±1.4* 
KDR [pA] 953.6±115.6 761.0±129.3 578.5±94.8 739.5±95.4 735.1±119.8 643.6±103.2 
KDR/Cm [pA/pF] 61.3±9.4 52.4±10.7 32.7±8.0 79.6±16.7 59.4±15.1 54.0±12.0 
KA [pA] 246.7±27.8 404.8±91.1 408.6±93.9 444.6±68.4 421.0±120.0 302.1±123.1 
KA/Cm [pA/pF] 15.9±4.9 27.2±8.7 26.5±9.5 39.0±7.9 38.7±13.5 26.3±11.7 
n 15 13 15 34 23 23 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed 
outwardly rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; KIR/Cm, KDR/Cm, KA/Cm – 
current densities; n – number of cells; Vm – membrane potential. Values in bold indicate 
significant differences between EtOH- and 4OHT-treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, 
p ˂ 0.001 (unpublished data). 
 
Cells with an outwardly rectifying current profile 
In cells displaying an outwardly rectifying current pattern, the effect of Wnt signaling 
inhibition on the Vm was reverse in CTRL and MCAO mice (Tables 9 and 10). In CTRL 
mice, the membrane was depolarized and conversely, after the induction of FCI, the cells 
became hyperpolarized, which was observed in all three cell types. The opposite impact 
of the Wnt signaling pathway on the Vm coincides well with the expression of K
+
 
channels mediating outward currents. After Wnt signaling inhibition, the current densities 
of KDR and KA were decreased or increased only negligibly in CTRL mice while in 
MCAO mice, their current densities increased significantly. Higher efflux of K
+
 ions out 
of the cell could potentially explain hyperpolarization observed after the induction of FCI 
in cells with a complex and outwardly rectifying current profile. 
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Table 9. Membrane properties of differentiated adult NS/PCs isolated from CTRL mice, 
and showing an outwardly rectifying current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -85.5±1.6 -79.4±1.8* -86.9±1.3 -81.8±1.2** -86.2±1.5 -77.8±1.8*** 
IR [MΩ] 997.1±97.3 887.5±96.0 959.7±97.2 352.4±30.2*** 1217.6±134.3 877.8±91.9* 
Cm [pF] 8.4±0.8 9.5±0.6 9.1±0.5 16.1±1.2*** 9.1±0.6 11.1±0.8* 
KDR [pA] 816.5±45.6 1024.3±70.0* 1149.2±65.4 1656.5±79.2*** 853.4±45.0 852.9±50.8 
KDR/Cm [pA/pF] 112.2±7.1 118.3±9.0 139.6±8.9 150.5±14.1 101.2±4.7 88.5±5.8 
KA [pA] 605.7±53.8 489.7±54.2 859.7±60.4 352.1±36.2*** 675.3±64.8 320.4±35.7*** 
KA/Cm [pA/pF] 84.5±7.6 75.5±12.3 110.9±9.8 40.1±7.2*** 80.6±7.3 44.0±7.1*** 
n 47 47 65 57 62 61 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed 
outwardly rectifying K
+
 currents; KDR/Cm, KA/Cm – current densities; n – number of cells; Vm – 
membrane potential. Values in bold indicate significant differences between EtOH- and 4OHT-
treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, p ˂ 0.001 (unpublished data). 
 
Table 10. Membrane properties of differentiated adult NS/PCs isolated from MCAO mice, 
and showing an outwardly rectifying current profile. 
 
dnTCF4 Dkk1 Ex3 
 
EtOH 4OHT EtOH 4OHT EtOH 4OHT 
Vm [mV] -77.4±2.4 -85.7±1.4* -78.1±2.3 -84.3±2.1 -80.1±2.5 -67.0±3.4** 
IR [MΩ] 1112.2±132.8 1028.2±123.1 1166.2±157.2 741.8±132.1 1230.8±228.2 1018.7±156.6 
Cm [pF] 8.9±0.4 8.8±0.3 9.0±0.4 7.9±1.3 10.2±1.1 9.1±0.8 
KDR [pA] 880.5±57.6 1296.0±156.5** 945.8±56.8 854.6±65.3 960.6±90.6 968.8±87.9 
KDR/Cm [pA/pF] 100.4±5.3 149.3±19.5** 109.5±6.7 137.1±17.1 99.3±6.6 114.6±10.9 
KA [pA] 647.0±42.8 826.3±95.9 879.1±82.3 924.1±108.3 785.4±98.2 746.5±152.4 
KA/Cm [pA/pF] 80.8±6.2 95.5±12.1 103.7±10.1 180.3±30.1** 87.5±12.3 94.9±19.4 
n 34 19 37 13 18 24 
Abbreviations: 4OHT – (Z)-4-hydroxytamoxifen; Cm – membrane capacitance; Dkk1 – Dickkopf 
1; dnTCF4 – dominant negative T-cell factor 4; EtOH – ethanol; Ex3 – exon 3; IR – input 
resistance; KA – fast activating and inactivating outwardly rectifying K
+




 currents; KDR/Cm, KA/Cm – current densities; n – number of cells; Vm – 
membrane potential. Values in bold indicate significant differences between EtOH- and 4OHT-
treated cultures; *, p ˂ 0.05; **, p ˂ 0.01; ***, p ˂ 0.001 (unpublished data). 
 
Additionally, we identified changes in the incidence of neuron-like cells 
expressing voltage-dependent Na
+
 channels (data not shown). Their counts increased both 
after Wnt signaling activation (from 3 to 11; total numbers in both CTRL and MCAO 
cultures) and its inhibition in the cell nucleus (from 3 to 9). On the other hand, the 
attenuation of the Wnt pathway at the membrane receptor level resulted in a smaller 
number of these cells (from 10 to 7). Interestingly, the same trends were found in in vitro 
cultures derived from CTRL as well as MCAO mice. Finally, the density of Na
+
 currents 
was significantly changed only in non-operated Dkk1 mice. We identified its increase 
(from 9.8 ± 1.1 pA/pF in EtOH to 19.1 ± 4.3 pA/pF in 4OHT) in cells with an outwardly 
rectifying current pattern, which could add to depolarization we observed in this cell type. 
The electrophysiological analysis gave us an outline of the effect of Wnt signaling 
on the functional properties of differentiated NS/PCs. Similar to neonatal mice, Wnt 
manipulation had a minimal impact on the electrophysiological properties of cells with a 
passive current pattern. Conversely, the most significant changes were identified after 
FCI in cells with a complex and outwardly rectifying current profile. We observed 
hyperpolarized cells especially after Wnt signaling inhibition, which can be explained by 
higher current densities of KDR and KA. Moreover, we detected only a few cells with 
voltage-dependent Na
+
 channels, corroborating our findings in neonatal cultures. These 




 channels and thus 
influences the membrane properties of differentiated cells. 
 
To summarize, the above-described experiments indicate that we were able to influence 
the output of the canonical Wnt signaling also in NS/PCs derived from adult animals. 
This was clearly documented in the experiments in vitro. When we utilized tissue lysates, 
the differences between the experimental groups became less significant. Nevertheless, 
the immunohistochemical analysis in coronal slices provided results that correspond with 
our findings in neonatal animals. Together, we found that Wnt signaling inhibition 
promotes gliogenesis and attenuates neurogenesis, while Wnt signaling activation exerts 
opposite effects. Moreover, the effects of Wnt signaling were enhanced following the 




Figure 35. Graphical representation of the changes observed in adult mice. According to our 
immunohistochemical staining analyses, Wnt signaling inhibition (dnTCF4 or Dkk1) led to the 
differentiation of NS/PCs to astrocytes, while activation of the pathway (Ex3) promoted 
neurogenesis. Similar impact of Wnt signaling manipulation after ischemia was confirmed also by 
the patch-clamp technique. Larger cells represent a greater effect of Wnt signaling after ischemia. 
Abbreviations: Dkk1 – Dickkopf 1; dnTCF4 – dominant negative T-cell factor 4; Ex3 – exon 3; 
NS/PCs – neural stem/progenitor cells (unpublished data). 
 
4.3 The differentiation potential of adult NG2 glia 
Following the experiments on NS/PCs, we turned our attention to NG2 glial cells, also 
called polydendrocytes. These cells are considered the most mitotically active glia in the 
postnatal brain (Dawson et al., 2000), which makes them a promising source of various 
newly derived cell types in the adult CNS (Kirdajova and Anderova, 2019). Here we 
analyzed the effect of cellular signaling pathways as well as the impact of FCI on the 
differentiation potential of these ubiquitous progenitors spread throughout the adult 
mammalian brain. To achieve this, we employed a transgenic mouse strain in which NG2 
cells expressed red fluorescent protein tdTomato, and thus facilitated their 'fate mapping'. 
 
4.3.1 Cell types and their incidence 
NG2 cells are restricted to the oligodendrocyte lineage under physiological conditions; 
nevertheless, ischemic injury turns them into multipotent progenitors. In this study, we 
assessed the differentiation potential of NG2 cells surrounding the ischemic lesion three, 
seven, and fourteen days after the induction of FCI by MCAO, and compared it with non-
operated controls (Figure 36A). In the CTRL cortex, we identified three distinct Tom-
96 
positive cell populations. One population expressed high levels of platelet-derived growth 
factor beta receptor (Pdgfrb), which is characteristic of pericytes. As this cell type does 
not belong to the oligodendrocyte lineage, it was from now on omitted. Employing the 
PCA analysis, comparing the expression profiles of cell-type-specific genes, we further 
identified two more Tom-positive cell types – oligodendrocytes and NG2 cells (Figures 
36A-C and 37). Oligodendrocytes (n = 46 cells and 8 mice) were characterized by the 
expression of Mbp and claudin-11 (Cldn11), while NG2 glia (n = 21 cells and 6 mice) 
expressed Cspg4 and platelet-derived growth factor α receptor (Pdgfra; Figure 36B). 
Surprisingly, Cnp, which is a marker of oligodendrocytes, was found in 90.5 ± 6.7% of 
NG2 glia. Nonetheless, its expression was 60.9 ± 1.2-fold higher in oligodendrocytes 
(Figure 36C). Besides the cell-type-specific genes, there were several other genes 
differently expressed in these two Tom-positive populations. Among others, typical 
astrocytic genes solute carrier family 1 member 2 (Slc1a2) and solute carrier family 1 
member 3 (Slc1a3), encoding excitatory amino acid transporter 2 (EAAT2; also known as 
glutamate transporter 1 (GLT-1) in mice) and excitatory amino acid transporter 1 in 
humans (EAAT1; also known as glutamate aspartate transporter 1 (GLAST-1) in mice), 
respectively, were both identified in all NG2 cells. Slc1a2 was detected in 17.4 ± 4.5% 
and Slc1a3 in 35.1 ± 5.6% of oligodendrocytes (Figure 36B). Also the expression of these 
two genes was higher in NG2 cells (Figure 36C). Another typical astroglial marker, 
glutamate-ammonia ligase (Glul), encoding glutamine synthetase (GS), was identified in 
96.6 ± 3.4% of oligodendrocytes and 61.9 ± 10.7% of NG2 glia, and its expression was 
5.7 ± 1.3-fold higher in the former (Figure 36C). Furthermore, it is known that the 
canonical Wnt signaling pathway orchestrates the regulation of oligodendrocytic 
maturation (Guo et al., 2015). For this reason, we analyzed two components of this 
pathway, Axin2 and low density lipoprotein receptor-related protein 5 (Lrp5), and found 





Figure 36. Cortical region of interest and cell types in non-operated mice. (A) Coronal brain 
slices showing the distribution of Tom-positive cells in the intact, control (CTRL) and ischemic 
(FCI) brain, and the respective cortical regions (dashed lines) isolated for experiments. (B, C) 
NG2 cells and oligodendrocytes derived from CTRL mice can be distinguished according to the 
different percentage of cells expressing various genes (B) as well as their distinct expression 
levels (C). All changes in (B) are statistically significant; ***, p ˂ 0.001. Abbreviations: Cldn11 – 
claudin-11; Cnp – 2',3'-cyclic-nucleotide 3'-phosphodiesterase; Cspg4 – chondroitin sulfate 
proteoglycan 4; Dcx – doublecortin; FCI – focal cerebral ischemia; Glul – glutamate-ammonia 
ligase; Gria2/3 – glutamate ionotropic receptor AMPA type subunit 2/3; Grik1/3 – glutamate 
ionotropic receptor kainate type subunit 1/3; Grin1/2d/3a – glutamate ionotropic receptor NMDA 
type subunit 1/2d/3; Grm3/5 – glutamate metabotropic receptor 3/5; Lrp5 – low density 
lipoprotein receptor-related protein 5; Mbp – myelin basic protein; Pdgfra – platelet-derived 
growth factor alpha receptor; Slc1a2 – solute carrier family 1 member 2; Slc1a3 – solute carrier 




Figure 37. Principal component analysis of cells derived from non-operated mice. Two 
distinct Tom-positive populations of cells of the oligodendrocytal lineage, separated based on 
their gene expression profiles, were identified as NG2 glia and oligodendrocytes. Abbreviations: 
PC – principal component; Tom – tomato (Valny et al., 2018). 
 
Following MCAO, the separation of NG2 glial (n = 199 cells and 8 mice) as well 
as oligodendroglial (n = 62 cells and 8mice) clusters became less apparent in the PCA 
analysis (Figure 38). Nevertheless, as the individual populations still expressed the cell-
type-specific genes, we were able to distinguish between them. Since the aim of this study 
was to elucidate the properties of precursor cells, we further dealt only with NG2 glia. 
After FCI induction, the expression profiles of NG2 cells became more complex and 
heterogenous and as a consequence, we merged CTRL NG2 cells with those isolated from 
MCAO mice. Subsequently, we performed SOM analysis, which divided Tom-positive 




Figure 38. Principal component analysis of cells derived from operated mice. (A) Scheme 
showing the principle of the SOM analysis. (B) Principal component analysis identified four 
distinct Tom-positive NG2 cells populations, defined by the SOM analysis and separated 
according to their gene expression profiles. The four violet/pink-ish cell subpopulations in the 
upper part of the figure represent oligodendrocytic cells, and were not incorporated in this thesis. 
Abbreviations: OL – oligodendrocyte; PC – principal component; SOM – self-organizing maps; 
td – tandem dimer; Tom – tomato (adapted from Valny et al. (2018)). 
 
One subpopulation resembled the population of NG2 cells from CTRL mice. 
These cells were further called bona fide NG2 cells (BF-NG2 cells). The other three 
subpopulations emerged after MCAO (Figure 39). One of them was characterized by a 
high incidence of cells expressing oligodendroglial markers such as Mbp (42.3 ± 9.5%), 
Cldn11 (84.6 ± 6.3%), and transcription factor 7-like 2 (Tcf7l2) (94.2 ± 4.9%), encoding 
the Tcf4 protein, which acts as a Wnt signaling component important for the maturation 
of oligodendrocytes (Guo et al., 2015). This subpopulation was termed oligodendrocyte-
like NG2 glia (OL-NG2 cells; Figure 39A) and also expressed high levels of Cldn11 and 
100 
Cnp, while Pdgfra was low when compared to BF-NG2 cells (Figure 39B). Another 
subpopulation, termed astrocyte-like NG2 glia (A-NG2 cells), predominantly expressed 
astrocytic genes Gfap (43.2 ± 6.0%) and aquaporin-4 (Aqp4; 51.6 ± 9.9%; Figure 39A), 
while Gfap levels were the highest among all subpopulations (Figure 39B). The third 
“ischemia-induced” subpopulation was composed of cells expressing the marker of 
proliferation, Mki67 (84.1 ± 8.3%) and nestin (Nes; 86.4 ± 8.7%; Figure 39A), a marker 
of precursor cells in the adult CNS. This subpopulation was named proliferating NG2 glia 
(P-NG2 cells) and was further characterized by high expression of Pcna (Figure 39B). 
Another typical feature of P-NG2 cells was high expression of Nes and Vim, while the 
latter is an intermediate filament commonly found in reactive glia (Figure 39B). 
Interestingly, the Shh signaling components Ptch1 and Smo were predominantly 
expressed in the P-NG2 cells subpopulation (81.8 ± 10.3% for Ptch1; 40.9 ± 4.0% for 
Smo; Figure 39A). 
According to our observations, the incidence of the NG2 glia subpopulations was 
distributed differently in the course of ischemia (Figure 39C). The highest incidence of P- 
and A-NG2 cells was detected three days after MCAO (31.5 ± 8.8% for P-NG2 cells; 
26.0 ± 3.9% for A-NG2 cells), while OL-NG2 cells predominated seven days after 
MCAO (34.4 ± 4.1%). At fourteen days after MCAO, the cell distribution started to 
resemble that observed in CTRL. Additionally, TAM administration on the second day 
after FCI induction resulted in a significant increase in the incidence of P-NG2 cells three 





Figure 39. Distinct cell types in operated mice. (A, B) Together four distinct subpopulations of 
Tom-positive NG2 cells derived from MCAO mice were identified according to the different 
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percentage of cells expressing various genes (A) and their distinct expression levels (B). 
Background colors in (A) highlight genes that represent markers of individual subpopulations. (C) 
In the progression of ischemia, the incidence of individual subpopulations changed. Gray 
background indicates tamoxifen administration after the onset of FCI. Scheme of tamoxifen 
administration is shown under the graph. Significance in (B) was calculated relative to the “Bona 
fide NG2 cells” subpopulation, while in (C), asterisks show significance compared to controls 
("CTRL"), hashtags show significance compared to "FCI D3", and circles show significance 
relative to "FCI D7"; *
/#/°
, p ˂ 0.05; **
/##/°°
, p ˂ 0.01; ***
/###/°°°
, p ˂ 0.001. Abbreviations: Aqp4 – 
aquaporin-4; Cldn11 – claudin-11; Cnp – 2',3'-cyclic-nucleotide 3'-phosphodiesterase; Cspg4 – 
chondroitin sulfate proteoglycan 4; D3/7/14 – day 3/7/14; Dcx – doublecortin; FCI – focal 
cerebral ischemia; Gfap – glial fibrillary acidic protein; Grin1/2d – glutamate ionotropic receptor 
NMDA type subunit 1/2d; Grm5/7 – glutamate metabotropic receptor 5/7; Mbp – myelin basic 
protein; MCAO – middle cerebral artery occlusion; Mki67 – marker of proliferation; Nes – nestin; 
Pcna – proliferating cell nuclear antigen; Pdgfra – platelet-derived growth factor alpha receptor; 
Ptch1 – patched 1; Smo – smoothened; Tcf7l2 – transcription factor 7-like 2; Tom – tomato; 
Trpv4 – transient receptor potential cation channel subfamily V member 4; Vim – vimentin 
(adapted from Valny et al. (2018)). 
 
To second our RT-qPCR data with an analysis at the protein level, we performed 
immunohistochemical stainings against markers of reactive astrocytes (GFAP), 
proliferating cells (Ki67), and oligodendrocytes (CC1). We found out that GFAP was 
expressed in 19.7 ± 3.5% of Tom-positive cells. Additionally, 10.6 ± 0.9% of Tom-
positive cells was Ki67-positive and 9.8 ± 0.8% was CC1-positive (Figure 40A-C). 
Moreover, polydendrocytes are capable of symmetric as well as asymmetric division. To 
investigate how reactive astrocytes were generated from NG2 cells, we performed EdU 
staining (Figure 41). We identified 73.1 ± 4.9% of GFAP- and Tom-positive cells as 
EdU-positive, suggesting that the rest differentiated without preceding cell division. 
Nevertheless, we were able to identify also EdU- and Tom-positive recently divided 





Figure 40. Immunohistochemical staining in operated mice. (A, B, C) Representative images 
showing the heterogeneity of NG2 glia close to the ischemic lesion seven days after MCAO. (A) 
Tom-positive NG2 glia express astroglial marker GFAP and the marker of proliferating cells, 
Ki67. (B) Tom-positive NG2 cells express GFAP together with CC1, a marker of 
oligodendrocytes. (C) Tomato-positive NG2 glia express CC1 and Ki67. Arrows signify the co-
localization of green and red signals, while arrowheads show the co-localization of red and blue 
signals. Abbreviations: CC1 – APC clone CC1; GFAP – glial fibrillary acidic protein; Ki67 – 
marker of proliferation; MCAO – middle cerebral artery occlusion; td – tandem dimer; Tom – 
tomato (Valny et al., 2018). 
 
 
Figure 41. Immunohistochemical staining of NG2-derived reactive astrocytes in operated 
mice. (A, B) Representative images show asymmetric (A) or symmetric (B) division of Tom-
positive dividing NG2 glia close to the ischemic lesion seven days after MCAO. Filled 
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arrowheads point at GFAP-negative cells, while empty arrowheads show GFAP-positive cells. 
Abbreviations: EdU – 5-ethynyl-2´-deoxyuridine; GFAP – glial fibrillary acidic protein; MCAO – 
middle cerebral artery occlusion; td – tandem dimer; Tom – tomato (adapted from Valny et al. 
(2018)). 
 
Our results show that NG2 glia under physiological conditions give rise to 
oligodendrocytes. During this process, they down-regulate the expression of Wnt pathway 
components such as Axin2 and Lrp5 (Figure 36B). Nevertheless, FCI induces the 
multipotent differentiation potential of polydendrocytes, as they are able to differentiate 
to OL-, A-, or P-NG2 cells, with their specific expression of Wnt signaling components 
and cell-type-specific genes, while the expression of Shh-associated genes was highest in 
the P-NG2 cells subpopulation. Differentiation to oligodendrocytes, reactive astrocytes, 
or proliferating cells was documented also at the protein level. Finally, we proved that 
NG2-derived GFAP-positive reactive astrocytes (A-NG2 cells) can be generated 
symmetrically as well as asymmetrically. 
 
4.3.2 Reactive astrocytes and Shh signaling 
Previously, we confirmed that NG2 cells are able to differentiate to reactive astrocytes 
characterized by high expression of Gfap. This subpopulation of NG2 cells appears after 
FCI induction and harbors certain mRNA levels of Wnt and Shh signaling components. In 
this study, we concentrated on the effect of the Shh signaling pathway on the 
differentiation potential of NG2 glia, with a particular focus on reactive astrocytes. 
Here, we researched NG2 cells under physiological as well as ischemic 
conditions, while the role of Shh inhibition/activation was assessed at the mRNA, protein, 
and functional levels, both in vitro and in vivo. First, we inspected whether Shh signaling 
is responsible for differentiation of Tom-positive NG2 cells, derived from CTRL mice, in 
vitro. Seven days after the onset of differentiation, the vast majority of analyzed cells 
(68.6 ± 6.4%) expressed NG2 proteoglycan, a marker typical of NG2 cells (Figure 42A, 
B). Approximately one third (34.5 ± 8.7%) of Tom-positive cells expressed MOSP, which 
categorized them into the oligodendroglial cell type. Additionally, 6.3 ± 2.4% of cells was 
positive to the astrocytic marker GFAP (Figure 42A, E). NG2-positive cells isolated four 
days after MCAO and cultured for another seven days constituted only 30.9 ± 3.0% of all 
Tom-positive cells (Figure 42A, C). Nevertheless, a strong impact of FCI resulted also in 
an increase in numbers of GFAP-positive cells (22.6 ± 3.4%) when compared to CTRLs 
(Figure 42A, F). To evaluate the effect of Shh signaling on the differentiation potential of 
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NG2 cells, we added the Shh blocker Cyc to differentiation medium and found out that it 
led to the higher number of NG2-expressing cells (87.6 ± 2.5%), while the counts of 
GFAP-positive cells decreased (3.6 ± 1.5%; Figure 42A,). Cultivation with the activator 
Shh increased the numbers of GFAP-positive cells (21.5 ± 6.4%) but in contrast to 
ischemic cells, it did not lower the proportion of NG2-positive precursors. Adding Cyc 
abolished the effect of Shh. We also assessed the effect of the potent Shh signaling 
activator SAG, which reproduced the phenotype observed after Shh treatment. However, 
we detected even more GFAP-positive cells (52.4 ± 7.7%; Figure 42A, D, and G). 
Interestingly, we did not observe any significant changes in the expression of 
oligodendrocytic markers under various in vitro conditions (data not shown), which 
suggests that activated Shh pathway promotes the differentiation of NG2 cells towards the 
astrocytic phenotype, while mimicking the impact of FCI. 
 
 
Figure 42. Ischemia and Shh signaling change the differentiation potential of Tom-positive 
cells in vitro. (A) Quantification of NG2 proteoglycan (NG2) and glial fibrillary acidic protein 
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(GFAP) expression in Tom-positive cells derived from CTRL and MCAO (FCI) mice. The 
signaling pathway was either inhibited (Cyc) or activated (Shh, SAG). (B-G) Representative 
immunofluorescence images of NG2 proteoglycan and GFAP in Tom-positive cells. The data are 
represented as means ± standard error of the mean (S.E.M.) and asterisks indicate significant 
differences when compared to CTRLs, while hashtags indicate differences when compared to the 
FCI groups. Scale bars = 50 µm. Abbreviations: CTRL – control, non-operated; Cyc – 
cyclopamine; DAPI – 4′,6-diamidino-2-phenylindole; FCI – focal cerebral ischemia; MCAO – 
middle cerebral artery occlusion; SAG – Smo agonist; Shh – Sonic hedgehog; Tom – tomato 
(Honsa et al., 2016). 
 
Employing the electrophysiological analysis, we identified five distinct Tom-
positive populations (Figure 43) with their characteristic membrane properties (Table 11). 
The prevalent cell type (42.7 ± 5.5%; Figure 43D) showed a complex current pattern, and 
these NG2 cells were mainly NG2- and PDGFαR-positive (Figure 43A). The GFAP-
positive cells displaying a non-decaying passive current profile (22.0 ± 4.1%; Figure 
43D) were considered astrocytes under control conditions (Figure 43B). The third most 
common subpopulation of Tom-positive cells (18.7 ± 5.0%; Figure 43D) showed a 
decaying passive current profile, and these oligodendrocytes were CNP- or MOSP-
positive (Figure 43C). The other two remaining cell types represented a minority of Tom-
positive cells. Whereas the PDGFβR-positive subpopulation of pericytes was detected 
also in our previous experiments with NG2 cells, DCX-positive neuroblasts/neuron-like 
cells formed only ~3% of all Tom-positive cells. 
The incidence of these identified subpopulations was influenced by ischemia as 
well as Shh signaling manipulation (Figure 43D). The incidence of astrocytes after FCI 
increased to 74.1 ± 5.4%, while only 14.9 ± 3.9% of NG2 cells was detected. This 
confirms the previous immunocytochemical analysis (Figure 42A). Furthermore, the Cyc 
blocker elevated the percentage of NG2 cells in ischemic cultures, while the number of 
astrocytes dropped. The presence of Shh and SAG activators resulted in increased 
incidence of astrocytes (43.2 ± 7.8% for Shh and 66.7 ± 12.2% for SAG), whereas Cyc 
treatment abrogated this effect and even decreased the number of cells with a non-
decaying passive current pattern. Thus, we demonstrated that changes in the cell 
incidence caused by FCI or/and Shh signaling manipulation, and confirmed at the protein 




Figure 43. Alterations in the incidence of distinct Tom-positive cell types after ischemia and 
Shh signaling manipulation in vitro. (A) Polydendrocytes (NG2 cells) displayed a complex 
current pattern and were positive to NG2 proteoglycan (A1-4). (B) Astrocytes showed a non-
decaying passive current profile, while they were glial fibrillary acidic protein (GFAP)-positive 
(B1-4). (C) Oligodendrocytes were characterized by their decaying passive current profiles, while 
showing myelin/oligodendrocyte-specific protein (MOSP) positivity (C1-4). (D) Graph shows the 
incidence of Tom-positive cells based on their current patterns. The cells were isolated from 
CTRL as well as MCAO (FCI) animals, and Shh signaling was either activated (Shh, SAG) or 
inhibited (Cyc). The data are represented as means ± standard error of the mean (S.E.M.) and 
asterisks indicate significant differences when compared to CTRLs, while hashtags indicate 
differences when compared to the FCI groups. Scale bars = 50 µm. Abbreviations: AF488 – 
Alexa Fluor 488 hydrazide; c.p. – current pattern; CTRL – control, non-operated; Cyc – 
cyclopamine; FCI – focal cerebral ischemia; MCAO – middle cerebral artery occlusion; SAG – 







Table 11. Membrane properties of Tom-positive cells isolated from CTRL mice. 
 
NG2 cells astrocytes oligodendrocytes pericytes neuroblasts 
Vm [mV] -78.0±2.2 -83.1±1.8 -41.7±3.9* -50.0±6.2** -82.3±1.5 
IR [MΩ] 124.6±11.3 85.9±7.3 694.1±196.4 2329.0±746.9* 654.8±247.8 
Cm [pF] 23.8±2.6 21.2±3.8 32.6±4.2 17.7±2.5 14.2±1.7 
KIR/Cm [pA/pF] 7.7±0.7 4.1±0.8* 3.4±1.0** 2.3±1.5** 2.4±1.3 
KDR/Cm [pA/pF] 19.8±2.3 1.9±0.8*** 6.0±1.6*** 2.1±0.9*** 97.6±11.4*** 
KA/Cm [pA/pF] 19.1±2.3 0.1±0.1*** 0.2±0.2*** 0.0±0.0*** 40.2±6.3*** 
Na/Cm [pA/pF] 4.9±1.4 0.0±0.0* 0.4±0.4 0.0±0.0 21.3±9.7*** 
n 56 35 28 16 6 
incidence  [%] 42.7±5.5 22.0±4.1 18.7±5.0 13.3±3.8 3.3±1.3 
Abbreviations: Cm – membrane capacitance; CTRL – control, non-operated; IR – input resistance; 
KA – fast activating and inactivating outwardly rectifying K
+
 currents; KDR – delayed outwardly 
rectifying K
+
 currents; KIR – inwardly rectifying K
+
 currents; KIR/Cm, KDR/Cm, KA/Cm, Na/Cm – 
current densities; n – number of cells; Na – Na
+
 current; Tom – tomato; Vm – membrane potential. 
Values in bold indicate significant differences when compared to NG2 cells; *, p ˂ 0.05; **, p ˂ 
0.01; ***, p ˂ 0.001 (adapted from Honsa et al. (2016)). 
 
To complement our data with the evaluation of mRNA expression in vivo, we 
employed the single-cell RT-qPCR analysis. We compared the gene expression of several 
genes in cells isolated from CTRL mice as well as from mice three, seven, and fourteen 
days after MCAO (FCI D3/7/14; Figure 44A). First, we excluded the aforementioned 
Pdgfrb-positive pericytes from our analyses. Then, we observed increased numbers of 
Tom-positive cells expressing Ki67 three and seven days after MCAO (Figure 44B). We 
also detected higher numbers of cells expressing Gfap, a marker of astrocytes and reactive 
astrocytes, after the induction of FCI, while the expression of Dcx was more abundant in 
the later phases of ischemia. Moreover, mRNA of the Shh signaling receptor Smo was 
found in Tom-positive cells mainly on the third day and roughly copied the gene 
expression of Ki67 and Gfap during the progression of ischemic injury. This analysis 




Figure 44. Gene expression in Tom-positive cells after ischemia. (A) Coronal brain slices 
showing the distribution of Tom-positive cells in the intact, control (CTRL) and ischemic (FCI) 
brain, and the respective cortical regions (dashed lines) isolated for the experiments. (B) 
Percentage of Tom-positive cells in CTRL mice as well as in mice three, seven, and fourteen days 
after MCAO (FCI D3/7/14) expressing Ki67, Gfap, Dcx, and Smo genes. We analyzed 65 CTRL 
cells, 95 FCI D3 cells, 133 FCI D7 cells, and 54 FCI D14 cells. Data represent means ± standard 
error of the mean (S.E.M.) and asterisks indicate significant differences when compared to 
CTRLs; *, p ˂ 0.05; **, p ˂ 0.01; ***, p ˂ 0.001. Abbreviations: Dcx – doublecortin; FCI – focal 
cerebral ischemia; Gfap – glial fibrillary acidic protein; Ki67 – marker of proliferation; MCAO – 
middle cerebral artery occlusion; Smo – smoothened; Tom – tomato (Honsa et al., 2016). 
 
As our previous data suggest, Shh shifts the differentiation potential of NG2 cells 
after FCI towards the phenotype of reactive astrocytes. We inhibited Shh signaling by i.p. 
injections of Cyc after FCI, and compared the gene expression of several genes with the 
Cyc-untreated counterparts seven days after MCAO (Figure 45). Inhibition of the 
pathway led to a decrease in the counts of cells expressing astrocytic genes Gfap, 10-
formyltetrahydrofolate dehydrogenase (Aldh1l1), and Vim (Figure 45A), while it 
stimulated the expression of Cspg4 and Pdgfra (Figure 45B). Additionally, a significant 
decrease in the incidence of Dcx-expressing cells was observed after inhibition of the 
pathway (from 60.1 ± 2.4% to 35.0 ± 7.0%). Manipulation of the pathway did not alter 
the expression of Ki67, which may imply that Shh did not influence proliferation of Tom-
positive cells. Moreover, it is worth pointing out that Shh signaling inhibition suppressed 




Figure 45. Differentiation of Tom-positive cells is influenced by Shh signaling. (A) Proportion 
of Tom-positive cells expressing genes specific for astrocytes (Gfap, Gfap delta, Aqp4, Aldh1l1, 
Vim) seven days after focal cerebral ischemia (FCI D7) in non-treated and cyclopamine (Cyc)-
treated mice. (B) Expression of several other genes was either unchanged (Ki67, Smo) or altered 
(Cspg4, Pdgfra, Dcx). We analyzed 133 non-treated FCI D7 cells and 65 Cyc-treated cells. Data 
represent means ± standard error of the mean (S.E.M.) and asterisks indicate significant changes 
when compared to FCI D7 cells; *, p ˂ 0.05; **, p ˂ 0.01. Abbreviations: Aldh1l1 – 10-
formyltetrahydrofolate dehydrogenase; Aqp4 – aquaporin-4; Cspg4 – chondroitin sulfate 
proteoglycan 4; Dcx – doublecortin; Gfap – glial fibrillary acidic protein; Ki67 – marker of 
proliferation; Pdgfra – platelet-derived growth factor alpha receptor; Smo – smoothened; Tom – 
tomato; Vim – vimentin (Honsa et al., 2016). 
 
Finally, we analyzed the effect of Shh signaling inhibition/activation after MCAO 
utilizing immunohistochemical staining against GFAP and DCX (Figure 46). This 
analysis was supplemented with the BrdU assay that detects proliferating cells. In 
untreated mice, with non-manipulated Shh signaling, 32.0 ± 2.6% of Tom-positive cells 
was also GFAP-positive (Figure 46A, B). It is worth mentioning that these cells were 
identified mainly in the penumbra, close to the ischemic core. Inhibition by Cyc resulted 
in decreased numbers of GFAP-positive cells (16.0 ± 1.4%), while SAG had the opposite 
effect (49.1 ± 2.7%). Furthermore, also the incidence of DCX-positive cells (Figure 46C, 
D) was lowered after Shh signaling inhibition. To eliminate the possibility that distinct 
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counts of GFAP-positive cells after Shh pathway manipulation were caused by altered 
proliferation of Tom-positive cells, we assessed BrdU incorporation in proliferating cells 
after different treatments (Figure 46E, F). We observed that 34.8 ± 2.3% of Tom-positive 
cells was BrdU-positive seven days after MCAO, and that this number was not markedly 
altered after Shh signaling manipulation. Altogether, this may signify that Shh signaling 
influences the differentiation potential of Tom-positive cells following FCI, and that the 
activated Shh pathway directly promotes differentiation of NG2 cells to reactive 
astrocytes (Figure 47). 
 
 
Figure 46. Shh signaling manipulation changes the differentaition potential of Tom-positive 
cells after ischemia. We employed immunohistochemical staining in mice with non-manipulated 
(FCI), inhibited (Cyc), or activated (SAG) Shh signaling seven days after focal cerebral ischemia 
(FCI). (A, B) Graph and representative images show the proportion of Tom-positive cells that are 
also GFAP-positive. Dashed curves mark the border between the ischemic core and the glial scar. 
(C, D) Graph and representative images show the proportion of Tom-positive cells that also 
express doublecortin (DCX). (E, F) Graph and representative images show unchanged numbers of 
dividing (BrdU) Tom-positive cells. Scale bars = 50 µm. Data represent means ± standard error of 
the mean (S.E.M.) and asterisks indicate significant alterations when compared to FCI treatment; 
*, p ˂ 0.05; ***, p ˂ 0.001. Abbreviations: BrdU – 5-bromo-2'-deoxyuridine; Cyc – cyclopamine; 
DCX – doublecortin; GFAP – glial fibrillary acidic protein; SAG – Smo agonist; Shh – Sonic 




Figure 47. Graphical representation of observed and possible differentiation scenarios of 
NG2 cells. Polydendrocytes (NG2 glia) can proliferate and give rise to more NG2 cells, or they 
can differentiate to other cell types. They generate oligodendrocytes mainly under physiological 
conditions, astrocytes during development or after severe CNS injuries (reactive astrocytes), and 
neuroblasts, probably only in in vitro conditions. The differentiation potential of NG2 cells is 
regulated by Shh signaling and ischemia. Ischemic injury or Shh signaling activation (SAG, Shh) 
both promote differentiation to astrocytes, while Shh signaling inhibition (cyclopamine) rises the 
counts of NG2 glial cells. Pericytes do not belong to the oligodendroglial lineage and 
preferentially give rise to the same cell type. Abbreviations: CNS – central nervous system; SAG 
















Although the role of canonical Wnt and Shh signalings in neural development has been a 
main subject of countless studies, relatively little is known about their functions in 
postnatal neurogenesis and gliogenesis. The lack of information may stem from the fact 
that severe dysregulations of these pathways result in embryonic lethality (van 
Amerongen and Berns, 2006; Kietzman et al., 2014). In this study, we employed 
transgenic mouse strains that allowed TAM-induced, conditional inhibition or activation 
of Wnt signaling, thus circumventing the issue of prenatal CNS malformations that cause 
mortality. Employing neonatal as well as adult transgenic mouse strains together with the 
series of aforementioned laboratory approaches, we demonstrated that, in our hands, 
Wnt/β-catenin signaling has an impact on the differentiation potential of NS/PCs. 
Moreover, we also showed that Wnt signaling is also active in NG2 cells, as we identified 
components of the pathway in this cell type of high differentiation potential, while NG2 
differentiation to astrocytes after FCI is regulated by Shh. 
 
5.1 Wnt signaling manipulation in neonatal cell cultures 
In the first part of our research work, we found out that the expression of Wnt signaling 
blocker Dkk1 resulted in decreased amounts of β-catenin, while the stabilization of the 
pathway, accompanied by higher quantities of β-catenin, was detected in Ex3 cells 
producing a stable, truncated variant of the protein. Wnt/β-catenin signaling activation 
enhanced the expression of the neuronal marker β III tubulin and decreased the incidence 
of GFAP-positive cells displaying passive time- and voltage-independent K
+
 currents. On 
the contrary, Wnt pathway suppression led to a marginal increase in the incidence of 
GFAP-positive cells, while the number of DCX/MAP2-positive cells expressing 
outwardly rectifying K
+
 currents decreased significantly. Furthermore, Wnt signaling 
activation increased the counts of cells showing outwardly rectifying K
+
 currents together 
with inwardly rectifying Na
+
 currents, and also influenced the ability of cells to transport 
Ca
2+
 after the application of glutamate and ATP. 
We employed three different strains of genetically manipulated mice, enabling 
tamoxifen-inducible Cre-mediated DNA recombination (Figure 12). They facilitated 
inhibition of Wnt signaling either at the nuclear or membrane receptor level or, 
alternatively, activation of the Wnt pathway via the production of a stable form of β-
catenin protein. Wnt pathway manipulation at various points of the signaling relay gave 
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us a better insight into the possible molecular mechanisms underlying NS/PCs 
differentiation in the neonatal mouse brain. In contrast to our study, other authors opted 
for different approaches. For example, Hirsch et al. (2007) added recombinant Wnt3a 
ligand to differentiation medium and Prajerova et al. (2010b) used NS/PCs that were 
transduced with Wnt7a. It is worth mentioning that this ligand was one of the highly 
expressed ligands in our in vitro cultures together with Wnt5a and Wnt7b (Figure 19). 
Additionally, Meyers et al. (2012) employed pharmacological and heat-shock-inducible 
genetic manipulation of the Wnt signaling pathway. However, none of the studies listed 
above combined all the approaches and methods utilized in the present study, where we 
carried out immunofluorescence analyses as well as functional studies (patch-clamp 
technique, Ca
2+
 imaging) on NS/PCs derived from the neonatal mouse brain. All this 
allowed us to perform a comprehensive analysis of effects caused by either activation or 
inhibition of the Wnt signaling pathway at different subcellular levels. Nonetheless, we 
obtained similar results as the above-mentioned authors. Inhibition of the pathway in the 
nucleus (dnTCF4 mice) did not affect the levels of β-catenin expression. This accords 
well with the fact that this alteration in the pathway occurs downstream of the β-catenin 
destruction complex, so that it should not influence the expression of β-catenin directly 
(Figures 20 and 21). This was not the case in Dkk1 and Ex3 mice, where the alterations 
occurred at the membrane and in the protein itself, respectively. Next, we assessed the 
expression of putative Wnt signaling target genes, namely Axin 2, Sp5 and Troy (Figure 
22). These genes should be correlated positively with Wnt/β-catenin signaling as shown 
previously (Buttitta et al., 2003; Fujimura et al., 2007; Jho et al., 2002). In our hands, Wnt 
signaling hyper-activation led to a markedly higher expression of all analyzed genes, 
which goes along with the findings of Fafilek et al. (2013), Fujimura et al. (2007) and 
Hirsch et al. (2007). These groups found that after Wnt stimulation, stem cells express 
higher levels of inhibitory components of the Wnt pathway. Examples of such 
components are the aforementioned genes – Axin 2, Sp5 and Troy. Surprisingly, the 
expression of Axin 2 was not altered after Wnt signaling inhibition. This inconsistency 
might be due to overall low expression of Axin 2 (Ct values ~32) in our dnTCF4 and 
Dkk1 cultures, which might imply that in these two models, the Wnt signaling pathway is 
prevented from activation, rather than being inhibited after its activation, while Wnt 
signaling is still able to affect the cell fate. On the other hand, after Wnt signaling 
activation, the expression of Axin 2 was much higher (Ct values ~27), and thus the protein 
was able to act as a negative feedback loop that controls Wnt signaling activity (Lustig et 
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al., 2002). Additionally, we analyzed mRNA levels of Wnt ligands and found out that 
Wnt4, Wnt5a, Wnt5b, Wnt7a, Wnt7b, Wnt9a, and Wnt10b are present in all control in vitro 
cultures (Figure 19), while these signals are typical of both canonical and non-canonical 
Wnt pathways. This correlates, to some extent, with the data from Hirsch et al. (2007), as 
they found Wnt3, Wnt4, Wnt5a, Wnt7a, Wnt7b and Wnt11 genes to be expressed in 
NS/PCs. For example, non-canonical Wnt5a enhances neurogenesis and improves 
functional integration of newly derived neurons in vivo (Parish et al., 2008). Similar 
functions are also exercised by Wnt7a, since this Wnt ligand stimulates NS/PCs 
proliferation and promotes neuronal differentiation and maturation (Qu et al., 2013). 
Interestingly, over-expression of Wnt7b impairs neuronal differentiation of neural 
progenitors, and thus antagonizes the effect of Wnt5a and Wnt7a ligands (Papachristou et 
al., 2014). However, other functions may also be performed by these ligands according to 
the developmental stages of experimental animals, as presented by Hirabayashi et al. 
(2004) and reviewed by Inestrosa and Varela-Nallar (2015). Moreover, it could be fairly 
challenging to determine the function of a Wnt ligand, as the very same ligand is able to 
activate both β-catenin-dependent and non-canonical pathways (Nalesso et al., 2011). 
Next, we showed that hyper-activated Wnt signaling increases the abundance of 
neuronal marker β III tubulin and decreases the expression of GFAP (Figure 25). This 
suggests a tendency towards neurogenesis after Wnt signaling activation. Hirsch et al. 
(2007) demonstrated similar effects of Wnt signaling on the expression of β III tubulin, 
although the numbers of GFAP-positive cells remained unchanged. This discrepancy 
might be explained by differences in Wnt pathway activation between our and their study. 
We took advantage of employing transgenic mouse models and activated the pathway in 
NS/PCs using the “general” intracellular signal mediator β-catenin, whereas Hirsch et al. 
(2007) applied specifically only Wnt3a ligand to their differentiation media. 
Furthermore, we observed that Wnt signaling causes higher incidence of 
DCX/MAP2-positive cells that display branched processes (this can be partially seen in 
Figure 25A), indicating a more advanced developmental stage. These branched and 
overlayed processes could be responsible for the fact that we were not able to identify 
significant changes in the levels of DCX and MAP2 (Figure 24). Our observations are in 
concordance with previously published data from the in vitro experiments by Kunke et al. 
(2009). These authors transduced mouse NS/PCs with constructs producing Wnt7a or 
Dkk1 and showed that those molecules influenced cell fate during differentiation. 
Expression of Wnt7a, which activates Wnt signaling, led to an increase in the incidence 
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of MAP2-positive cells, while the numbers of GFAP-positive cells decreased. In contrast, 
Dkk1, i.e. inhibiting Wnt signaling, significantly increased gliogenesis at the expense of 
neurogenesis. In the above mentioned study, the authors incubated single cells derived 
from trypsinized neurospheres for only four days. In the present study, we employed the 
same approach but analyzed differentiated cells after eight days of in vitro differentiation. 
Therefore, our results complement those of Kunke et al. (2009) and show that after Wnt 
signaling inhibition or activation, differentiated cells preserve similar characteristics for a 
longer period of time. Mardones et al. (2016) showed that Wnt signaling inhibition by 
retrovirus-mediated RNAi, causing knockdown of Frizzled-1 receptor, though in the adult 
hippocampus, resulted in a decrease in the percentage of cells expressing DCX and 
concomitantly, in increased differentiation to astrocytes. Independently of the Wnt 
signaling inhibition or activation, the incidence of PDGFαR-positive precursors showing 
a complex current pattern was increased. This phenotype might be attributed to the fact 
that any intervention in the homeostasis of the CNS (either artificial, non-physiological 
Wnt signaling manipulation or ischemia) can “activate” precursor cells and alter the 
expression of cell-type-specific proteins or ion channels. In summary, from our results 
(Figures 24 and 25) and previously published studies it is evident that Wnt signaling plays 
a crucial role in the control of the differentiation potential of neuronal progenitors. 
Relatively recently, it has been shown that Wnt signaling activation affects the 
electrophysiological properties of differentiated neural precursors (Prajerova et al., 
2010b). Activated Wnt signaling caused a higher incidence of cells expressing outwardly 
rectifying K
+
 currents together with TTX-sensitive inwardly rectifying Na
+
 currents and 
generating action potentials. This neuron-like current pattern with outward currents also 
prevailed in our experiments (Figure 26). In our work, we further disclosed that MAP2-
positive cells displayed large KA and KDR current amplitudes (Table 4), which agrees with 
previous studies in neonatal NS/PCs transduced with Wnt7a (Prajerova et al., 2010b). 
Concurrently, in differentiated NS/PCs upon Wnt signaling inhibition, we found that the 
response of MAP2/DCX-positive cells to glutamate application decreased (Figure 27A). 
These data based on calcium imaging analyses support the presence of glutamate 
receptors on neural progenitors. As suggested by Deisseroth et al. (2004), glutamate 
receptors mediate excitation-induced neurogenesis by inhibiting the expression of the 
glial transcription factor hairy and enhancer of split-1 (Hes1) and inhibitor of DNA 
binding 2 (Id2), and by promoting expression of the pro-neuronal transcription factor 
neuronal differentiation (NeuroD). Using retrovirus-mediated gene knock-out in mice, 
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Tashiro et al. (2006) showed that the survival of maturing neurons is competitively 
regulated by their own N-methyl-D-aspartate (NMDA) receptors, which was observed 
during a short period after neuronal birth. Following this, we found that inhibition of the 
Wnt pathway led to increased numbers of cells responding to the ATP application (Figure 
27A) but nevertheless, elevated Wnt/β-catenin signaling resulted in a lower average 
response amplitude (Figure 27B). This is in contrast with the observations that ATP 
upregulates the expression of neuronal markers, such as neuron-specific class III β-
tubulin (Tuj1), neuronal nuclei (NeuN) and β-catenin expression, and thus promotes 
neuronal differentiation of stem cells (Tu et al., 2014). This discrepancy might be related 
to the use of different cells. Whereas we utilized NS/PCs, Tu et al. (2014) employed 
mesenchymal stem cells in their study. 
In summary, Wnt signaling regulates neurogenesis, as its hyper-activation drives 
neonatal NS/PCs differentiation to the DCX/MAP2-positive cells that express outwardly 
rectifying K
+
 currents and inwardly rectifying Na
+
 currents. Importantly, our results 
indicate that the manipulation of Wnt/β-catenin signaling in NS/PCs might provide novel 
approaches for the treatment of neurological disorders. For instance, studies of progenitor 
cells in the olfactory epithelium performed in neonatal as well as adult mice suggested a 
key role of Wnt signaling in progenitor cells proliferation and neuroregeneration after 
epithelial lesion (Chen et al., 2014). Moreover, a connection between Alzheimer’s disease 
and Wnt signaling pathway impairments has also been suggested (Inestrosa and Varela-
Nallar, 2015; Inestrosa et al., 2002). 
 
5.2 Effect of Wnt pathway on adult NS/PCs 
Having assessed the effect of Wnt signaling on the differentiation potential of NS/PCs 
isolated from adult non-operated mice as well as from those that had undergone MCAO, 
we observed alterations in the expression of various cell-type-specific markers. Wnt 
signaling inhibition by Dkk1 caused lower immunopositivity of NS/PCs cultures for β-
catenin, while higher immunoreactivity was identified after the hyper-activation of the 
pathway. The expression of several Wnt target genes was also affected by our TAM-
induced animal model. However, these changes were not translated into any alterations in 
the incidence of distinct cell types in CTRL mice, based on electrophysiological 
measurements. Interestingly, a neonatal-like pattern of the shifts in the incidence was 
recovered after the induction of ischemia. Our immunohistochemical analysis revealed 
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similar effects of Wnt signaling on the expression of PCNA, GFAP, and DCX in CTRL 
and MCAO mice. Nonetheless, the expression of all markers was upregulated three days 
after the induction of FCI, which represents earlier phases of ischemia, while in later 
phases, the expression of cell-type specific proteins may be different. Wnt signaling 
manipulation also affected passive electrophysiological properties (Vm, IR, Cm) of all cell 
types found in our in vitro cultures, while it had no effect on the expression of voltage-
dependent K
+
 channels in cells with a passive current profile. 
In our experiments on NS/PCs derived from the adult SVZ, we employed the 
same three mouse strains as in the study on neonatal mice (Figure 12) so that we could 
take advantage of these convenient means of either Wnt/β-catenin pathway activation or 
inhibition at two different subcellular levels. This TAM-induced and Cre-mediated 
system, together with the high reproducibility of well-defined in vitro conditions, was 
probably the strong point of our research. Here, we assessed CTRL mice as well as 
MCAO mice. Nevertheless, there were a few main differences in utilizing neonatal and 
adult NS/PCs. Some of them were only minor matters for consideration, while the other 
ones represented setbacks in our experiments. 
A variety of factors may influence the differentiation potential of NS/PCs as well 
as the outcome of FCI in the adult mouse. Among others, the differences in gender, age, 
region of the brain, or even the circadian system are probably the most important players 
in these processes (Vancamp et al., 2019; Lembach et al., 2018). A lot of publications 
have emerged in the last years particularly on the topic of sex-specific differences 
impeding the interpretation of experiments. These publications declare that high amount 
of estrogen in females acts as an endogenous neuroprotectant after the induction of 
cerebral ischemia, which was confirmed in clinical observations as well as in 
experimental stroke (Hurn and Macrae, 2000). Since the comparison between males and 
females was not the aim of this study, we had to choose whether we would work only on 
female mice or only on male mice and because a stronger impact of ischemia is usually 
seen in males, we decided to employ male animals. The use of female mice would 
otherwise contradict our effort to induce focal ischemic injury in the brain. In our 
experiments on neonatal mice, we did not distinguish between male and female pups 
because it is not easy to determine the gender in neonatal mice (Wolterink-Donselaar et 
al., 2009) and, above all, in newborns, estrogen levels are relatively low as well as the 
quantities of estradiol, the most potent and prevalent estrogen, are similar in males and 
females (Konkle and McCarthy, 2011). Nevertheless, once the pups are weaned, which is 
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around postnatal day 21 in mice, establishing the gender can be easily carried out 
(Wolterink-Donselaar et al., 2009). Taken together, to avoid any gender-, age-, region-of-
the-brain-, or circadian-system-related disturbances in our experiments, we used only 
male mice, with a strictly defined time window when we sacrificed them, and only one 
experimenter isolated all the SVZs at the specific time of the day. 
Another difference between neonatal and adult mice was that in the former, we 
isolated a presumptive SVZ region (a part of the frontal lobe) while in the latter, we cut 
out a specified region of the brain – the SVZ (Figure 17). There is a slim chance that this 
could lead to lower yields of differentiated cells for our further experiments, 
a phenomenon that was not improved even by a longer incubation of highly proliferative 
NS/PCs in proliferation medium. A more probable explanation of the lower numbers of 
cells derived from adult mice would be the fact that adult NS/PCs are normally found in a 
quiescent state (Urbán and Guillemot, 2014). Bone morphogenetic protein (BMP), which 
was identified in non-dividing cells of the adult hippocampus, is responsible for this 
behavior of precursor cells. Active BMP signaling reversibly diminished the proliferation 
of NS/PCs, while its inactivation enhanced proliferation only transiently, with a 
subsequent reduction in the numbers of precursors (Mira et al., 2010). However, once 
activated, young and old NS/PCs exhibit similar proliferation and differentiation capacity 
(Kalamakis et al., 2019). Activated NS/PCs are characterized by the expression of 
epidermal growth factor receptor (EGFR; Codega et al., 2014). Since EGF is required for 
increased proliferation of SVZ-derived cells (O'Keeffe et al., 2009) and, at the same time, 
NS/PCs can interconvert between the quiescent and activated state (Codega et al., 2014; 
Lugert et al., 2010), we increased the concentration of EGF in proliferation media by 50% 
(from 20 ng/ml in neonatal cultures to 30 ng/ml in adult cultures) in an attempt to enhance 
the yield of cells. Nevertheless, to initiate differentiation of expanded NS/PCs, we had to 
withdraw this mitogenic agent from differentiation medium (Johe et al., 1996). 
Unfortunately, much fewer cells were retrieved from neurospheres after two weeks of in 
vitro proliferation (~500,000 cells from an adult mouse versus several millions of cells 
from a single neonatal mouse). Together with a worse survival of adult cells, this resulted 
in insufficient material for our experiments. As a consequence, only electrophysiological 
measurements and immunocytochemical staining against β-catenin were performed in 
vitro. After those, we switched from cell cultures to the utilization of brain tissue in our 
next experiments, specifically Western blotting, RT-qPCR analysis, and 
immunohistochemical staining. The use of tissue specimens from the SVZ on the one 
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hand guaranteed the enrichment in NS/PCs but on the other hand, it could result in a sort 
of dilution of NS/PCs by other cell types in the brain tissue. As a result, this might also 
interfere with the composition of the niche, with a subsequent impact on the 
differentiation potential of NS/PCs. This is in contrast with our in vitro experiments, 
where only cells derived from NS/PCs were present in a well-defined environment of 
culture media, while they spent 8-9 days in differentiation medium. In tissue specimens, 
cells had only 3 days to differentiate after i.p. TAM injections or after MCAO. However, 
this amount of time should be sufficient for their differentiation (Honsa et al., 2013; Zhao 
et al., 2009), which was, after all, shown also in our study (Figure 34). The fact that the 
microenvironment around NS/PCs in the tissue specimens was not thoroughly defined 
might be considered a weakness of our study. Nevertheless, as we had controls for each 
mouse strain and for each treatment, this should not have a big impact on the assessment 
of the effect of Wnt signaling on differentiation of neural precursors in our mouse 
models. 
Our results from immunocytochemical staining against β-catenin in adult CTRL 
cell cultures (Figure 29) resembled those obtained in young animals (Figure 20), showing 
elevated expression of the protein after Wnt signaling activation and decreased expression 
of β-catenin only after inhibition by Dkk1. Nevertheless, the results from adult mice were 
less significant, which could be partially attributed to the transition from neonatal to adult 
NS/PCs niche, with possible changes in the responsiveness to intrinsic or extrinsic stimuli 
(Urbán and Guillemot, 2014; Morrison and Spradling, 2008). The exact moment when the 
switch from embryonic to adult neurogenesis occurs is elusive but it has been suggested 
that it is between the first and the third postnatal week in the rodent dentate gyrus 
(Pleasure et al., 2000). 
In the rest of our experiments, except for the electrophysiological analysis, we 
assessed the impact of the Wnt pathway in CTRL as well as MCAO mice. The 
differentiated NS/PCs were evaluated three days after MCAO. This time period 
represents earlier phases of ischemia and differentiation of precursor cells probably has 
different outcome in the later phases. Additionally, we utilized tissue specimens of the 
SVZ, as explained and discussed earlier in this chapter. Here, it is worth mentioning that 
in our in vitro cultures, bFGF was present, which was not the case in the directly 
dissected, non-cultured tissue specimens. It was reported that this growth factor increases 
the activity of the Wnt/β-catenin pathway and, which is more important, overexpression 
of β-catenin in the presence of bFGF promotes the proliferative state of NS/PCs, while in 
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its absence, neuronal differentiation is enhanced (Israsena et al., 2004). This could be at 
the root of the discrepancies detected between in vitro and in situ experiments. 
The Western blotting analysis of β-catenin protein in differentiated adult NS/PCs 
(Figure 30) only partly corresponded with immunocytochemical staining of the protein. 
This inconsistency might be caused by the presence of other cell types in the tissue and 
the finding that Wnt/b-catenin responses can be cell-type-specific (Wallmen et al., 2012). 
The expression of Wnt target genes was similarly influenced by Wnt signaling in both 
CTRL and MCAO mice (Figure 31) but we detected higher mRNA levels of the studied 
targets after ischemia. This observation coincided well with our immunohistochemical 
analysis, where we found that after FCI, all analyzed proteins were upregulated (Figure 
34). Otherwise, the changes in the expression of the Wnt target genes corresponded with 
those identified in neonatal mice (Figure 22), with few exceptions. In neonatal mice, least 
responsive strain appeared to be Dkk1, while in adult mice, it was Ex3. This could be a 
result of an overall reduction in the activity of Wnt signaling, which increases with age 
and may compensate the hyper-activation of the pathway by Ex3. It was found that with 
age, various components of the pathway are downregulated, while levels of Wnt 
antagonists Dkk1 and secreted frizzled-related proteins (sFRPs) as well as niche-derived 
inflammatory signals are increased. The combination of these processes might induce 
quiescence of NS/PCs and at least partly interfere with the mouse model (Kalamakis et 
al., 2019; Kase et al., 2019; Seib et al., 2013). The expression pattern of one target gene, 
Sp5, was distinct from the others (Figure 31). In CTRL mice, it was always overexpressed 
after Wnt signaling manipulation, while its expression dropped after MCAO. This target 
gene is positively regulated by Wnt signaling and acts as a transcriptional repressor of 
another protein from the same family, Sp1 (Fujimura et al., 2007), while the latter is a 
transcription factor that probably plays a role in protecting cells against oxidative stress 
following brain injury (https://www.uniprot.org/uniprot/P08047#function). We deem that 
after ischemic injury, Sp5 is downregulated, which releases Sp1 from its inhibition. 
Subsequently, Sp1 can perform its function in the tissue affected by ischemia and add to 
its recovery. 
Our primary cultures consisted of the same three cell types that were identified 
within neonatal cell cultures. These cell types comprised GFAP-positive astrocytes, 
DCX/MAP2-positive neuron-like cells, and PDGFαR-positive precursors, all with their 
specific electrophysiological properties (Figure 23). The incidence of these cell types 
after Wnt signaling manipulation was not changed in intact (CTRL) mice. Nonetheless, 
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the effect of Wnt signaling manipulation observed in neonatal cultures was partially 
recovered in MCAO mice, especially in the Dkk1 strain (Figure 32). The reason why we 
did not detect any changes in the incidence in CTRL cultures might be the continuous, 
age-related depletion of the NS/PCs pool (Encinas et al., 2011). Another feature of the 
adult mammalian brain is that quiescent NS/PCs prevail (Codega et al., 2014), and while 
Wnt inhibition (dnTCF4 and Dkk1) adds to this BMP- and Notch-induced quiescence, its 
activation in Ex3 mice may only ineffectively go against this state of NS/PCs (Urbán and 
Guillemot, 2014). Moreover, majority of cells differentiated from NS/PCs undergo 
apoptosis and are rapidly phagocytized by resident microglia in the niche (Sierra et al., 
2010). Interestingly, subpopulations of microglia have distinct effects on the 
differentiation potential of NS/PCs, as one subpopulation promotes astrogliogenesis, 
while the other supports neurogenesis, while both inhibit NS/PCs proliferation (Vay et al., 
2018). On the other hand, we detected alterations in the incidence of distinct cell types 
among differentiated cells that were isolated from MCAO animals. This corresponds with 
our observations from Western blotting experiments, where the majority of identified 
changes in the expression of cell-type-specific proteins occurred after ischemia (Figure 
33). As we mentioned, Notch signaling as well as its transcriptional target Shh perform 
the same function as BMP in the CTRL CNS. However, they are upregulated after 
MCAO and both increase cell proliferation in the adult SVZ and may be thus involved in 
ischemia-induced neurogenesis (Wang et al., 2009). Another study corroborated the 
previous one with the finding that CNS injury induces proliferation of NS/PCs, while 
over-expression of Notch1 and nestin was observed. Although CNS injury is known to 
activate primary astrogliosis, their results suggested that NS/PCs preferentially gave rise 
to gamma-aminobutyric acid (GABA)ergic neurons (Anderson et al., 2020). This might 
be resolved by the observation that transplantation of NS/PCs early after hypoxia–
ischemia leads to greater differentiation into astrocytes, whereas transplantation at later 
time points leads to preferential differentiation into neurons (Rosenblum et al., 2012). 
The Western blotting experiments on the expression of cell-type-specific proteins 
in differentiated adult NS/PCs from tissue specimens were mostly inconclusive (Figure 
33). For this reason, we performed an exhaustive immunohistochemical analysis of 
coronal slices with the SVZ region (Figure 34). This approach revealed overall increased 
immunoreactivity after FCI. This ischemia-triggered upregulation of cell-type-specific 
proteins was observed also in our experiments analyzing Cspg4
+
 precursors, where a 
steep rise in the expression of GFAP and PCNA was detected three as well as seven days 
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after MCAO (data not shown). Also Shruster et al. (2012) showed that stroke potently 
stimulates cell proliferation in the neurogenic niches and that newly generated cells 
migrate to the injured striatum and cortex, while Wnt signaling promotes the survival of 
differentiated cells. Furthermore, in the present work we documented that Wnt signaling 
inhibition results in the abundance of GFAP in the SVZ, while, conversely, Wnt pathway 
hyper-activation leads to overexpression of PCNA and DCX in CTRL mice. This finding 
corresponds well with the data obtained from neonatal animals, where Wnt signaling 
activation promoted neurogenesis at the expense of gliogenesis (Figures 24 and 25). The 
neurogenic effect of the Wnt pathway was seconded also by others (Kase et al., 2019; 
Mastrodonato et al., 2018). 
Wnt signaling in adult NS/PCs influenced also their membrane properties, while 
its manipulation resulted in complex changes in their passive membrane properties as 
well as in the expression of K
+
 channels. We identified three distinct cell types and 
characterized their expression of voltage-dependent K
+
 channels, which were manifested 
as distinct combinations of K
+
 currents, and their different cell densities. Our data accord 
with other authors that also measured electrophysiological properties of these cell types. 
For example, we identified DCX/MAP2-positive neuron-like cells that showed highest 
KA and KDR current densities (Tables 9 and 10) which were comparable with previous 
studies from our laboratory (Prajerova et al., 2010b). Moreover, we characterized GFAP-
positive astrocytes with only very low densities of K
+
 currents (Tables 5 and 6), and 
PDGFαR-positive precursors that were defined by moderate values of KA, KDR, and KIR, 
with sporadic expression of voltage-gated Na
+
 channels (Tables 7 and 8). Similar 
membrane properties were observed and discussed also by others (Walz, 2000). 
Additionally, we identified significant changes in the density of Na
+
 currents of neuron-
like cells only in CTRL mice. The inability to detect any significant changes in the 
cultures derived from MCAO mice could be caused by overall decreased expression of 
voltage-dependent Na
+
 channels after ischemia (Yao et al., 2002). However, another 
group identified exactly opposite effects of ischemia on ion channels expression 
(Hernandez-Encarnacion et al., 2017). Regardless of the downregulation or upregulation, 
the effect of ischemic injury could overwhelm the effect of Wnt signaling in our model. 
All in all, canonical Wnt signaling has a specific impact also on the differentiation 
potential of NS/PCs in adult mice. Nevertheless, our data suggest that it takes effect to a 
greater extent in cells affected by ischemia. As in some of our experiments we were not 
able to distinguish NS/PCs from other cell types in the SVZ and the surrounding nervous 
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tissue, this study would probably deserve a deeper molecular analysis of intra- and 
extracellular processes specifically in this cell type. For example, utilizing the state-of-
the-art approaches such as RNA sequencing (RNA-Seq) could afford another view on the 
brain cells affected by Wnt signaling manipulation or by ischemia. Another strategy could 
be employing single-cell RT-qPCR analysis on FACS-sorted cells isolated from the SVZ. 
However, it is arduous to find a set of high-quality, working fluorescent antibodies 
against NS/PCs. This issue could be overcome by a method, in which a researcher pulls 
the cells after patch-clamp measurement out of the tissue for further single-cell RT-qPCR 
analysis. However, this method would be challenging and time-consuming since our 
study comprised many experimental groups of cells. This is the reason why the method of 
our choice was to use tissue specimens. 
It seems that, at least in our hands, ageing takes its toll on the regenerative 
potential of NS/PCs since in adult mice, the differentiation potential of these cells was 
reduced to that extent that we were not able to identify any changes in the cell incidence 
caused by Wnt signaling manipulation. In our experiments, we analyzed the effect of 
ischemia only as a catalyst, modulator of Wnt-signaling-dependent alterations. As it can 
be seen in the immunohistochemical stainings of the SVZ (Figure 34), the expression of 
all studied proteins was elevated after MCAO. For this reason, we assessed the effect of 
Wnt signaling in CTRL mice and, in a similar way, the effect of Wnt signaling in MCAO 
mice, while keeping the controls for all the experimental groups. 
Researchers as well as clinicians have high hopes for postnatal endogenous 
NS/PCs, or for induced pluripotent stem cells (iPSC), to be utilized in regenerative 
medicine after decline in numbers of neural cells caused by ischemia, traumatic injury, or 
neurodegenerative diseases. Hopefully, our findings add to the knowledge of the 
processes that are necessary for the proper guidance of stem cells to the desired cell types. 
 
5.3 Differentiation potential of NG2 glia 
In the experiments on NG2 cells, we employed the fate-mapping analysis, tracking the 
fluorescence of Tom-positive polydendrocytes and their progeny. Here we utilized the 
single-cell RT-qPCR analysis, supplemented with immunohistochemical staining and 
electrophysiological recordings, to assess the influence of cellular signaling pathways as 
well as ischemia on the differentiation potential of NG2 glia. To induce ischemia, we 
used the MCAO model in 3-month-old mice. This model of FCI in rodents is well 
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established and highly reproducible, as it was reported that in ~80% of animals, the 
cerebral cortex is affected (Ginsberg, 2003). Nevertheless, our own experience says that 
the infarct lesion in the cortical region occurs more frequently, in more than 90% of cases 
(data not shown). To evaluate the impact of the progression of ischemic injury, we 
collected tissue after three, seven, and fourteen days upon its induction. The tissue was 
isolated from the cortex surrounding the ischemic lesion, the site where the penumbra 
occurs. 
At the beginning, we looked into the NG2 cells differentiation under physiological 
conditions and detected three Tom-positive populations – pericytes, oligodendrocytes, 
and NG2 glia. Pericytes were identified because of their relatively high expression of 
NG2 proteoglycan (Smyth et al., 2018). In later phases of brain injury, these cells are 
essential for tissue scarring, blood–brain barrier (BBB) repair, and angiogenesis in the 
CNS. However, as they do not belong to the oligodendroglial lineage, they were excluded 
from further analyses. This was possible due to their expression of Pdgfrb (Roth et al., 
2019; Zehendner et al., 2015). The presence of the other two populations clearly 
confirmed that NG2 cells are oligodendrocyte precursor cells (Figures 36 and 37), which 
has already been shown (Butt et al., 2019; Chen et al., 2018). Besides the markers typical 
of individual cell types, we assessed also several other genes. Among others, we detected 
higher expression of astroglial Slc1a2 and Slc1a3 in NG2 cells and, conversely, higher 
levels of Glul in oligodendrocytes. Similar expression patterns were also observed by 
others (Marques et al., 2016; Zhang et al., 2014b; Liu et al., 2013). The presence of 
glutamate transporters was found to support oligodendrocyte maturation (Martinez-
Lozada et al., 2014), while GS in myelinating cells may regulate cell differentiation and 
promote myelination (Saitoh and Araki, 2010). Furthermore, we identified components of 
the canonical Wnt signaling pathway in Tom-positive cells. Axin2 was expressed 
predominantly by NG2 cells, while no levels of Lrp5 were identified in oligodendrocytes. 
This corresponds well with the finding that Wnt signaling regulates the differentiation of 
OPCs to oligodendrocytes, as well as their subsequent maturation (Guo et al., 2015). It 
was suggested that the Wnt pathway inhibits the development of oligodendrocytes in the 
spinal cord, as it prevents OPCs from differentiation to immature oligodendrocytes 
(Shimizu et al., 2005). Another study showed that active Wnt signaling inhibits the 
differentiation of OPCs and delays oligodendrocyte development in vivo, while it does 
not interfere with OPCs proliferation (Feigenson et al., 2009). On the contrary, inhibition 
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of Wnt signaling by dnLRP6 co-receptor resulted in hypomyelination in another in vivo 
study; however, this study was conducted in zebrafish embryos (Tawk et al., 2011). 
Brain ischemia triggered the expanded differentiation potential of NG2 cells. After 
MCAO, we identified together four distinct Tom-positive cell subpopulations – BF-, OL-, 
A-, and P-NG2 cells (Figures 38 and 39), while the heterogeneity of NG2 cells after FCI 
was supported by the immunohistochemical analysis (Figure 40). The BF-NG2 cells 
subpopulation resembled NG2 cells identified in CTRL mice, while OL-NG2 cells 
expressed oligodendrocyte-commited genes. Moreover, mRNA of Tcf7l2 gene, encoding 
the Wnt-associated transcription factor Tcf4, was identified in all cells of this 
subpopulation. This finding is quite surprising and unexpected as we mentioned earlier 
that Wnt signaling probably hinders the differentiation of OPCs to oligodendrocytes 
(Shimizu et al., 2005). As a consequence, its components should not be present in OL-
NG2 cells, at least not in all cells. Nevertheless, this discrepancy can be also found in the 
literature, showing that it is still not well established whether Tcf7l2 is more highly 
expressed in NG2 cells or in differentiated oligodendrocytes during distinct 
developmental stages. For example, one work showed that Tcf7l2 is expressed in OPCs, 
but not in mature oligodendrocytes (Fancy et al., 2009), while another publication from 
the same group revealed the presence of this transcription factor in a subpopulation of 
oligodendrocytes (Fancy et al., 2011). These incompatible results might lead to a 
hypothesis that Tcf4 has also another role in oligodendroglial lineage cells. This idea can 
be supported by the fact that its role in the Wnt signaling relay can adapt another protein 
called B cell lymphoma 9 (BCL9), which is highly expressed in tumors (Takada et al., 
2012). Moreover, the impact of FCI may be another explanation of the the ubiquitous 
expression of Tcf7l2 in OL-NG2 cells. This opinion is based on the findings that OPCs 
transplanted after MCAO promoted neurological recovery via increased β-catenin 
expression (Wang et al., 2020) and that Tcf4 was not detected in normal adult white 
matter, but it was found after artificially induced demyelination in the mouse CNS (Fancy 
et al., 2009). 
The subpopulation defined by high expression of Mki67, Nes, Vim, and Pcna was 
formed by P-NG2 cells. This cell type typically arises after FCI (Honsa et al., 2012; 
Anderova et al., 2011), which was probably also the case in our experiments on NS/PCs 
in MCAO mice (Figures 32 and 34). It is worth mentioning that a large proportion of 
these cells expressed Ptch1 and Smo. Overall spread expression of these genes in the 
subpopulation may result from the need to rapidly replace lost oligodendrocytes after 
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ischemic injury, since the Shh pathway was identified as an essential factor for 
oligodendrocyte lineage development (Shimizu et al., 2005). 
The A-NG2 cells subpopulation was characterized by the highest levels of Gfap 
mRNA, while this gene was here expressed also by the highest proportion of cells among 
all Tom-positive subpopulations. Such expression pattern is a hallmark of reactive 
astrocytes (Hara et al., 2017), confirming thus that NG2 cells are able to differentiate to 
reactive astrocytes after a CNS insult (Honsa et al., 2012; Zhao et al., 2009). 
Nevertheless, their differentiation to GFAP-positive cells strongly depends on the nature 
of the injury and the ontogenetic stage (Dimou and Gallo, 2015). Additionally, we 
examined whether NG2 glia give rise to GFAP-positive cells by symmetric or asymmetric 
division, and found out that both processes occur in the ischemic CNS. This result is 
concomitant with the findings of Boda et al. (2015), who furthermore revealed that both 
intrinsic and extrinsic factors influence the heterogeneity of daughter cells. 
The distribution of the four Tom-positive NG2-glia-derived subpopulations was 
unequal at different time points after MCAO (Figure 39C). Three days after FCI, P- and 
A-NG2 cells reached their maximal incidence, while OL-NG2 cells were most abundant 
later, seven days after FCI. The BF-NG2 cells subpopulation became prevalent two weeks 
after MCAO. Tamoxifen administration just after the induction of FCI resulted in 
dominant P-NG2 cells three days after MCAO, while no A-NG2 cells were detected. 
Such a steep rise in the counts of P-NG2 cells in the early phases of ischemia was 
observed also by Honsa et al. (2012), and could signify the need for subsequent prompt 
glial scarring by A-NG2 cells to prevent ischemia-associated detrimental factors from 
entering the spared penumbral regions. The transition from P-NG2 cells to their A-NG2 
counterparts may be regulated by Shh. This hypothesis stems from our observation that 
the expression of Shh components was found predominantly in P-NG2 cells, and from the 
work of others, localizing this pathway specifically to astrocytes under physiological as 
well as pathophysiological conditions (Ugbode et al., 2017). 
For this reason, we utilized the very same transgenic mouse strain in the following 
in vitro and in vivo experiments, where we analyzed the effect of Shh signaling on the 
differentiation potential of Tom-positive NG2 glia after FCI. We observed increased 
numbers of reactive astrocytes after Shh signaling activation, while its inhibition resulted 
in the reverse effect. 
Previously, it was reported that following severe brain injury, Shh has a key role 
in the signaling among reactive glia and is probably responsible for their multipotency 
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(Sirko et al., 2013). Interestingly, this ligand is under physiological conditions released by 
neurons and maintains the non-reactive phenotypes of astrocytes (Garcia et al., 2010). 
Nevertheless, following injury to the cerebral cortex, it is reactive astrocytes what 
produces Shh, while astrocytic Shh probably promotes NG2 proliferation and the 
transition into, and maintenance of, the reactive status (Amankulor et al., 2009). To 
investigate the effect of Shh signaling in more detail, we first analyzed NG2 cells under 
physiological conditions in vitro. We observed that the majority of Tom-positive cells 
were NG2-positive (Figure 42A, B), while we also identified a relatively large population 
of oligodendrocytes and a small proportion of GFAP-positive cells (Figure 42A, E). After 
ischemia, the number of NG2 cells decreased, while the counts of GFAP-positive cells 
increased (Figure 42A, C, F). In the spinal cord, the effect of injury was similar, as 
enhanced proliferation of precursor cells was accompanied with higher incidence of 
GFAP-positive cells. Only a very few astrocytes in the cultures from uninjured animals 
were observed, while increased numbers of GFAP-positive cells were identified after 
spinal cord injury as well as after longer in vitro cultivation (Yoo and Wrathall, 2007). 
The Shh blocker Cyc increased the numbers of NG2 cells and, at the same time, the 
counts of astrocytes decreased (Figure 42A,). Conversely, the activator Shh enhanced 
differentiation to GFAP-positive cells; however, the proportion of NG2 cells remained the 
same, unlike after ischemia, which could indicate a more complex role of ischemic injury, 
perhaps due to some factors present at the site of injury. This could be manifested by the 
treatment of OPCs with neuroinflammatory interferon γ, which led to downregulation of 
PDGFαR and to the simultaneous increased generation of GFAP-positive astrocytes from 
NG2 cells (Tanner et al., 2011). The blocker Cyc suppressed the effect of Shh. The 
activator SAG had a similar effect on the differentiation as Shh (Figure 42A, D, and G). 
Next, we detected five Tom-positive subpopulations in our CTRL cultures. These 
populations were distinguished by their specific membrane properties (Table 11) and 
markers (Figure 43). We detected NG2 cells, astrocytes, oligodendrocytes, pericytes, and 
neuroblasts (or immature neurons). Their incidence was affected by ischemia and Shh 
signaling manipulation, while it copied the trends from our immunochemical analyses. 
The analysis of mRNA levels in Tom-positive cells revealed higher expression of 
Ki67, Gfap, Dcx, and Smo after FCI, mainly three and seven days after its induction 
(Figure 44B). These results might again signify that ischemia has its role in proliferation 
and differentiation of NG2 cells. Increased proliferation of NG2 cells after FCI was 
observed also in our previous experiments (Figure 39), where we also indicated, based on 
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elevated levels of Gfap, that this cell type may serve as a source for reactive astrocytes 
(Figures 39 and 41), while others reported a shortened cell cycle in NG2 cells also after 
stab wound injury (Simon et al., 2011). Moreover, the increase in Smo expression can 
indicate a role of Shh signaling in the process of polydendrocyte-to-reactive-astrocyte 
transition. Higher Smo expression was confirmed also after cortical stab wound injury 
(Sirko et al., 2013). Next, we assessed the effect of Shh signaling on polydendrocytes in 
vivo. Our belief that Shh influences differentiation of polydendrocytes preferentially to 
reactive astrocytes was nourished also in these experiments, while its role in proliferation 
of NG2 glia was rejected (Figures 45 and 46). The application of SAG to the injured 
cortex resulted in higher counts of astrocytes also in another study (Sirko et al., 2013). 
Moreover, Shh signaling was identified as a factor responsible for proliferation of 
NS/PCs and DCX-positive cells; nevertheless, its effect on NG2 cells after traumatic 
brain injury was null (Mierzwa et al., 2014). This was supported by our BrdU assay that 
revealed no Shh-signaling-induced cell proliferation in ischemic tissue (Figure 46E, F). 
Finally, in our studies on NG2 cells, we failed to identify mature neuronal cells. This is in 
agreement with some other studies (Kang et al., 2010), while there is also evidence of 
development to neurons (Geha et al., 2010). This may indicate that NG2 cells are void of 
the ability to generate this cell type, or that a synergic effect of more factors that normally 
do not coincide in vivo is required to promote the neurogenic potential of NG2 cells 
(Heinrich et al., 2014). 
Taken together, we documented that the generation of reactive astrocytes from 
NG2 cells is regulated by Shh signaling. Since reactive astrocytes form the glial scar, Shh 
may shape its composition and thus have a beneficial impact on the extent of ischemic 










In the present work, we assessed the differentiation potential of NS/PCs and NG2 glia. To 
follow the fate of these precursor cells under various conditions, we employed transgenic 
mice and took advantage of several laboratory methods that helped us identify changes at 
the mRNA, protein, or functional level. 
First, we analyzed the impact of Wnt signaling manipulation on differentiation of 
NS/PCs derived from neonatal mice. Since Wnt signaling was manipulated in each of the 
mouse strains slightly differently and evaluating its effect at several points of the 
signaling relay would give us a better insight into the possible molecular mechanisms 
underlying NS/PCs differentiation, we could not exclude any of them from further 
experiments (Hypothesis 1, Aim 1). Furthermore, our results showed that canonical Wnt 
signaling affects the fate of neonatal NS/PCs, as it influenced the incidence of distinct cell 
types differentiated from NS/PCs, as well as their electrophysiological properties. We 
concluded that Wnt signaling in neonatal mice promotes neurogenesis at the expense of 
gliogenesis (Hypothesis 1, Aim 2). 
Next, we assessed NS/PCs isolated from the adult mouse brain and found out that 
under physiological conditions, the Wnt/β-catenin pathway influences differentiation of 
these cells to a lesser extent as we failed to detect any changes in the cell incidence. 
Nevertheless, we observed alterations in the expression of cell-type-specific proteins 
(Hypothesis 1, Aim 2). On the other hand, the effect of Wnt signaling was stronger after 
the induction of FCI. The alterations in the incidence of distinct cell types resembled the 
changes we identified in neonatal mice, while the effect of the Wnt pathway was 
particularly evident in Dkk1 mice. Our immunohistochemical analysis revealed overall 
higher expression of cell-type-specific markers after MCAO, together with the abundance 
of proliferating and neuron-like precursors after Wnt signaling hyper-activation 
(Hypothesis 2, Aim 3). 
Finally, we evaluated the differentiation potential of NG2 glia and confirmed that 
under physiological conditions, they give rise predominantly to oligodendrocytes, and 
that this transition is probably inhibited by Wnt signaling. However, after the induction of 
ischemia, NG2 cells started to proliferate and acquired a multipotent phenotype. As a 
result, they differentiated mainly to astrocytes and oligodendrocytes. Moreover, we found 
that the generation of reactive astrocytes from NG2 glia is regulated by Shh signaling 
(Hypothesis 3, Aim 4). 
131 
Taken together, cellular signaling pathways have a substantial impact on the fate 
of neural precursor cells in the postnatal mouse brain. In healthy tissue, they exert their 
functions in proliferation and differentiation. Additionally, ischemic injury also affects 
the differentiation potential of NS/PCs and NG2 cells, as it induces their multipotency. 
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